[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 1649 Reported in Senate (RS)]

                                                       Calendar No. 705
111th CONGRESS
  2d Session
                                S. 1649

                          [Report No. 111-377]

To prevent the proliferation of weapons of mass destruction, to prepare 
 for attacks using weapons of mass destruction, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           September 8, 2009

 Mr. Lieberman (for himself, Ms. Collins, Mrs. McCaskill, Mr. Bennett, 
and Mr. Bennet) introduced the following bill; which was read twice and 
referred to the Committee on Homeland Security and Governmental Affairs

                           December 17, 2010

              Reported by Mr. Lieberman, with an amendment
 [Strike out all after the enacting clause and insert the part printed 
                               in italic]

_______________________________________________________________________

                                 A BILL


 
To prevent the proliferation of weapons of mass destruction, to prepare 
 for attacks using weapons of mass destruction, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

<DELETED>SECTION 1. SHORT TITLE; AND TABLE OF CONTENTS.</DELETED>

<DELETED>    (a) Short Title.--This Act may be cited as the ``Weapons 
of Mass Destruction Prevention and Preparedness Act of 2009'' or the 
``WMD Prevention and Preparedness Act of 2009''.</DELETED>
<DELETED>    (b) Table of Contents.--The table of contents is as 
follows:</DELETED>

<DELETED>Sec. 1. Short title; and table of contents.
                 <DELETED>TITLE I--ENHANCED BIOSECURITY

<DELETED>Sec. 101. Designation of Tier I agents.
<DELETED>Sec. 102. Enhanced biosecurity measures.
<DELETED>Sec. 103. Laboratory and facility registration and database.
<DELETED>Sec. 104. Background checks.
<DELETED>Sec. 105. Biological laboratory protection.
<DELETED>Sec. 106. Biosecurity information sharing.
   <DELETED>TITLE II--RESPONSE TO A WEAPON OF MASS DESTRUCTION ATTACK

<DELETED>Subtitle A--Ensuring Access to Medical Countermeasures During 
                              Emergencies

<DELETED>Sec. 201. National Medical Countermeasure Dispensing Strategy.
<DELETED>Sec. 202. Tailoring of the national medical countermeasure 
                            dispensing strategy.
<DELETED>Sec. 203. Expansion in the use of the U.S. Postal Service to 
                            deliver medical countermeasures.
<DELETED>Sec. 204. Dispensing medical countermeasures through 
                            employers.
<DELETED>Sec. 205. Personal medkits for emergency response providers.
<DELETED>Sec. 206. General public medkit pilot program.
      <DELETED>Subtitle B--Bioforensics Capabilities and Strategy

<DELETED>Sec. 211. Bioforensics capabilities and strategy.
              <DELETED>Subtitle C--Communications Planning

<DELETED>Sec. 221. Communications planning.
<DELETED>Sec. 222. Plume modeling.
   <DELETED>TITLE III--INTERNATIONAL MEASURES TO PREVENT BIOLOGICAL 
                               TERRORISM

 <DELETED>Subtitle A--Prevention and Protection Against International 
                           Biological Threats

<DELETED>Sec. 301. International Threat Assessment: Tier I Pathogen 
                            Facilities.
<DELETED>Sec. 302. Strengthening international biosecurity.
<DELETED>Sec. 303. Promoting secure biotechnology advancement.
           <DELETED>Subtitle B--Global Pathogen Surveillance

<DELETED>Sec. 321. Short title.
<DELETED>Sec. 322. Findings; purpose.
<DELETED>Sec. 323. Definitions.
<DELETED>Sec. 324. Eligibility for assistance.
<DELETED>Sec. 325. Restriction.
<DELETED>Sec. 326. Fellowship program.
<DELETED>Sec. 327. In-country training in laboratory techniques and 
                            disease and syndrome surveillance.
<DELETED>Sec. 328. Assistance for the purchase and maintenance of 
                            public health laboratory equipment and 
                            supplies.
<DELETED>Sec. 329. Assistance for improved communication of public 
                            health information.
<DELETED>Sec. 330. Assignment of public health personnel to United 
                            States missions and international 
                            organizations.
<DELETED>Sec. 331. Expansion of certain United States Government 
                            laboratories abroad.
<DELETED>Sec. 332. Assistance for international health networks and 
                            expansion of Field Epidemiology Training 
                            Programs.
<DELETED>Sec. 333. Reports.
<DELETED>Sec. 334. Authorization of appropriations.
               <DELETED>TITLE IV--GOVERNMENT ORGANIZATION

<DELETED>Sec. 401. Intelligence on weapons of mass destruction.
<DELETED>Sec. 402. Intelligence community language capabilities and 
                            cultural knowledge.
<DELETED>Sec. 403. Counterterrorism technology assessments.
     <DELETED>TITLE V--EMERGENCY MANAGEMENT AND CITIZEN ENGAGEMENT

<DELETED>Sec. 501. Communication of threat information and alerts.
<DELETED>Sec. 502. Guidelines concerning weapons of mass destruction.
<DELETED>Sec. 503. Individual and community preparedness.

            <DELETED>TITLE I--ENHANCED BIOSECURITY</DELETED>

<DELETED>SEC. 101. DESIGNATION OF TIER I AGENTS.</DELETED>

<DELETED>    (a) Amendments to the Public Health Service Act.--Section 
351A of the Public Health Service Act (42 U.S.C. 262a) is amended--
</DELETED>
        <DELETED>    (1) in subsection (a)--</DELETED>
                <DELETED>    (A) by redesignating paragraph (2) as 
                paragraph (3);</DELETED>
                <DELETED>    (B) by inserting after paragraph (1) the 
                following:</DELETED>
        <DELETED>    ``(2) Tier i agents.--</DELETED>
                <DELETED>    ``(A) Designation of tier i agents.--
                </DELETED>
                        <DELETED>    ``(i) In general.--Not later than 
                        180 days after the date of enactment of the 
                        Weapons of Mass Destruction Prevention and 
                        Preparedness Act of 2009, the Secretary, in 
                        coordination with the Secretary of Homeland 
                        Security, shall designate as `Tier I agents' 
                        those agents and toxins--</DELETED>
                                <DELETED>    ``(I) for which the 
                                Secretary of Homeland Security has 
                                issued a Material Threat Determination 
                                under section 319F-2(c)(2) regarding 
                                the agent or toxin, unless the 
                                Secretary of Health and Human Services 
                                determines, in coordination with the 
                                Secretary of Homeland Security, that 
                                such inclusion is unwarranted; 
                                or</DELETED>
                                <DELETED>    ``(II) that meet the 
                                criteria under subparagraph 
                                (B).</DELETED>
                        <DELETED>    ``(ii) Inclusion in the select 
                        agent program of agents and toxins subject to a 
                        material threat determination.--Not later than 
                        60 days after the Secretary designates as a 
                        Tier I agent an agent or toxin for which the 
                        Secretary of Homeland Security has issued a 
                        Material Threat Determination under section 
                        319F-2(c)(2), the Secretary shall ensure that 
                        such agent or toxin is included in the list 
                        maintained by the Secretary under the Select 
                        Agent Program under paragraph (1).</DELETED>
                <DELETED>    ``(B) Criteria.--In determining whether to 
                designate an agent or toxin as a Tier I agent under 
                subparagraph (A), the Secretary, in coordination with 
                the Secretary of Homeland Security, shall consider--
                </DELETED>
                        <DELETED>    ``(i) whether the agent or toxin 
                        has significant potential to be used 
                        effectively in a biological attack;</DELETED>
                        <DELETED>    ``(ii) whether the risk posed by 
                        the agent or toxin requires additional 
                        biosecurity measures, beyond those required 
                        under subsection (b), to prevent misuse 
                        domestically or abroad;</DELETED>
                        <DELETED>    ``(iii) information available from 
                        any biological or bioterrorism risk assessments 
                        conducted by the Department of Homeland 
                        Security or other relevant assessments by other 
                        departments or the intelligence community; 
                        and</DELETED>
                        <DELETED>    ``(iv) such other criteria and 
                        information that the Secretary determines 
                        appropriate and relevant.</DELETED>
                <DELETED>    ``(C) Inclusion of agents and toxins not 
                previously listed.--If the Secretary designates as a 
                Tier 1 agent an agent or toxin that has not been 
                included in the list maintained by the Secretary under 
                the Select Agent Program under paragraph (1), the 
                Secretary shall include such agent or toxin in such 
                list not later than 60 days after the designation of 
                the agent or toxin as a Tier I agent.</DELETED>
                <DELETED>    ``(D) Evaluation of tier i agents.--The 
                Secretary, in coordination with the Secretary of 
                Homeland Security, shall--</DELETED>
                        <DELETED>    ``(i) on an ongoing basis, 
                        consider the inclusion of additional agents or 
                        toxins on the list of Tier I agents, as 
                        appropriate; and</DELETED>
                        <DELETED>    ``(ii) at least biennially, review 
                        the list of Tier I agents to determine whether 
                        any agents or toxins should be removed from the 
                        list.''; and</DELETED>
                <DELETED>    (C) in paragraph (3), as redesignated, by 
                striking ``list under paragraph (1)'' and inserting 
                ``lists under paragraphs (1) and (2)''; and</DELETED>
        <DELETED>    (2) in subsection (l), by adding at the end the 
        following:</DELETED>
        <DELETED>    ``(9) The term `Tier I overlap agent' means a 
        biological agent or toxin that--</DELETED>
                <DELETED>    ``(A) is listed pursuant to subsection 
                (a)(2); and</DELETED>
                <DELETED>    ``(B) is listed pursuant to section 
                212(a)(2) of the Agricultural Bioterrorism Protection 
                Act of 2002.''.</DELETED>
<DELETED>    (b) Amendments to the Agricultural Bioterrorism Protection 
Act of 2002.--Section 212(a) of the Agricultural Bioterrorism 
Protection Act of 2002 (7 U.S.C. 8401(a)) is amended--</DELETED>
        <DELETED>    (1) by redesignating paragraph (2) as paragraph 
        (3);</DELETED>
        <DELETED>    (2) by inserting after paragraph (1) the 
        following:</DELETED>
        <DELETED>    ``(2) Tier i agents.--</DELETED>
                <DELETED>    ``(A) Designation of tier i agents.--
                </DELETED>
                        <DELETED>    ``(i) In general.--Not later than 
                        180 days after the date of enactment of the 
                        Weapons of Mass Destruction Prevention and 
                        Preparedness Act of 2009, the Secretary, in 
                        coordination with the Secretary of Homeland 
                        Security, shall designate as `Tier I agents' 
                        those agents and toxins--</DELETED>
                                <DELETED>    ``(I) for which the 
                                Secretary of Homeland Security has 
                                issued a Material Threat Determination 
                                under section 319F-2(c)(2) of the 
                                Public Health Service Act (42 U.S.C. 
                                247d-6b(c)(2)) regarding the agent or 
                                toxin, unless the Secretary of 
                                Agriculture determines, in coordination 
                                with the Secretary of Homeland 
                                Security, that such inclusion is 
                                unwarranted; or</DELETED>
                                <DELETED>    ``(II) that meet the 
                                criteria under subparagraph 
                                (B).</DELETED>
                        <DELETED>    ``(ii) Inclusion in the select 
                        agent program of agents and toxins subject to a 
                        material threat determination.--Not later than 
                        60 days after the Secretary designates as a 
                        Tier 1 agent an agent or toxin for which the 
                        Secretary of Homeland Security has issued such 
                        Material Threat Determination under section 
                        319F-2(c)(2) of the Public Health Service Act 
                        (42 U.S.C. 247d-6b(c)(2)), the Secretary shall 
                        ensure that such agent or toxin is included in 
                        the list maintained by the Secretary under the 
                        Select Agent Program under paragraph 
                        (1).</DELETED>
                <DELETED>    ``(B) Criteria.--In determining whether to 
                designate an agent or toxin as a Tier I agent under 
                subparagraph (A), the Secretary, in coordination with 
                the Secretary of Homeland Security, shall consider--
                </DELETED>
                        <DELETED>    ``(i) whether the agent or toxin 
                        has significant potential to be used 
                        effectively in a biological attack;</DELETED>
                        <DELETED>    ``(ii) whether the risk posed by 
                        the agent or toxin requires additional 
                        biosecurity measures, beyond those required 
                        under subsection (b), to prevent misuse 
                        domestically or abroad;</DELETED>
                        <DELETED>    ``(iii) information available from 
                        any biological or bioterrorism risk assessments 
                        conducted by the Department of Homeland 
                        Security or other relevant assessments by other 
                        agencies or departments; and</DELETED>
                        <DELETED>    ``(iv) such other criteria and 
                        information that the Secretary determines 
                        appropriate and relevant.</DELETED>
                <DELETED>    ``(C) Inclusion of agents and toxins not 
                previously listed.--If the Secretary designates as a 
                Tier 1 agent an agent or toxin that has not been 
                included in the list maintained by the Secretary under 
                paragraph (1), the Secretary shall include such agent 
                or toxin in such list no later than 60 days after the 
                designation of the agent or toxin as a Tier I 
                agent.</DELETED>
                <DELETED>    ``(D) Evaluation of tier i agents.--The 
                Secretary, in coordination with the Secretary of 
                Homeland Security, shall--</DELETED>
                        <DELETED>    ``(i) on an ongoing basis, 
                        consider the inclusion of additional agents or 
                        toxins on the list of Tier I agents, as 
                        appropriate; and</DELETED>
                        <DELETED>    ``(ii) at least biennially, review 
                        the list of Tier I agents to determine whether 
                        any agents or toxins should be removed from the 
                        list.''; and</DELETED>
        <DELETED>    (3) by striking ``list under paragraph (1)'' and 
        inserting ``lists under paragraphs (1) and (2)''.</DELETED>

<DELETED>SEC. 102. ENHANCED BIOSECURITY MEASURES.</DELETED>

<DELETED>    (a) In General.--Title III of the Homeland Security Act (6 
U.S.C. 181 et seq.) is amended by adding at the end the 
following:</DELETED>

<DELETED>``SEC. 318. ENHANCED BIOSECURITY MEASURES.</DELETED>

<DELETED>    ``(a) Definitions.--In this section:</DELETED>
        <DELETED>    ``(1) Agent or toxin.--The term `agent or toxin' 
        means an agent or toxin regulated under section 351A(a)(1) of 
        the Public Health Service Act or section 212(a)(1) of the 
        Agricultural Bioterrorism Protection Act of 2002.</DELETED>
        <DELETED>    ``(2) Tier i agent.--The term `Tier I agent' means 
        an agent or toxin so designated under section 351A(a)(2) of the 
        Public Health Service Act or section 212(a)(2) of the 
        Agricultural Bioterrorism Protection Act of 2002.</DELETED>
<DELETED>    ``(b) Regulations.--The Secretary, in consultation with 
the Secretary of Health and Human Services and the Secretary of 
Agriculture, shall through a negotiated rulemaking under subchapter III 
of chapter 5 of title 5, United States Code, establish enhanced 
biosecurity measures for entities registered under section 351A(d) of 
the Public Health Service Act (42 U.S.C. 262a(d)) to use in handling 
Tier I agents, which shall include--</DELETED>
        <DELETED>    ``(1) standards for personnel reliability 
        programs;</DELETED>
        <DELETED>    ``(2) standards for training and requirements for 
        responsible officials, lab personnel, and support personnel 
        employed by entities registered under section 351A(d) of the 
        Public Health Service Act (42 U.S.C. 262a(d));</DELETED>
        <DELETED>    ``(3) standards for performing laboratory risk 
        assessments;</DELETED>
        <DELETED>    ``(4) risk-based laboratory security performance 
        standards;</DELETED>
        <DELETED>    ``(5) any other standards determined necessary by 
        the Secretary; and</DELETED>
        <DELETED>    ``(6) procedures, with appropriate restrictions on 
        access, for sharing information, including vulnerability 
        assessments, site security plans, and other security related 
        information, as the Secretary determines appropriate, with 
        State, local, and tribal government officials, including law 
        enforcement officials and emergency response 
        providers.</DELETED>
<DELETED>    ``(c) Negotiated Rulemaking Committee.--The negotiated 
rulemaking committee established by the Secretary under subsection (b) 
shall include representatives from--</DELETED>
        <DELETED>    ``(1) the Department, including the Office of 
        Intelligence and Analysis, Office of Infrastructure Protection, 
        Science and Technology Directorate, and Office of Health 
        Affairs;</DELETED>
        <DELETED>    ``(2) the Department of Health and Human Services, 
        including the Centers for Disease Control and 
        Prevention;</DELETED>
        <DELETED>    ``(3) the Department of Agriculture, including the 
        Animal and Plant Health Inspection Service;</DELETED>
        <DELETED>    ``(4) the Department of Defense;</DELETED>
        <DELETED>    ``(5) the Federal Bureau of 
        Investigation;</DELETED>
        <DELETED>    ``(6) for profit research institutions;</DELETED>
        <DELETED>    ``(7) academic research institutions;</DELETED>
        <DELETED>    ``(8) nonprofit research institutions; 
        and</DELETED>
        <DELETED>    ``(9) other interested parties, as the Secretary 
        determines appropriate.</DELETED>
<DELETED>    ``(d) Time Requirement.--The procedures for the negotiated 
rulemaking conducted under subsection (b) shall be conducted in a 
timely manner to ensure that--</DELETED>
        <DELETED>    ``(1) any recommendations with respect to proposed 
        regulations are provided to the Secretary not later than 6 
        months after the date of enactment of this section; 
        and</DELETED>
        <DELETED>    ``(2) a final rule is promulgated not later than 
        12 months after the date of enactment of this 
        section.</DELETED>
<DELETED>    ``(e) Factors To Be Considered.--In developing proposed 
and final standards under subsection (b), the Secretary and the 
negotiated rulemaking committee shall consider factors including--
</DELETED>
        <DELETED>    ``(1) the recommendations of the Commission on the 
        Prevention of Weapons of Mass Destruction Proliferation and 
        Terrorism (established under section 1851 of the Implementing 
        Recommendations of the 9/11 Commission Act of 2007 (Public Law 
        110-53; 121 Stat. 501)), the National Science Advisory Board 
        for Biosecurity (established under section 205 of the Pandemic 
        and All-Hazards Preparedness Act (Public Law 109-417; 120 Stat. 
        2851)), the Trans-Federal Task Force on Optimizing Biosafety 
        and Biocontainment Oversight, and any working group established 
        under Executive Order 13486 (74 Fed. Reg. 2289) relating to 
        strengthening laboratory biosecurity; and</DELETED>
        <DELETED>    ``(2) how any disincentives to biological research 
        arising from enhanced biosecurity measures can be 
        minimized.</DELETED>
<DELETED>    ``(f) Implementation of Enhanced Biosecurity Measures.--
</DELETED>
        <DELETED>    ``(1) In general.--Each registered entity that 
        works with Tier I agents shall establish procedures that meet 
        or exceed the standards promulgated under subsection 
        (b).</DELETED>
        <DELETED>    ``(2) Training standards.--The Secretary of Health 
        and Human Services, in consultation with the Secretary, shall 
        accredit training programs that meet the standards promulgated 
        under subsection (b).</DELETED>
        <DELETED>    ``(3) Personnel reliability programs.--The 
        Secretary, in consultation with, where appropriate, the 
        Secretary of Health and Human Services and the Secretary of 
        Agriculture, shall evaluate and ensure the implementation of, 
        and compliance with, personnel reliability programs at 
        laboratories that handle Tier I agents developed under the 
        regulations promulgated under subsection (b).</DELETED>
        <DELETED>    ``(4) Risk assessments.--The Secretary, in 
        consultation with, where appropriate, the Secretary of Health 
        and Human Services and the Secretary of Agriculture, shall 
        ensure that facilities handling Tier I agents submit laboratory 
        risk assessments that comply with the standards promulgated 
        under subsection (b).</DELETED>
        <DELETED>    ``(5) Security plans.--The Secretary, in 
        consultation with, where appropriate, the Secretary of Health 
        and Human Services and the Secretary of Agriculture, shall 
        ensure that facilities handling Tier I agents submit site 
        security plans that comply with the standards promulgated under 
        subsection (b).</DELETED>
        <DELETED>    ``(6) Harmonization of regulations.--</DELETED>
                <DELETED>    ``(A) Regulations under public health 
                service act.--Not later than 120 days after the 
                Secretary promulgates regulations or amendments thereto 
                pursuant to this section, the Secretary of Health and 
                Human Services shall amend regulations promulgated 
                under the Select Agent Program under section 351A(a)(1) 
                of the Public Health Service Act (42 U.S.C. 262a(a)(1)) 
                to ensure that such regulations do not overlap or 
                conflict with the regulations promulgated by the 
                Secretary under this section.</DELETED>
                <DELETED>    ``(B) Regulations under agriculture 
                bioterrorism protection act of 2002.--Not later than 
                120 days after the Secretary promulgates regulations or 
                amendments thereto pursuant to this section, the 
                Secretary of Agriculture shall amend regulations 
                promulgated under the Select Agent Program under 
                section 212(a)(1) of the Agricultural Bioterrorism 
                Protection Act of 2002 to ensure that such regulations 
                do not overlap or conflict with the regulations 
                promulgated by the Secretary under this 
                section.</DELETED>
        <DELETED>    ``(7) Penalties.--</DELETED>
                <DELETED>    ``(A) Civil money penalty.--In addition to 
                any other penalties that may apply under law, any 
                person who violates any provision of regulations 
                promulgated under subsection (b) shall be subject to a 
                civil money penalty in an amount not exceeding $250,000 
                in the case of an individual and $500,000 in the case 
                of a laboratory handling a Tier I agent.</DELETED>
                <DELETED>    ``(B) Intermediate sanctions.--</DELETED>
                        <DELETED>    ``(i) In general.--If the 
                        Secretary determines that an individual or 
                        laboratory has violated any provision of 
                        regulations under this section, the Secretary 
                        may impose intermediate sanctions in lieu of 
                        the actions authorized by subsection 
                        (A).</DELETED>
                        <DELETED>    ``(ii) Types of sanctions.--The 
                        intermediate sanctions which may be imposed 
                        under paragraph (1) shall consist of--
                        </DELETED>
                                <DELETED>    ``(I) directed plans of 
                                correction;</DELETED>
                                <DELETED>    ``(II) civil money 
                                penalties in an amount not to exceed 
                                $10,000 for each violation of, or for 
                                each day of substantial noncompliance 
                                with, the regulations promulgated under 
                                this section;</DELETED>
                                <DELETED>    ``(III) payment for the 
                                costs of onsite monitoring; 
                                or</DELETED>
                                <DELETED>    ``(IV) any combination of 
                                the actions described in subclauses 
                                (I), (II), and (III).</DELETED>
                        <DELETED>    ``(iii) Procedures.--The Secretary 
                        shall develop and implement procedures with 
                        respect to when and how each of the 
                        intermediate sanctions is to be imposed under 
                        clause (i). Such procedures shall provide for 
                        notice to the individual or laboratory, a 
                        reasonable opportunity to respond to the 
                        proposed sanction, and appropriate procedures 
                        for appealing determinations relating to the 
                        imposition of intermediate sanctions.</DELETED>
        <DELETED>    ``(8) Simultaneous laboratory inspections.--
        </DELETED>
                <DELETED>    ``(A) Inspections by the department of 
                homeland security.--The Secretary shall inspect 
                laboratories that handle Tier I agents for compliance 
                with regulations promulgated under this 
                section.</DELETED>
                <DELETED>    ``(B) Inspections by the departments of 
                homeland security and health and human services.--Any 
                inspections of the same laboratory conducted by the 
                Secretary pursuant to this subsection and the Secretary 
                of Health and Human Services for compliance with 
                regulations promulgated under the Select Agent Program 
                under section 351A(a)(1) of the Public Health Service 
                Act shall be conducted simultaneously to the extent 
                practicable.</DELETED>
                <DELETED>    ``(C) Inspections by the departments of 
                homeland security and agriculture.--Any inspections of 
                the same laboratory conducted by the Secretary pursuant 
                to this subsection and the Secretary of Agriculture for 
                compliance with regulations promulgated under the 
                Select Agent Program under section 212(a)(1) of the 
                Agricultural Bioterrorism Protection Act of 2002 shall 
                be conducted simultaneously to the extent 
                practicable.</DELETED>
                <DELETED>    ``(D) Participation by the department of 
                defense.--To the extent practicable, the Secretary of 
                Defense shall conduct inspections simultaneously with 
                the Secretary and, as appropriate, the Secretary of 
                Health and Human Services or the Secretary of 
                Agriculture, when the Secretary of Defense conducts 
                inspections of laboratories that receive funding from 
                the Department of Defense for work with Tier I 
                agents.</DELETED>
                <DELETED>    ``(E) Joint inspection procedures.--
                Departments conducting simultaneous inspections of a 
                laboratory under this subsection shall ensure, to the 
                maximum extent practicable, that such inspections are 
                conducted using a common set of inspection procedures 
                across such departments in order to minimize the 
                administrative burden on such laboratory.</DELETED>
                <DELETED>    ``(F) Inspection reports.--Inspection 
                reports conducted under this paragraph shall be made 
                available to each Federal agency that supports select 
                agent research at the institution that is the subject 
                of the inspection report.''.</DELETED>
<DELETED>    (b) Report.--Not later than 60 days after the date of 
enactment of this Act, the Secretary of Homeland Security, the 
Secretary of Agriculture, and the Secretary of Health and Human 
Services shall jointly report to the Committee on Homeland Security and 
Governmental Affairs, the Committee on Health, Education, Labor, and 
Pensions, the Committee on Agriculture, Nutrition, and Forestry, and 
the Committee on Armed Services of the Senate and the Committee on 
Homeland Security, the Committee on Energy and Commerce, the Committee 
on Agriculture, and the Committee on Armed Services of the House of 
Representatives regarding how the Secretary of Homeland Security, the 
Secretary of Agriculture, and the Secretary of Health and Human 
Services intend to comply with the requirements under section 318 of 
the Homeland Security Act, as added by subsection (a), and shall detail 
what additional resources, if any, will be required to so 
comply.</DELETED>
<DELETED>    (c) Authorization of Appropriations.--There are authorized 
to be appropriated such sums as may be necessary to carry out this 
section and the amendments made by this section.</DELETED>
<DELETED>    (d) Technical and Conforming Amendment.--The table of 
contents in section 1(b) of the Homeland Security Act of 2002 (6 U.S.C. 
101 et seq.) is amended by inserting after the item relating to section 
317 the following:</DELETED>

<DELETED>``Sec. 318. Enhanced biosecurity measures.''.

<DELETED>SEC. 103. LABORATORY AND FACILITY REGISTRATION AND 
              DATABASE.</DELETED>

<DELETED>    (a) In General.--Section 351A of the Public Health Service 
Act (42 U.S.C. 262a) is amended--</DELETED>
        <DELETED>    (1) by redesignating subsections (f) through (m) 
        as (g) through (n) respectively; and</DELETED>
        <DELETED>    (2) by inserting after subsection (e) the 
        following:</DELETED>
<DELETED>    ``(f) Laboratory and Facility Registration and Database.--
</DELETED>
        <DELETED>    ``(1) In general.--The Secretary, in coordination 
        with the Secretary of Homeland Security and the Secretary of 
        Agriculture, shall establish and maintain a database of 
        laboratories and facilities that have sufficient potential to 
        pose a threat to public health and safety, or to animal or 
        plant health, as to require the awareness by the Federal 
        Government of the location and nature of the laboratory or 
        facility.</DELETED>
        <DELETED>    ``(2) Criteria.--</DELETED>
                <DELETED>    ``(A) In general.--The Secretary, in 
                coordination with the Secretary of Homeland Security 
                and the Secretary of Agriculture, shall by regulation 
                establish criteria defining which laboratories and 
                facilities are described in paragraph (1) and subject 
                to the requirements of this subsection.</DELETED>
                <DELETED>    ``(B) Exclusion of select agent 
                laboratories.--The criteria established under 
                subparagraph (A) shall exclude laboratories listed in 
                the national database established pursuant to 
                subsection (d)(2) of this section and section 212(d)(2) 
                of the Agricultural Bioterrorism Protection Act of 2002 
                (7 U.S.C. 8401(d)(2)).</DELETED>
                <DELETED>    ``(C) Content.--The criteria established 
                under subparagraph (A) shall include--</DELETED>
                        <DELETED>    ``(i) whether a laboratory or 
                        facility handles a biological agent or toxin 
                        designated as a Registry Agent pursuant to 
                        paragraph (4);</DELETED>
                        <DELETED>    ``(ii) whether a laboratory or 
                        facility has specified characteristics, 
                        features, or equipment that could facilitate 
                        the misuse of the laboratory or facility for 
                        the purposes of developing a biological weapon, 
                        which may include--</DELETED>
                                <DELETED>    ``(I) technology that is 
                                particularly suitable to the 
                                development of an effective biological 
                                weapon, such as technology that would 
                                enable synthesis of Tier I agents; 
                                and</DELETED>
                                <DELETED>    ``(II) features that would 
                                protect an individual developing a 
                                biological weapon from accidental 
                                exposure or discovery; and</DELETED>
                        <DELETED>    ``(iii) such other characteristics 
                        as the Secretary determines 
                        appropriate.</DELETED>
        <DELETED>    ``(3) Regulations requiring registration.--The 
        Secretary shall by regulation require the registration with the 
        Secretary of laboratories and facilities that meet the criteria 
        established pursuant to paragraph (2).</DELETED>
        <DELETED>    ``(4) Registry agents.--</DELETED>
                <DELETED>    ``(A) In general.--The Secretary, in 
                coordination with the Secretary of Agriculture and the 
                Secretary of Homeland Security, shall establish and 
                maintain by regulation a list of biological agents and 
                toxins that have the potential to pose a serious threat 
                to public, animal, or plant health but for which the 
                potential to be used effectively in a biological attack 
                has not been clearly established.</DELETED>
                <DELETED>    ``(B) Designation.--Agents listed pursuant 
                to subparagraph (A) shall be designated as `Registry 
                Agents'.</DELETED>
                <DELETED>    ``(C) Exclusion of select agents.--In 
                determining whether to designate a biological agent or 
                toxin as a Registry Agent, the Secretary shall exclude 
                agents or toxins listed pursuant to subsection (a)(1) 
                of this section and section 212(a)(1) of the 
                Agricultural Bioterrorism Protection Act of 
                2002.</DELETED>
        <DELETED>    ``(5) Penalties.--In addition to any other 
        penalties that may apply under law, any person who violates any 
        provision of this section shall be subject to the United States 
        for a civil penalty in an amount not to exceed $25,000 in the 
        case of an individual and $50,000 in the case of any other 
        person.</DELETED>
        <DELETED>    ``(6) Access to database.--The Secretary shall 
        make the database established under paragraph (1) available to 
        the Secretary of Homeland Security, the Secretary of 
        Agriculture, the Secretary of Defense, the Attorney General, 
        and such agencies as the Secretary determines 
        appropriate.</DELETED>
        <DELETED>    ``(7) Biosecurity and biosafety best practices.--
        The Secretary, in consultation with the Secretary Homeland 
        Security and the Secretary of Agriculture, shall promote 
        biosecurity and biosafety best practices to entities registered 
        under paragraph (3).''.</DELETED>
<DELETED>    (b) Revision of the List of Biological Agents and 
Toxins.--</DELETED>
        <DELETED>    (1) Review of listed agents.--</DELETED>
                <DELETED>    (A) Review by secretary of health and 
                human services.--Not later than 180 days after the 
                establishment of the list pursuant to subsection (f)(4) 
                of section 351A of the Public Health Service Act (as 
                added by subsection (a)), the Secretary of Health and 
                Human Services shall conduct a comprehensive review of 
                the list of biological agents and toxins maintained 
                pursuant to subsection (a)(1) of such section to 
                determine which listed agents and toxins more 
                accurately fit the criteria for Registry Agents (as 
                described under such subsection (f)(4)).</DELETED>
                <DELETED>    (B) Revision by secretary of 
                agriculture.--Not later than 180 days after the 
                establishment of the list pursuant to subsection (f)(4) 
                of section 351A of the Public Health Service Act (as 
                amended by subsection (a)), the Secretary of 
                Agriculture shall conduct a comprehensive review of the 
                list of biological agents and toxins maintained 
                pursuant to section 212(a)(1) of the Agricultural 
                Bioterrorism Protection Act of 2002 (7 U.S.C. 
                8401(a)(1)) to determine which listed agents and toxins 
                more accurately fit the criteria for Registry Agents 
                (as described under such subsection (f)(4)).</DELETED>
        <DELETED>    (2) Amendments to the public health service act.--
        Section 351A(a)(1)(B)(i) of the Public Health Service Act (42 
        U.S.C. 262a(a)(1)(B)(i)) is amended--</DELETED>
                <DELETED>    (A) in subclause (III), by striking ``; 
                and'' and inserting a semicolon;</DELETED>
                <DELETED>    (B) by redesignating subclause (IV) as 
                subclause (V); and</DELETED>
                <DELETED>    (C) by inserting after subclause (III) the 
                following:</DELETED>
                                <DELETED>    ``(IV) security risks 
                                identified by biological risk 
                                assessments conducted by the Department 
                                of Homeland Security, the Department of 
                                Health and Human Services, the 
                                Department of Agriculture, the 
                                Department of Defense, and other 
                                relevant agencies and entities; 
                                and''.</DELETED>
        <DELETED>    (3) Amendment to the agricultural bioterrorism 
        protection act of 2002.--Section 212(a)(1)(B)(i) of the 
        Agricultural Bioterrorism Protection Act of 2002 (7 U.S.C. 
        8401(a)(1)(B)(i)) is amended--</DELETED>
                <DELETED>    (A) in subclause (III), by striking ``; 
                and'' and inserting a semicolon;</DELETED>
                <DELETED>    (B) by redesignating subclause (IV) as 
                subclause (V); and</DELETED>
                <DELETED>    (C) by inserting after subclause (III) the 
                following:</DELETED>
                                <DELETED>    ``(IV) security risks 
                                identified by biological risk 
                                assessments conducted by the Department 
                                of Homeland Security, the Department of 
                                Health and Human Services, the 
                                Department of Agriculture, the 
                                Department of Defense, and other 
                                relevant agencies and entities; 
                                and''.</DELETED>
<DELETED>    (c) Report.--Not later than 270 days after the date of 
enactment of this Act, the Secretary of Health and Human Services, in 
coordination with the Secretary Homeland Security and the Secretary of 
Agriculture, shall report to the Committee on Homeland Security and 
Governmental Affairs, the Committee on Health, Education, Labor, and 
Pensions, the Committee on Agriculture, Nutrition, and Forestry, and 
the Committee on Armed Services of the Senate, and to the Committee on 
Homeland Security, the Committee on Energy and Commerce, the Committee 
on Agriculture, and the Committee on Armed Services of the House of 
Representatives regarding the implementation of this section.</DELETED>
<DELETED>    (d) Authorization of Appropriations.--There are authorized 
to be appropriated such sums as may be necessary to carry out this 
section.</DELETED>
<DELETED>    (e) Conforming Amendments.--</DELETED>
        <DELETED>    (1) Public health service act.--Section 351A of 
        the Public Health Service Act (42 U.S.C. 262a) is amended--
        </DELETED>
                <DELETED>    (A) in subsection (e)(7)(B)(ii) by 
                striking ``subsection (h)'' and inserting ``subsection 
                (i)'';</DELETED>
                <DELETED>    (B) in subsection (i)(1)(E), as so 
                redesignated, by striking ``subsection (f)'' and 
                inserting ``subsection (g)'';</DELETED>
                <DELETED>    (C) in subsection (k), as so redesignated, 
                by striking ``subsection (l)'' and inserting 
                ``subsection (m)''; and</DELETED>
                <DELETED>    (D) in subsection (l), as so redesignated, 
                by striking ``subsection (j)'' and inserting 
                ``subsection (k)''.</DELETED>
        <DELETED>    (2) Agricultural bioterrorism protection act of 
        2002.--Section 212(g)(1)(E) of the Agricultural Bioterrorism 
        Protection Act of 2002 (7 U.S.C. 8401(g)(1)(E)) is amended by 
        striking ``351A(g)(3)'' and inserting ``351A(h)(3)''.</DELETED>

<DELETED>SEC. 104. BACKGROUND CHECKS.</DELETED>

<DELETED>    Section 351A(e)(3)(A) of the Public Health Service Act (42 
U.S.C. 262a(e)(3)(A)) is amended by adding at the end the following: 
``In identifying whether an individual is within a category specified 
in subparagraph (B)(ii)(II), the Attorney General shall consult with 
the Secretary of Homeland Security to determine if the Department of 
Homeland Security possesses any information relevant to the 
identification of such an individual by the Attorney 
General.''.</DELETED>

<DELETED>SEC. 105. BIOLOGICAL LABORATORY PROTECTION.</DELETED>

<DELETED>    (a) Academic and Nonprofit High Containment Biological 
Laboratory Protection Grants.--</DELETED>
        <DELETED>    (1) Grants authorized.--The Secretary of Homeland 
        Security, acting through the Administrator of the Federal 
        Emergency Management Agency, may award grants to academic and 
        nonprofit organizations to implement security improvements at 
        laboratories that handle Tier I agents or toxins, as so 
        designated under section 351A(a)(2) of the Public Health 
        Service Act or section 212(a)(2) of the Agricultural 
        Bioterrorism Protection Act of 2002.</DELETED>
        <DELETED>    (2) Authorization of appropriations.--There are 
        authorized to be appropriated to the Department of Homeland 
        Security to carry out this subsection, $50,000,000 for each of 
        fiscal years 2010 through 2013.</DELETED>
<DELETED>    (b) Voluntary Vulnerability Assessments.--In carrying out 
section 201(d)(2) of the Homeland Security Act of 2002 (6 U.S.C. 
121(d)(2)), the Secretary of Homeland Security shall encourage the 
voluntary participation of laboratories working with biological agents 
and toxins, as so designated under section 351A(a)(1) of the Public 
Health Service Act (42 U.S.C. 262a(a)(1)) or section 212(a)(1) of the 
Agricultural Bioterrorism Protection Act of 2002 (7 U.S.C. 8401(a)(1)), 
commensurate with the risks such agents and toxins pose.</DELETED>

<DELETED>SEC. 106. BIOSECURITY INFORMATION SHARING.</DELETED>

<DELETED>    (a) In General.--Title III of the Homeland Security Act of 
2002 (6 U.S.C. 181 et seq.), as amended by section 102, is amended by 
adding at the end the following:</DELETED>

<DELETED>``SEC. 319. BIOSECURITY INFORMATION SHARING.</DELETED>

<DELETED>    ``(a) In General.--Consistent with the responsibilities 
under section 201(d), the Secretary shall ensure that State, local, and 
tribal governments have access to relevant safety and security 
information relating to biological laboratories and facilities in or in 
close proximity to the jurisdiction of the State, local, or tribal 
government, as the Secretary determines appropriate.</DELETED>
<DELETED>    ``(b) Access to Information in Databases.--In carrying out 
this section, the Secretary may disseminate to State, local, and tribal 
governments relevant information from the national databases 
established under subsections (d)(2) and (f)(1) of section 351A of the 
Public Health Service Act (42 U.S.C. 262a) and section 212(d)(2) of the 
Agricultural Bioterrorism Protection Act of 2002 (7 U.S.C. 
8401(d)(2)).</DELETED>
<DELETED>    ``(c) Classified and Sensitive Information.--The Secretary 
shall ensure that any information disseminated under this section is 
disseminated consistent with--</DELETED>
        <DELETED>    ``(1) the authority of the Director of National 
        Intelligence to protect intelligence sources and methods under 
        the National Security Act of 1947 (50 U.S.C. 401 et seq.) and 
        related procedures or similar authorities of the Attorney 
        General concerning sensitive law enforcement 
        information;</DELETED>
        <DELETED>    ``(2) section 552a of title 5, United States Code 
        (commonly referred to as the Privacy Act of 1974); 
        and</DELETED>
        <DELETED>    ``(3) other relevant laws.''.</DELETED>
<DELETED>    (b) Technical and Conforming Amendment.--The table of 
contents in section 1(b) of the Homeland Security Act of 2002 (6 U.S.C. 
101 et seq.) is amended by inserting after the item relating to section 
318, as added by section 102, the following:</DELETED>

<DELETED>``Sec. 319. Biosecurity information sharing.''.

      <DELETED>TITLE II--RESPONSE TO A WEAPON OF MASS DESTRUCTION 
                            ATTACK</DELETED>

<DELETED>Subtitle A--Ensuring Access to Medical Countermeasures During 
                         Emergencies</DELETED>

<DELETED>SEC. 201. NATIONAL MEDICAL COUNTERMEASURE DISPENSING 
              STRATEGY.</DELETED>

<DELETED>    Title III of the Public Health Service Act (42 U.S.C. 241 
et seq.) is amended by inserting after section 319M the 
following:</DELETED>

<DELETED>``SEC. 319N. NATIONAL MEDICAL COUNTERMEASURE DISPENSING 
              STRATEGY.</DELETED>

<DELETED>    ``(a) Definitions.--In this section--</DELETED>
        <DELETED>    ``(1) the term `appropriate committees of 
        Congress' means--</DELETED>
                <DELETED>    ``(A) the Committee on Homeland Security 
                and Governmental Affairs and the Committee on Health, 
                Education, Labor, and Pensions of the Senate; 
                and</DELETED>
                <DELETED>    ``(B) the Committee on Homeland Security, 
                the Committee on Energy and Commerce, and the Committee 
                on Oversight and Government Reform of the House of 
                Representatives;</DELETED>
        <DELETED>    ``(2) the term `dispense' means to provide 
        prophylaxis and other related medical material to an affected 
        population in response to a threat or incident; and</DELETED>
        <DELETED>    ``(3) the term `medical countermeasures' means a 
        drug or biological product used to mitigate, prevent, or treat 
        harm from any biological agent (including organisms that cause 
        an infectious disease) or toxin or chemical, radiological, or 
        nuclear threat that may cause a public health 
        emergency.</DELETED>
<DELETED>    ``(b) Strategy.--The Secretary, in coordination with the 
Secretary of Homeland Security and the Postmaster General, shall 
develop, coordinate, and maintain a National Medical Countermeasure 
Dispensing Strategy (referred to in this section as the `National MCM 
Dispensing Strategy').</DELETED>
<DELETED>    ``(c) Contents.--The National MCM Dispensing Strategy 
shall--</DELETED>
        <DELETED>    ``(1) encompass all aspects of the Federal role in 
        dispensing medical countermeasures (referred to in this section 
        as `MCMs') and describe methods by which the Federal Government 
        may assist State, local, and tribal governments to dispense 
        MCMs;</DELETED>
        <DELETED>    ``(2) address a variety of geographical areas, 
        population densities, and demographics;</DELETED>
        <DELETED>    ``(3) create a multilayered approach for the 
        dispensing of MCMs that includes redundancies;</DELETED>
        <DELETED>    ``(4) address--</DELETED>
                <DELETED>    ``(A) a staffing plan for dispensing MCMs, 
                including--</DELETED>
                        <DELETED>    ``(i) for MCM dispensing 
                        locations; and</DELETED>
                        <DELETED>    ``(ii) for dispensing through the 
                        United States Postal Service;</DELETED>
                <DELETED>    ``(B) requirements for timeliness of MCM 
                dispensing;</DELETED>
                <DELETED>    ``(C) appropriateness, effectiveness, and 
                efficiency of differing methods of MCM 
                dispensing;</DELETED>
                <DELETED>    ``(D) measures and evaluations of MCM 
                dispensing effectiveness and efficiency;</DELETED>
                <DELETED>    ``(E) liability issues associated with MCM 
                dispensing, considering--</DELETED>
                        <DELETED>    ``(i) the volunteer 
                        force;</DELETED>
                        <DELETED>    ``(ii) medical 
                        personnel;</DELETED>
                        <DELETED>    ``(iii) potential adverse 
                        reactions to medications;</DELETED>
                        <DELETED>    ``(iv) participating employees of 
                        the United States Postal Service; and</DELETED>
                        <DELETED>    ``(v) security 
                        personnel;</DELETED>
                <DELETED>    ``(F) security issues, including--
                </DELETED>
                        <DELETED>    ``(i) partnerships with law 
                        enforcement; and</DELETED>
                        <DELETED>    ``(ii) necessary levels of 
                        security to protect MCM dispensing locations 
                        and related personnel, participating employees 
                        of the United States Postal Service, and 
                        transportation of MCMs;</DELETED>
                <DELETED>    ``(G) communications issues, including--
                </DELETED>
                        <DELETED>    ``(i) communications between the 
                        Federal, State, local, and tribal government 
                        officials that may be involved in dispensing 
                        MCMs;</DELETED>
                        <DELETED>    ``(ii) communications between the 
                        government and private sector; and</DELETED>
                        <DELETED>    ``(iii) the creation of 
                        prescripted public message statements informing 
                        people how they can acquire MCMs;</DELETED>
                <DELETED>    ``(H) transportation of MCMs to dispensing 
                locations;</DELETED>
                <DELETED>    ``(I) implementation and operations of 
                dispensing plans;</DELETED>
                <DELETED>    ``(J) necessary levels of Federal 
                technical assistance in developing MCM dispensing 
                capabilities; and</DELETED>
                <DELETED>    ``(K) any other topics that the Secretary 
                determines appropriate;</DELETED>
        <DELETED>    ``(5) in coordination with the Secretary of 
        Homeland Security, include a plan to develop a pre-incident 
        public information campaign that will inform the public of--
        </DELETED>
                <DELETED>    ``(A) personal preparedness for a 
                biological attack or naturally occurring disease 
                outbreak;</DELETED>
                <DELETED>    ``(B) options for obtaining 
                MCMs;</DELETED>
                <DELETED>    ``(C) options for receiving medical care 
                during a public health emergency; and</DELETED>
                <DELETED>    ``(D) any other issues that the Secretary 
                determines appropriate; and</DELETED>
        <DELETED>    ``(6) be exercised regularly in various 
        jurisdictions.</DELETED>
<DELETED>    ``(d) Coordination.--Where appropriate, the Secretary, in 
coordination with the Secretary of Homeland Security and the Postmaster 
General, shall coordinate with State, local, and tribal government 
officials, private sector, and nongovernmental organizations in 
development of the National MCM Dispensing Strategy.</DELETED>
<DELETED>    ``(e) Reports to Congress.--</DELETED>
        <DELETED>    ``(1) In general.--The Secretary, in coordination 
        with the Secretary of Homeland Security and the Postmaster 
        General, shall--</DELETED>
                <DELETED>    ``(A) not later than 180 days after the 
                date of enactment of this section, submit the National 
                MCM Dispensing Strategy to the appropriate committees 
                of Congress; and</DELETED>
                <DELETED>    ``(B) not later than 180 days after the 
                submission of the Strategy under subparagraph (A), 
                submit an implementation plan for such Strategy to the 
                appropriate committees of Congress.</DELETED>
        <DELETED>    ``(2) Status report.--Not later than 1 year after 
        the submission of the implementation plan under paragraph 
        (1)(B), the Secretary, in coordination with the Secretary of 
        Homeland Security and the Postmaster General, shall submit to 
        the appropriate committees of Congress a report describing the 
        status of the activities taken pursuant to the implementation 
        plan.''.</DELETED>

<DELETED>SEC. 202. TAILORING OF THE NATIONAL MEDICAL COUNTERMEASURE 
              DISPENSING STRATEGY.</DELETED>

<DELETED>    (a) In General.--</DELETED>
        <DELETED>    (1) Plans.--The Secretary of Health and Human 
        Services, in coordination with the Secretary of Homeland 
        Security and, where appropriate, the Postmaster General, shall 
        tailor the National MCM Dispensing Strategy established under 
        section 319N of the Public Health Service Act (as added by 
        section 201) for--</DELETED>
                <DELETED>    (A) Cities Readiness Initiative 
                jurisdictions and other densely populated metropolitan 
                areas deemed at highest risk of being the target of a 
                terrorist attack;</DELETED>
                <DELETED>    (B) representative localities of varying 
                geographic sizes, population densities, and 
                demographics; and</DELETED>
                <DELETED>    (C) any other unique or specific local 
                needs the Secretary of Health and Human Services deems 
                appropriate.</DELETED>
        <DELETED>    (2) Consultation with state, local, and tribal 
        governments.--In fulfilling the requirements of paragraph (1), 
        the Secretary of Health and Human Services, in coordination 
        with the Secretary of Homeland Security and, where appropriate, 
        the Postmaster General, shall consult with State, local, and 
        tribal officials.</DELETED>
        <DELETED>    (3) Review.--The Secretary of Homeland Security, 
        during and in conjunction with the creation of tailored 
        National MCM Dispensing Strategy plans under paragraph (1), 
        shall--</DELETED>
                <DELETED>    (A) provide a review of transportation and 
                logistics capabilities for moving medical 
                countermeasures from State, local, and tribal 
                receiving, staging, and storing sites to dispensing 
                locations;</DELETED>
                <DELETED>    (B) review security plans and capabilities 
                for protecting transportation of medical 
                countermeasures and dispensing locations;</DELETED>
                <DELETED>    (C) work in coordination with the 
                Postmaster General to review security for protecting 
                United States Postal Service employees performing 
                dispensing;</DELETED>
                <DELETED>    (D) assist State, local, and tribal 
                governments in building partnerships with law 
                enforcement to perform security for medical 
                countermeasure transportation and dispensing;</DELETED>
                <DELETED>    (E) assist State, local, and tribal 
                governments in working with emergency response 
                providers to create appropriate roles for their 
                participation in the tailored Strategy plans; 
                and</DELETED>
                <DELETED>    (F) determine other assistance that may be 
                offered to State, local, and tribal governments with 
                respect to logistics, transportation, security, or 
                other issues that the Secretary of Homeland Security 
                determines appropriate.</DELETED>
<DELETED>    (b) Definition.--In this section, the term ``emergency 
response provider'' has the meaning given that term in section 2 of the 
Homeland Security Act of 2002 (6 U.S.C. 101).</DELETED>

<DELETED>SEC. 203. EXPANSION IN THE USE OF THE U.S. POSTAL SERVICE TO 
              DELIVER MEDICAL COUNTERMEASURES.</DELETED>

<DELETED>    (a) In General.--The Secretary of Health and Human 
Services, in coordination with the Postmaster General and the Secretary 
of Homeland Security, shall expand existing pilot programs to utilize 
the United States Postal Service to deliver medical countermeasures in 
a public health emergency.</DELETED>
<DELETED>    (b) Timeline.--The Postmaster General shall increase the 
ability of the United States Postal Service to deliver medical 
countermeasures to homes in--</DELETED>
        <DELETED>    (1) 5 additional Cities Readiness Initiative 
        jurisdictions not later than 1 year after the date of enactment 
        of this Act; and</DELETED>
        <DELETED>    (2) 15 additional Cities Readiness Initiative 
        jurisdictions not later than 2 years after the date of 
        enactment of this Act.</DELETED>
<DELETED>    (c) USPS Medkits.--The Secretary of Health and Human 
Services, in coordination with the Postmaster General and the Secretary 
of Homeland Security, shall, on a biennial basis, reevaluate the 
contents of medkits provided to enrolled United States Postal Service 
employees under the U.S. Postal Service Dispensing Plan.</DELETED>
<DELETED>    (d) Content Consideration.--In establishing the 
appropriate contents for medkits under subsection (c), the Secretary of 
Health and Human Services shall--</DELETED>
        <DELETED>    (1) consider information available from any 
        biological or bioterrorism risk assessments conducted by the 
        Department of Homeland Security or other relevant assessments 
        by other departments or the intelligence community;</DELETED>
        <DELETED>    (2) consider the criteria described in section 
        351A(a)(1)(B) of the Public Health Service Act (42 U.S.C. 
        262a(a)(1)(B));</DELETED>
        <DELETED>    (3) consult with private and public organizations, 
        as appropriate; and</DELETED>
        <DELETED>    (4) consider such other criteria and information 
        that the Secretary of Health and Human Services and the 
        Secretary of Homeland Security determine appropriate.</DELETED>
<DELETED>    (e) Report.--Not later than 18 months after the date of 
enactment of this Act, the Secretary of Health and Human Services, the 
Postmaster General, and the Secretary of Homeland Security shall submit 
to the appropriate committees of Congress a report on the 
implementation of this section.</DELETED>
<DELETED>    (f) Definitions.--In this section--</DELETED>
        <DELETED>    (1) the term ``appropriate committees of 
        Congress'' means--</DELETED>
                <DELETED>    (A) the Committee on Homeland Security and 
                Governmental Affairs and the Committee on Health, 
                Education, Labor, and Pensions of the Senate; 
                and</DELETED>
                <DELETED>    (B) the Committee on Homeland Security, 
                the Committee on Energy and Commerce, and the Committee 
                on Oversight and Government Reform of the House of 
                Representatives;</DELETED>
        <DELETED>    (2) the term ``medkit'' means a cache of 
        antibiotics and other medical countermeasures to be used during 
        a public health emergency; and</DELETED>
        <DELETED>    (3) the term ``public health emergency'' means a 
        public health emergency declared by the Secretary of Health and 
        Human Services under section 319 of the Public Health Service 
        Act (42 U.S.C. 247d).</DELETED>
<DELETED>    (g) Authorization of Appropriations.--There are authorized 
to be appropriated such sums as may be necessary to carry out this 
section.</DELETED>

<DELETED>SEC. 204. DISPENSING MEDICAL COUNTERMEASURES THROUGH 
              EMPLOYERS.</DELETED>

<DELETED>    (a) Definitions.--In this section--</DELETED>
        <DELETED>    (1) the term ``appropriate committees of 
        Congress'' means--</DELETED>
                <DELETED>    (A) the Committee on Homeland Security and 
                Governmental Affairs and the Committee on Health, 
                Education, Labor, and Pensions of the Senate; 
                and</DELETED>
                <DELETED>    (B) the Committee on Homeland Security and 
                the Committee on Energy and Commerce of the House of 
                Representatives;</DELETED>
        <DELETED>    (2) the terms ``biological agent'' and ``toxin'' 
        have the meanings given those terms in section 178 of title 18, 
        United States Code;</DELETED>
        <DELETED>    (3) the term ``covered Federal facility'' means a 
        Federal facility determined by the Secretary of Health and 
        Human Services, in coordination with the Secretary of Homeland 
        Security, to be of sufficient size, workforce level, and 
        geographic location to warrant developing a plan for receiving 
        and dispensing medical countermeasures to employees working in 
        the Federal facility;</DELETED>
        <DELETED>    (4) the term ``dispense'' means to provide 
        prophylaxis and other related medical material to an affected 
        population in response to a threat or incident; and</DELETED>
        <DELETED>    (5) the term ``medical countermeasures'' means a 
        drug or biological product used to mitigate, prevent, or treat 
        harm from any biological agent (including organisms that cause 
        an infectious disease) or toxin or chemical, radiological, or 
        nuclear threat that may cause a public health 
        emergency.</DELETED>
<DELETED>    (b) Federal Plan.--</DELETED>
        <DELETED>    (1) In general.--The head of each executive 
        agency, in consultation with the Secretary of Health and Human 
        Services and the Secretary of Homeland Security, shall develop 
        a plan to receive and dispense medical countermeasures to 
        individuals employed by the executive agency--</DELETED>
                <DELETED>    (A) if the individuals work in a covered 
                Federal facility that is likely the target, or located 
                in an area that is likely a target, of an act of 
                terrorism involving a biological agent or toxin; 
                or</DELETED>
                <DELETED>    (B) in the event of a naturally occurring 
                outbreak of an infectious disease that may result in a 
                national epidemic.</DELETED>
        <DELETED>    (2) Contents.--The plans developed under paragraph 
        (1) shall identify individuals in the covered Federal facility 
        who will be performing receiving and dispensing of medical 
        countermeasures to employees.</DELETED>
        <DELETED>    (3) Review.--The Secretary of Health and Human 
        Services, in coordination with the Secretary of Homeland 
        Security, shall review and approve the plans developed under 
        paragraph (1).</DELETED>
        <DELETED>    (4) Exercises.--On a biennial basis, the head of 
        each executive agency shall conduct exercises of the plan 
        developed by the head of the executive agency under paragraph 
        (1).</DELETED>
<DELETED>    (c) Other Employers.--The Secretary of Health and Human 
Services, in coordination with Secretary of Homeland Security, shall 
establish a set of best practices to guide and promote medical 
countermeasure dispensing capabilities among private sector 
entities.</DELETED>
<DELETED>    (d) Report.--Not later than 180 days after the date of 
enactment of this Act, the Secretary of Health and Human Services, in 
coordination with the Secretary of Homeland Security, shall submit to 
the appropriate committees of Congress a report on the implementation 
of this section.</DELETED>

<DELETED>SEC. 205. PERSONAL MEDKITS FOR EMERGENCY RESPONSE 
              PROVIDERS.</DELETED>

<DELETED>    (a) In General.--Title III of the Homeland Security Act of 
2002 (6 U.S.C. 181 et seq.), as amended by section 106, is further 
amended by adding at the end the following:</DELETED>

<DELETED>``SEC. 320. PERSONAL MEDKITS FOR EMERGENCY 
              RESPONDERS.</DELETED>

<DELETED>    ``(a) Definitions.--In this section--</DELETED>
        <DELETED>    ``(1) the term `appropriate committees of 
        Congress' means--</DELETED>
                <DELETED>    ``(A) the Committee on Homeland Security 
                and Governmental Affairs and the Committee on Health, 
                Education, Labor, and Pensions of the Senate; 
                and</DELETED>
                <DELETED>    ``(B) the Committee on Homeland Security 
                and the Committee on Energy and Commerce of the House 
                of Representatives;</DELETED>
        <DELETED>    ``(2) the term `emergency responders' means an 
        emergency response provider or an active member of a local 
        citizen preparedness organization, including Community 
        Emergency Response Teams, the Medical Reserve Corps, the Fire 
        Corps, and the citizen preparedness programs of the American 
        Red Cross;</DELETED>
        <DELETED>    ``(3) the term `immediate family member' means an 
        individual who is a cohabitating family member or domestic 
        partner;</DELETED>
        <DELETED>    ``(4) the term `medkit' means a cache of 
        antibiotics and other medical countermeasures to be used during 
        a public health emergency;</DELETED>
        <DELETED>    ``(5) the term `medkit program' means the program 
        established under subsection (b); and</DELETED>
        <DELETED>    ``(6) the term `public health emergency' means a 
        public health emergency declared by the Secretary of Health and 
        Human Services under section 319 of the Public Health Service 
        Act (42 U.S.C. 247d).</DELETED>
<DELETED>    ``(b) Establishment.--The Secretary, in coordination with 
the Secretary of Health and Human Services, shall establish a program 
to distribute medkits to emergency responders and immediate family 
members of emergency responders.</DELETED>
<DELETED>    ``(c) Medkit Program Components.--</DELETED>
        <DELETED>    ``(1) In general.--An emergency responder or 
        immediate family member of an emergency responder participating 
        in the medkit program shall--</DELETED>
                <DELETED>    ``(A) register with the 
                Secretary;</DELETED>
                <DELETED>    ``(B) before the distribution of a medkit, 
                receive training regarding--</DELETED>
                        <DELETED>    ``(i) the proper use and dosing of 
                        medical countermeasures;</DELETED>
                        <DELETED>    ``(ii) reporting of the use of a 
                        medkit;</DELETED>
                        <DELETED>    ``(iii) the proper storage of a 
                        medkit; and</DELETED>
                        <DELETED>    ``(iv) any other topic determined 
                        appropriate by the Secretary;</DELETED>
                <DELETED>    ``(C) before the distribution of a medkit, 
                undergo appropriate medical screening; and</DELETED>
                <DELETED>    ``(D) report the use of a medkit within a 
                reasonable time period, as established by the 
                Secretary.</DELETED>
        <DELETED>    ``(2) Inventory.--The Secretary shall conduct an 
        annual inventory of medkits distributed under the medkit 
        program.</DELETED>
<DELETED>    ``(d) Authorization and Contents.--</DELETED>
        <DELETED>    ``(1) In general.--The Secretary shall coordinate 
        with the Secretary of Health and Human Services and the 
        Commissioner of Food and Drugs to--</DELETED>
                <DELETED>    ``(A) seek a pre-incident emergency use 
                authorization under section 564 of the Federal Food, 
                Drug, and Cosmetic Act (21 U.S.C. 360bbb-3) to allow 
                distribution and use of medkits under the medkit 
                program; and</DELETED>
                <DELETED>    ``(B) establish the appropriate contents 
                for medkits distributed under the medkit 
                program.</DELETED>
        <DELETED>    ``(2) Content consideration.--In establishing the 
        appropriate contents for medkits under paragraph (1)(B), the 
        Secretary shall--</DELETED>
                <DELETED>    ``(A) consider information available from 
                any biological or bioterrorism risk assessments 
                conducted by the Department of Homeland Security or 
                other relevant assessments by other departments or the 
                intelligence community;</DELETED>
                <DELETED>    ``(B) consider the criteria described in 
                section 351A(a)(1)(B) of the Public Health Service Act 
                (42 U.S.C. 262a(a)(1)(B));</DELETED>
                <DELETED>    ``(C) consult with relevant private and 
                public organizations; and</DELETED>
                <DELETED>    ``(D) consider such other criteria and 
                information that the Secretary and the Secretary of 
                Health and Human Services determine 
                appropriate.</DELETED>
<DELETED>    ``(e) Report.--Not later than 180 days after the date of 
enactment of this section, the Secretary shall submit to the 
appropriate committees of Congress a report on the implementation of 
this section.</DELETED>
<DELETED>    ``(f) Authorization of Appropriations.--There are 
authorized to be appropriated such sums as may be necessary to carry 
out this section.''.</DELETED>
<DELETED>    (b) Technical and Conforming Amendment.--The table of 
contents in section 1(b) of the Homeland Security Act of 2002 (6 U.S.C. 
101 et seq.) is amended by inserting after the item relating to section 
319, as added by section 106 of this Act, the following:</DELETED>

<DELETED>``Sec. 320. Personal medkits for emergency responders.''.

<DELETED>SEC. 206. GENERAL PUBLIC MEDKIT PILOT PROGRAM.</DELETED>

<DELETED>    (a) Definitions.--In this section--</DELETED>
        <DELETED>    (1) the term ``medical countermeasures'' means a 
        drug or biological product used to mitigate, prevent, or treat 
        harm from any biological agent (including organisms that cause 
        an infectious disease) or toxin or chemical, radiological, or 
        nuclear agent that may cause a public health emergency; 
        and</DELETED>
        <DELETED>    (2) the term ``medkit'' means a cache of 
        antibiotics and other medical countermeasures to be used during 
        a public health emergency declared by the Secretary of Health 
        and Human Services under section 319 of the Public Health 
        Service Act (42 U.S.C. 247d).</DELETED>
<DELETED>    (b) Pilot Program.--The Secretary of Health and Human 
Services, in coordination with the Secretary of Homeland Security, 
shall conduct a pilot program to study the feasibility of providing 
personal medkits to the public.</DELETED>
<DELETED>    (c) Requirements.--In carrying out the pilot program, the 
Secretary of Health and Human Services, in coordination with the 
Secretary of Homeland Security, shall ensure that--</DELETED>
        <DELETED>    (1) enrollment of participants in the pilot 
        program encompasses a diverse range of municipality sizes, 
        various geographic locations, and different socioeconomic 
        statuses;</DELETED>
        <DELETED>    (2) the number of enrolled participants in the 
        program shall be expanded significantly beyond the number of 
        those enrolled in the 2006 St. Louis Medkit evaluation study, 
        conducted by the Centers for Disease Control and Prevention, to 
        at least 10,000 participants;</DELETED>
        <DELETED>    (3) the program shall evaluate the ability of 
        households to maintain medkits in the home as directed and 
        reserve for emergency use; and</DELETED>
        <DELETED>    (4) prior to obtaining a medkit, participants are 
        required to receive training regarding--</DELETED>
                <DELETED>    (A) proper use and dosing of medical 
                countermeasures;</DELETED>
                <DELETED>    (B) reporting of use of medkits;</DELETED>
                <DELETED>    (C) proper storage of medkits; 
                and</DELETED>
                <DELETED>    (D) any other information that the 
                Secretary of Health and Human Services and the 
                Secretary of Homeland Security determine 
                appropriate.</DELETED>
<DELETED>    (d) Authorization and Content.--The Secretary of Health 
and Human Services and the Secretary of Homeland Security shall 
coordinate with the Commissioner of Food and Drugs--</DELETED>
        <DELETED>    (1) to obtain an emergency use authorization under 
        section 564 of the Federal Food, Drug, and Cosmetic Act (21 
        U.S.C. 360bbb-3) to allow distribution of medkits for the 
        purpose of the pilot program; and</DELETED>
        <DELETED>    (2) to establish the appropriate contents of 
        medkits to the public for the pilot program.</DELETED>
<DELETED>    (e) Report.--</DELETED>
        <DELETED>    (1) Appropriate committees of congress.--In this 
        subsection, the term ``appropriate committees of Congress'' 
        means--</DELETED>
                <DELETED>    (A) the Committee on Homeland Security and 
                Governmental Affairs and the Committee on Health, 
                Education, Labor, and Pensions of the Senate; 
                and</DELETED>
                <DELETED>    (B) the Committee on Homeland Security and 
                the Committee on Energy and Commerce of the House of 
                Representatives.</DELETED>
        <DELETED>    (2) Report.--Not later than 90 days after 
        completion of the program under this section, the Secretary of 
        Health and Human Services, in coordination with the Secretary 
        of Homeland Security, shall submit to the appropriate 
        committees of Congress a report on the conclusions of such 
        program. The report shall include recommendations and 
        conclusions on the feasibility of creating a national medkit 
        program, through which medkits would be distributed widely to 
        the public.</DELETED>
<DELETED>    (f) Authorization of Appropriations.--There are authorized 
to be appropriated such sums as may be necessary to carry out this 
section.</DELETED>

 <DELETED>Subtitle B--Bioforensics Capabilities and Strategy</DELETED>

<DELETED>SEC. 211. BIOFORENSICS CAPABILITIES AND STRATEGY.</DELETED>

<DELETED>    (a) In General.--Title III of the Homeland Security Act of 
2002 (6 U.S.C. 181 et seq.), as amended by section 205, is further 
amended by adding at the end the following:</DELETED>

<DELETED>``SEC. 321. BIOFORENSICS CAPABILITIES AND STRATEGY.</DELETED>

<DELETED>    ``(a) Definitions.--In this section--</DELETED>
        <DELETED>    ``(1) the term `appropriate committees of 
        Congress' means--</DELETED>
                <DELETED>    ``(A) the Committee on Homeland Security 
                and Governmental Affairs, the Committee on the 
                Judiciary, the Committee on Health, Education, Labor, 
                and Pensions, the Committee on Agriculture, Nutrition, 
                and Forestry, and the Committee on Armed Services of 
                the Senate; and</DELETED>
                <DELETED>    ``(B) the Committee on Homeland Security, 
                the Committee on the Judiciary, the Committee on Energy 
                and Commerce, the Committee on Agriculture, and the 
                Committee on Armed Services of the House of 
                Representatives;</DELETED>
        <DELETED>    ``(2) the term `bioforensic' means the scientific 
        discipline dedicated to analyzing evidence from a bioterrorism 
        act, biological agent or toxin based criminal act, or 
        inadvertent biological agent or toxin release for attribution 
        purposes;</DELETED>
        <DELETED>    ``(3) the term `National Bioforensics Analysis 
        Center' means the National Bioforensics Analysis Center 
        established under subsection (b);</DELETED>
        <DELETED>    ``(4) the term `national bioforensics repository 
        collection' means the national bioforensics repository 
        collection established under subsection (c)(1); and</DELETED>
        <DELETED>    ``(5) the term `national bioforensics strategy' 
        means the national bioforensics strategy developed under 
        subsection (d)(1).</DELETED>
<DELETED>    ``(b) National Bioforensics Analysis Center.--There is in 
the Department a National Bioforensics Analysis Center which shall--
</DELETED>
        <DELETED>    ``(1) serve as the lead Federal facility to 
        conduct and facilitate bioforensic analysis in support of the 
        executive agency with primary responsibility for responding to 
        the biological incident;</DELETED>
        <DELETED>    ``(2) maintain the national bioforensics 
        repository collection as a reference collection of biological 
        agents and toxins for comparative bioforensic identifications; 
        and</DELETED>
        <DELETED>    ``(3) support threat agent characterization 
        studies and bioforensic assay development.</DELETED>
<DELETED>    ``(c) National Bioforensic Repository Collection.--
</DELETED>
        <DELETED>    ``(1) In general.--The National Bioforensics 
        Analysis Center shall maintain a national bioforensics 
        repository collection.</DELETED>
        <DELETED>    ``(2) Activities.--The national bioforensics 
        repository collection shall--</DELETED>
                <DELETED>    ``(A) receive, store, and distribute 
                biological threat agents and toxins and related 
                biological agents and toxins;</DELETED>
                <DELETED>    ``(B) serve as a reference collection for 
                comparative bioforensic identifications; and</DELETED>
                <DELETED>    ``(C) support threat agent 
                characterization studies and bioforensic assay 
                development.</DELETED>
        <DELETED>    ``(3) Participation.--</DELETED>
                <DELETED>    ``(A) In general.--The Secretary, the 
                Attorney General, the Secretary of Health and Human 
                Services, the Secretary of Agriculture, the Secretary 
                of Defense, and the head of any other appropriate 
                executive agency with a biological agent or toxin 
                collection that is useful for the bioforensic analysis 
                of biological incidents, performance of biological 
                threat agent characterization studies, or development 
                of bioforensic assays shall provide all relevant 
                biological agents and toxins, as determined by the 
                Secretary, which shall not include any variola virus, 
                to the national bioforensics repository 
                collection.</DELETED>
                <DELETED>    ``(B) Other biological agents and 
                toxins.--The Secretary shall encourage the contribution 
                of public and private biological agent and toxin 
                collections to the national bioforensics repository 
                collection that were collected or created with support 
                from a Federal grant or contract and that support the 
                functions described in paragraph (2).</DELETED>
        <DELETED>    ``(4) Access.--The Secretary shall--</DELETED>
                <DELETED>    ``(A) provide an executive agency that 
                submits a biological agent or toxin to the national 
                bioforensics repository collection with access to the 
                national bioforensics repository collection; 
                and</DELETED>
                <DELETED>    ``(B) establish a mechanism to provide 
                public and private entities with access to the national 
                bioforensics repository collection, as appropriate, for 
                academic analysis of a biological agent or toxin in the 
                national bioforensics repository collection.</DELETED>
        <DELETED>    ``(5) Report.--</DELETED>
                <DELETED>    ``(A) In general.--Not later than 180 days 
                after the date of enactment of this section, the 
                Secretary, in consultation with the Attorney General, 
                the Secretary of Health and Human Services, the 
                Secretary of Agriculture, the Secretary of Defense, and 
                the head of any other appropriate executive agency that 
                will participate in or contribute to the national 
                bioforensics repository collection, shall submit to the 
                appropriate committees of Congress a report regarding 
                the national bioforensics repository 
                collection.</DELETED>
                <DELETED>    ``(B) Contents.--The report submitted 
                under subparagraph (A) shall--</DELETED>
                        <DELETED>    ``(i) discuss the status of the 
                        establishment of the national bioforensics 
                        repository collection;</DELETED>
                        <DELETED>    ``(ii) identify domestic and 
                        international biological agent and toxin 
                        collections that would prove useful in carrying 
                        out the functions of the national bioforensics 
                        repository collection;</DELETED>
                        <DELETED>    ``(iii) examine any access or 
                        participation issues affecting the 
                        establishment of the national bioforensics 
                        repository collection or the ability to support 
                        bioforensic analysis, threat characterization 
                        studies, or bioforensic assay development, 
                        including--</DELETED>
                                <DELETED>    ``(I) intellectual 
                                property concerns;</DELETED>
                                <DELETED>    ``(II) access to collected 
                                or created biological agent or toxin 
                                collections funded by a Federal grant 
                                or contract;</DELETED>
                                <DELETED>    ``(III) costs for the 
                                national bioforensics repository 
                                collection associated with accessing 
                                domestic and international biological 
                                agent and toxin collections;</DELETED>
                                <DELETED>    ``(IV) costs incurred by 
                                domestic and international biological 
                                agent and toxin collections to allow 
                                broad access or contribute biological 
                                agents or toxins to the national 
                                bioforensics repository collection; 
                                and</DELETED>
                                <DELETED>    ``(V) access to the 
                                national bioforensics repository 
                                collection by public and private 
                                researchers to support threat 
                                characterization studies and 
                                bioforensic assay development; 
                                and</DELETED>
                        <DELETED>    ``(iv) other issues determined 
                        appropriate by the Secretary.</DELETED>
<DELETED>    ``(d) National Bioforensic Strategy.--</DELETED>
        <DELETED>    ``(1) In general.--The Secretary, in coordination 
        with the Attorney General, the Secretary of Health and Human 
        Services, the Secretary of Agriculture, the Secretary of 
        Defense, and the head of any other appropriate executive 
        agency, as determined by the Secretary, shall develop, 
        coordinate, and maintain a national bioforensics 
        strategy.</DELETED>
        <DELETED>    ``(2) Contents.--The national bioforensics 
        strategy shall--</DELETED>
                <DELETED>    ``(A) provide for a coordinated approach 
                across all executive agencies with responsibilities for 
                analyzing evidence from a bioterrorism act, biological 
                agent or toxin based criminal act, or inadvertent 
                biological agent or toxin release for attribution 
                purposes;</DELETED>
                <DELETED>    ``(B) describe the roles and 
                responsibilities of all relevant executive 
                agencies;</DELETED>
                <DELETED>    ``(C) establish mechanisms, in 
                coordination with State, local, and tribal governments, 
                for coordinating with law enforcement agencies in 
                analyzing bioforensic evidence;</DELETED>
                <DELETED>    ``(D) include guidance for collecting, 
                processing, and analyzing samples; and</DELETED>
                <DELETED>    ``(E) provide for a coordinated approach 
                across all executive agencies to support threat agent 
                characterization research, funding, and assay 
                development.</DELETED>
        <DELETED>    ``(3) Report.--Not later than 180 days after the 
        date of enactment of this section, the Secretary, in 
        consultation with the Attorney General, the Secretary of Health 
        and Human Services, the Secretary of Agriculture, the Secretary 
        of Defense, and the head of any other appropriate executive 
        agency, as determined by the Secretary, shall submit to the 
        appropriate committees of Congress the national bioforensics 
        strategy.</DELETED>
<DELETED>    ``(e) Authorization of Appropriations.--There are 
authorized to be appropriated such sums as may be necessary to carry 
out this section.''.</DELETED>
<DELETED>    (b) Technical and Conforming Amendment.--The table of 
contents in section 1(b) of the Homeland Security Act of 2002 (6 U.S.C. 
101 et seq.) is amended by inserting after the item relating to section 
320, as added by section 205 of this Act, the following:</DELETED>

<DELETED>``Sec. 321. Bioforensics capabilities and strategy.''.

         <DELETED>Subtitle C--Communications Planning</DELETED>

<DELETED>SEC. 221. COMMUNICATIONS PLANNING.</DELETED>

<DELETED>    (a) In General.--Title V of the Homeland Security Act of 
2002 (6 U.S.C. 311 et seq.) is amended by adding at the end the 
following:</DELETED>

<DELETED>``SEC. 525. COMMUNICATIONS PLANNING.</DELETED>

<DELETED>    ``(a) Incorporation of Communications Plans.--</DELETED>
        <DELETED>    ``(1) In general.--The Secretary, acting through 
        the Administrator of the Federal Emergency Management Agency, 
        shall incorporate into each operational plan developed under 
        sections 653(a)(4) and 653(b) of the Post-Katrina Emergency 
        Management Reform Act of 2006 (6 U.S.C. 701 note) a 
        communications plan for providing information to the public 
        related to preventing, preparing for, protecting against, and 
        responding to imminent natural disasters, acts of terrorism, 
        and other man-made disasters, including incidents involving the 
        use of weapons of mass destruction and other potentially 
        catastrophic events.</DELETED>
        <DELETED>    ``(2) Consultation.--In developing communications 
        plans under paragraph (1), the Administrator shall consult with 
        State, local, and tribal governments and coordinate, as the 
        Administrator considers appropriate, with other Federal 
        departments and agencies that have responsibilities under the 
        National Response Framework and other relevant Federal 
        departments and agencies.</DELETED>
<DELETED>    ``(b) Prescripted Messages and Message Templates.--
</DELETED>
        <DELETED>    ``(1) In general.--As part of the communication 
        plans, the Administrator shall develop prescripted messages or 
        message templates, as appropriate, to be included in the plans 
        to be provided to State, local, and tribal officials so that 
        those officials can quickly and rapidly disseminate critical 
        information to the public in anticipation or in the immediate 
        aftermath of a disaster or incident.</DELETED>
        <DELETED>    ``(2) Development and design.--The prescripted 
        messages or message templates shall--</DELETED>
                <DELETED>    ``(A) be developed, as the Administrator 
                determines appropriate, in consultation with State, 
                local, and tribal governments and in coordination with 
                other Federal departments and agencies that have 
                responsibilities under the National Response Framework 
                and other relevant Federal departments and 
                agencies;</DELETED>
                <DELETED>    ``(B) be designed to provide accurate, 
                essential, and appropriate information and instructions 
                to the population directly affected by a disaster or 
                incident, including information related to evacuation, 
                sheltering in place, and issues of immediate health and 
                safety; and</DELETED>
                <DELETED>    ``(C) be designed to provide accurate, 
                essential, and appropriate technical information and 
                instructions to emergency response providers and 
                medical personnel responding to a disaster or 
                incident.</DELETED>
<DELETED>    ``(c) Communications Formats.--In developing the 
prescripted messages or message templates required under subsection 
(b), the Administrator shall develop each such prescripted message or 
message template in multiple formats to ensure delivery--</DELETED>
        <DELETED>    ``(1) in cases where the usual communications 
        infrastructure is unusable as a result of the nature of a 
        disaster or incident; and</DELETED>
        <DELETED>    ``(2) to individuals with disabilities or other 
        special needs and individuals with limited English proficiency 
        in accordance with section 616 of the Post-Katrina Emergency 
        Management Reform Act of 2006 (6 U.S.C. 701 note).</DELETED>
<DELETED>    ``(d) Dissemination and Technical Assistance.--The 
Administrator shall ensure that all prescripted messages and message 
templates developed under this section are made available to State, 
local, and tribal governments so that those governments may incorporate 
them, as appropriate, into their emergency plans. The Administrator 
shall also make available relevant technical assistance to those 
governments to support communications planning.</DELETED>
<DELETED>    ``(e) Exercises.--To ensure that the prescripted messages 
or message templates developed under this section can be effectively 
utilized in a disaster or incident, the Administrator shall incorporate 
such prescripted messages or message templates into exercises conducted 
under the National Exercise Program described in section 648 of the 
Post-Katrina Emergency Management Reform Act of 2006 (6 U.S.C. 701 
note).</DELETED>
<DELETED>    ``(f) Report.--Not later than 1 year after the date of the 
enactment of this section, the Administrator shall submit to the 
Committee on Homeland Security and Governmental Affairs of the Senate 
and the Committee on Homeland Security of the House of Representatives 
a copy of the communications plans required to be developed under this 
section, including prescripted messages or message templates developed 
in conjunction with the plans and a description of the means that will 
be used to deliver such messages in a natural disaster, act of 
terrorism, or other man-made disaster.''.</DELETED>
<DELETED>    (b) Table of Contents.--The table of contents in section 
1(b) of the Homeland Security Act of 2002 (6 U.S.C. 101) is amended by 
inserting after the item relating to section 524 the 
following:</DELETED>

<DELETED>``Sec. 525. Communications planning.''.

<DELETED>SEC. 222. PLUME MODELING.</DELETED>

<DELETED>    (a) Definitions.--In this section--</DELETED>
        <DELETED>    (1) the term ``appropriate committees of 
        Congress'' means--</DELETED>
                <DELETED>    (A) the Committee on Homeland Security and 
                Governmental Affairs, the Committee on Energy and 
                Natural Resources, the Committee on Armed Services, and 
                the Committee on Health, Education, Labor, and Pensions 
                of the Senate; and</DELETED>
                <DELETED>    (B) the Committee on Homeland Security, 
                the Committee on Energy and Commerce, and the Committee 
                on Armed Services of the House of 
                Representatives;</DELETED>
        <DELETED>    (2) the term ``executive agency'' has the meaning 
        given that term in section 2 of the Homeland Security Act of 
        2002 (6 U.S.C. 101);</DELETED>
        <DELETED>    (3) the term ``integrated plume model'' means a 
        plume model that integrates protective action guidance and 
        other information as the Secretary of Homeland Security 
        determines appropriate; and</DELETED>
        <DELETED>    (4) the term ``plume model'' means the assessment 
        of the location and prediction of the spread of nuclear, 
        radioactive, or chemical fallout and biological pathogens 
        resulting from an explosion or release of nuclear, radioactive, 
        chemical, or biological substances.</DELETED>
<DELETED>    (b) Development.--</DELETED>
        <DELETED>    (1) In general.--The Secretary of Homeland 
        Security shall develop and disseminate integrated plume models 
        to enable rapid response activities following a nuclear, 
        radiological, chemical, or biological explosion or 
        release.</DELETED>
        <DELETED>    (2) Scope.--The Secretary of Homeland Security 
        shall--</DELETED>
                <DELETED>    (A) ensure the rapid development and 
                distribution of integrated plume models to appropriate 
                officials of the Federal Government and State, local, 
                and tribal governments to enable immediate response to 
                a nuclear, radiological, chemical, or biological 
                incident; and</DELETED>
                <DELETED>    (B) establish mechanisms for dissemination 
                by appropriate emergency response officials of the 
                integrated plume models described in paragraph (1) to 
                nongovernmental organizations and the public to enable 
                appropriate response activities by 
                individuals.</DELETED>
        <DELETED>    (3) Consultation with other departments and 
        agencies.--In developing the integrated plume models described 
        in this section, the Secretary of Homeland Security shall 
        consult, as appropriate, with--</DELETED>
                <DELETED>    (A) the Secretary of Energy, the Secretary 
                of Defense, the Secretary of Health and Human Services, 
                and the heads of other executive agencies determined 
                appropriate by the Secretary of Homeland Security; 
                and</DELETED>
                <DELETED>    (B) State, local, and tribal governments 
                and nongovernmental organizations.</DELETED>
<DELETED>    (c) Exercises.--The Secretary of Homeland Security shall 
ensure that the development and dissemination of integrated plume 
models are assessed during exercises administered by the Department of 
Homeland Security.</DELETED>
<DELETED>    (d) Reporting.--Not later than 180 days after the date of 
enactment of this Act, and every year thereafter, the Secretary of 
Homeland Security shall submit to the appropriate committees of 
Congress a report regarding--</DELETED>
        <DELETED>    (1) the development and dissemination of 
        integrated plume models under this section; and</DELETED>
        <DELETED>    (2) lessons learned from assessing the development 
        and dissemination of integrated plume models during exercises 
        administered by the Department of Homeland Security, and plans 
        for improving the development and dissemination of integrated 
        plume models, as appropriate.</DELETED>

   <DELETED>TITLE III--INTERNATIONAL MEASURES TO PREVENT BIOLOGICAL 
                          TERRORISM</DELETED>

 <DELETED>Subtitle A--Prevention and Protection Against International 
                      Biological Threats</DELETED>

<DELETED>SEC. 301. INTERNATIONAL THREAT ASSESSMENT: TIER I PATHOGEN 
              FACILITIES.</DELETED>

<DELETED>    (a) Review.--Not later than 6 months after the date of the 
enactment of this Act, the Director of National Intelligence, in 
coordination with the Secretary of State, the Secretary of Homeland 
Security, the Secretary of Health and Human Services, the Secretary of 
Agriculture, and the heads of other appropriate Federal agencies, shall 
complete a global review of international biological security threats 
to the United States.</DELETED>
<DELETED>    (b) Content.--The review under this section shall--
</DELETED>
        <DELETED>    (1) assess global biological risks, including by 
        describing regions or countries with the greatest biological 
        security risk, taking into account factors such as--</DELETED>
                <DELETED>    (A) the presence and capabilities of a 
                foreign terrorist organization;</DELETED>
                <DELETED>    (B) the location of highest risk pathogen 
                collections; and</DELETED>
                <DELETED>    (C) the location of biological 
                laboratories operating with inadequate security 
                measures; and</DELETED>
        <DELETED>    (2) assess any gaps in knowledge about 
        international biosecurity threats.</DELETED>
<DELETED>    (c) Updates.--The Director shall update the review under 
this section as new or revised intelligence becomes available, but not 
less frequently than biennially.</DELETED>
<DELETED>    (d) Submission of Review or Update.--Not later than 6 
months after the date of the enactment of this Act, and biennially 
thereafter, the Director shall submit the classified review or update 
to--</DELETED>
        <DELETED>    (1) the Select Committee on Intelligence of the 
        Senate;</DELETED>
        <DELETED>    (2) the Committee on Armed Services of the 
        Senate;</DELETED>
        <DELETED>    (3) the Permanent Select Committee on Intelligence 
        of the House of Representatives; and</DELETED>
        <DELETED>    (4) the Committee on Armed Services of the House 
        of Representatives.</DELETED>
<DELETED>    (e) Submission of Unclassified Summary and Classified 
Annex.--Not later than 6 months after the date of the enactment of this 
Act, and biennially thereafter, the Director shall submit an 
unclassified report and a classified annex summarizing the review or 
update to--</DELETED>
        <DELETED>    (1) the Committee on Agriculture of the 
        Senate;</DELETED>
        <DELETED>    (2) the Committee on Health, Education, Labor, and 
        Pensions of the Senate;</DELETED>
        <DELETED>    (3) the Committee on Homeland Security and 
        Governmental Affairs of the Senate;</DELETED>
        <DELETED>    (4) the Committee on Agriculture of the House of 
        the Representatives;</DELETED>
        <DELETED>    (5) the Committee on Energy and Commerce of the 
        House of Representatives; and</DELETED>
        <DELETED>    (6) the Committee on Homeland Security of the 
        House of Representatives.</DELETED>
<DELETED>    (f) Sunset Date.--The requirements specified in 
subsections (c), (d), and (e) of this section shall terminate four 
years after the date of the enactment of this Act.</DELETED>

<DELETED>SEC. 302. STRENGTHENING INTERNATIONAL BIOSECURITY.</DELETED>

<DELETED>    (a) Technical and Financial Assistance Authorized.--The 
Secretary of State, in coordination with the Secretary of Health and 
Human Services, the Secretary of Agriculture, the Secretary of Homeland 
Security, and other appropriate agencies, shall provide technical and 
financial assistance, including the activities described in subsection 
(b), to countries or regions identified by the Threat Assessment 
mandated in section 301.</DELETED>
<DELETED>    (b) Authorized Activities.--</DELETED>
        <DELETED>    (1) Reducing and securing dangerous pathogen 
        collections.--The Secretary of State shall--</DELETED>
                <DELETED>    (A) provide assistance to remove or 
                consolidate an agent or toxin designated as a Tier I 
                agent under section 351A(a)(2) of the Public Health 
                Service Act or section 212(a)(2) of the Agricultural 
                Bioterrorism Protection Act of 2002 (in this subtitle 
                referred to as a ``Tier I agent'') and other dangerous 
                pathogen collections spread among multiple locations 
                within a country or region into facilities with 
                appropriate safety and security;</DELETED>
                <DELETED>    (B) provide assistance to replace 
                dangerous or obsolete pathogen isolation techniques 
                with modern diagnostic tools to improve safety and 
                security and to reduce the number and size of dangerous 
                pathogen collections in high risk regions and 
                countries;</DELETED>
                <DELETED>    (C) encourage countries to eliminate 
                stores of Tier I agents and other dangerous pathogen 
                collections in exchange for facilitating access to 
                state-of-the-art civilian research at international 
                facilities;</DELETED>
                <DELETED>    (D) provide assistance to identify and 
                secure Tier I agents and other dangerous pathogen 
                collections in high risk regions and countries; 
                and</DELETED>
                <DELETED>    (E) carry out such other activities as the 
                Secretary of State considers necessary to achieve the 
                purposes of this subtitle.</DELETED>
        <DELETED>    (2) Prevention and protection.--The Secretary of 
        State shall--</DELETED>
                <DELETED>    (A) raise awareness of international 
                biological threats with foreign governments, academic 
                institutions, and industrial laboratories handling Tier 
                I agents and other dangerous pathogen collections 
                through conferences, seminars and workshops;</DELETED>
                <DELETED>    (B) provide physical security upgrades at 
                high risk laboratories;</DELETED>
                <DELETED>    (C) train foreign partners in high risk 
                regions on best laboratory biosecurity practices within 
                facilities handling Tier I agents and other dangerous 
                pathogen collections;</DELETED>
                <DELETED>    (D) assist foreign countries in 
                establishing personnel reliability measures, as part of 
                a comprehensive laboratory management system;</DELETED>
                <DELETED>    (E) partner with foreign governments, 
                laboratories, and scientists in activities that 
                strengthen and reinforce best biological safety and 
                security practices within facilities handling Tier I 
                agents and other dangerous pathogen 
                collections;</DELETED>
                <DELETED>    (F) enhance information sharing through 
                regular meetings of relevant United States and foreign 
                government agencies with subject matter expertise on 
                pathogen security and laboratory best practices in high 
                risk regions;</DELETED>
                <DELETED>    (G) increase support for United States 
                science and technology agreements and initiatives in 
                high risk regions and countries, including 
                collaborative projects in the areas of bioterrorism 
                prevention, infectious disease control, disease 
                surveillance, bioforensics, laboratory biosafety, and 
                hazardous waste management; and</DELETED>
                <DELETED>    (H) develop laboratory biosafety and 
                biosecurity standards and guidelines, including 
                personnel reliability measures, for facilities handling 
                Tier I agents and other dangerous pathogen 
                collections.</DELETED>
        <DELETED>    (3) Science and technology exchange.--The 
        Secretary of State shall--</DELETED>
                <DELETED>    (A) promote research and development 
                collaboration on highly infectious human, animal and 
                plant disease agents in facilities with appropriate 
                safety and security measures;</DELETED>
                <DELETED>    (B) provide opportunities for foreign 
                scientists, particularly those located in highest risk 
                countries identified in section 301, to receive 
                training in the United States on biological safety and 
                security best practices, standard operating procedures, 
                and maintenance for high containment facilities; 
                and</DELETED>
                <DELETED>    (C) facilitate the secure exchange of 
                research samples between laboratories in the United 
                States and foreign national laboratories for the 
                development of vaccines and diagnostics for Tier I 
                agents and other dangerous pathogens.</DELETED>

<DELETED>SEC. 303. PROMOTING SECURE BIOTECHNOLOGY 
              ADVANCEMENT.</DELETED>

<DELETED>    (a) Plan To Promote International Adherence to 
International Agreements.--The Secretary of State, in coordination with 
appropriate agencies, shall produce and implement a plan for promoting 
international adherence to, and implementation of, frameworks, 
treaties, and other international agreements regarding weapons of mass 
destruction, including the Biological Weapons Convention, World Health 
Organization International Health regulations, and United Nations 
Security Council Resolution 1540.</DELETED>
<DELETED>    (b) Biotechnology Discussions.--</DELETED>
        <DELETED>    (1) In general.--The Secretary of State shall 
        pursue discussions with government, academic, and industry 
        representatives in countries that possess established or 
        emerging biotechnology sectors or are identified as high-risk 
        countries in the Threat Assessment required under section 
        301.</DELETED>
        <DELETED>    (2) Topics.--Topics to be discussed under 
        paragraph (1) shall include--</DELETED>
                <DELETED>    (A) multilateral initiatives intended to 
                promote safe and secure biotechnology;</DELETED>
                <DELETED>    (B) norms and safeguards necessary to 
                prevent the misuse of biotechnology;</DELETED>
                <DELETED>    (C) multilateral initiatives intended to 
                counter the threat of biological terrorism; 
                and</DELETED>
                <DELETED>    (D) other topics on international 
                biosecurity that the Secretary of State considers to be 
                relevant.</DELETED>

      <DELETED>Subtitle B--Global Pathogen Surveillance</DELETED>

<DELETED>SEC. 321. SHORT TITLE.</DELETED>

<DELETED>    This subtitle may be cited as the ``Global Pathogen 
Surveillance Act of 2009''.</DELETED>

<DELETED>SEC. 322. FINDINGS; PURPOSE.</DELETED>

<DELETED>    (a) Findings.--Congress makes the following 
findings:</DELETED>
        <DELETED>    (1) The frequency of the occurrence of biological 
        events that could threaten the national security of the United 
        States has increased and is likely increasing. The threat to 
        the United States from such events includes threats from 
        diseases that infect humans, animals, or plants regardless of 
        whether such diseases are introduced naturally, accidentally, 
        or intentionally.</DELETED>
        <DELETED>    (2) Bioterrorism poses a grave national security 
        threat to the United States. The insidious nature of a 
        bioterrorist attack, the likelihood that the recognition of 
        such an attack would be delayed, and the underpreparedness of 
        the domestic public health infrastructure to respond to such an 
        attack could result in catastrophic consequences following a 
        biological weapons attack against the United States.</DELETED>
        <DELETED>    (3) The ability to recognize that a country or 
        organization is carrying out a covert biological weapons 
        program is dependent on a number of indications and warnings. A 
        critical component of this recognition is the timely detection 
        of sentinel events such as community-level outbreaks that could 
        be the earliest indication of an emerging bioterrorist program 
        in a foreign country. Early detection of such events may enable 
        earlier counterproliferation intervention.</DELETED>
        <DELETED>    (4) A contagious pathogen engineered as a 
        biological weapon and developed, tested, produced, or released 
        in a foreign country could quickly spread to the United States. 
        Considering the realities of international travel, trade, and 
        migration patterns, a dangerous pathogen appearing naturally, 
        accidentally, or intentionally anywhere in the world can spread 
        to the United States in a matter of days, before any effective 
        quarantine or isolation measures could be 
        implemented.</DELETED>
        <DELETED>    (5) To combat bioterrorism effectively and ensure 
        that the United States is fully prepared to prevent, recognize, 
        and contain a biological weapons attack or emerging infectious 
        disease, measures to strengthen the domestic public health 
        infrastructure and improve domestic event detection, 
        surveillance, and response, while absolutely essential, are not 
        sufficient.</DELETED>
        <DELETED>    (6) The United States should enhance cooperation 
        with the World Health Organization, regional international 
        health organizations, and individual countries, including data 
        sharing with appropriate agencies and departments of the United 
        States, to help detect and quickly contain infectious disease 
        outbreaks or a bioterrorism agent before such a disease or 
        agent is spread.</DELETED>
        <DELETED>    (7) The World Health Organization has done an 
        impressive job in monitoring infectious disease outbreaks 
        around the world, notably in the April 2000 establishment and 
        subsequent operation of the Global Outbreak Alert and Response 
        Network.</DELETED>
        <DELETED>    (8) The capabilities of the World Health 
        Organization depend on the timeliness and quality of the data 
        and information the Organization receives from the countries 
        that are members of the Organization, pursuant to the 2005 
        revision of the International Health Regulations. Developing 
        countries, in particular, often lack the necessary resources to 
        build and maintain effective public health 
        infrastructures.</DELETED>
        <DELETED>    (9) Developing countries could benefit from--
        </DELETED>
                <DELETED>    (A) better trained public health 
                professionals and epidemiologists to recognize disease 
                patterns;</DELETED>
                <DELETED>    (B) appropriate laboratory equipment for 
                diagnosis of pathogens;</DELETED>
                <DELETED>    (C) disease reporting systems that--
                </DELETED>
                        <DELETED>    (i) are based on disease and 
                        syndrome surveillance; and</DELETED>
                        <DELETED>    (ii) could enable an effective 
                        response to a biological event to begin at the 
                        earliest possible opportunity;</DELETED>
                <DELETED>    (D) a narrowing of the existing technology 
                gap in disease and syndrome surveillance capabilities, 
                based on reported symptoms, and real-time information 
                dissemination to public health officials; and</DELETED>
                <DELETED>    (E) appropriate communications equipment 
                and information technology to efficiently transmit 
                information and data within national, international 
                regional, and international health networks, including 
                inexpensive, Internet-based geographic information 
                systems and relevant telephone-based systems for early 
                recognition and diagnosis of diseases.</DELETED>
        <DELETED>    (10) An effective international capability to 
        detect, monitor, and quickly diagnose infectious disease 
        outbreaks will offer dividends not only in the event of 
        biological weapons development, testing, production, and 
        attack, but also in the more likely cases of naturally 
        occurring infectious disease outbreaks that could threaten the 
        United States. Furthermore, a robust surveillance system will 
        serve to deter or contain terrorist use of biological weapons, 
        mitigating the intended effects of such malevolent 
        uses.</DELETED>
<DELETED>    (b) Purposes.--The purposes of this subtitle are as 
follows:</DELETED>
        <DELETED>    (1) To enhance the capability of the international 
        community, through international health organizations and 
        individual countries, to detect, identify, and contain 
        infectious disease outbreaks, whether the cause of those 
        outbreaks is intentional human action or natural in 
        origin.</DELETED>
        <DELETED>    (2) To enhance the training of public health 
        professionals and epidemiologists from eligible developing 
        countries in advanced Internet-based disease and syndrome 
        surveillance systems, in addition to traditional epidemiology 
        methods, so that such professionals and epidemiologists may 
        better detect, diagnose, and contain infectious disease 
        outbreaks, especially such outbreaks caused by the pathogens 
        that may be likely to be used in a biological weapons 
        attack.</DELETED>
        <DELETED>    (3) To provide assistance to eligible developing 
        countries to purchase appropriate communications equipment and 
        information technology to detect, analyze, and report 
        biological threats, including--</DELETED>
                <DELETED>    (A) relevant computer equipment, Internet 
                connectivity mechanisms, and telephone-based 
                applications to effectively gather, analyze, and 
                transmit public health information for infectious 
                disease surveillance and diagnosis; and</DELETED>
                <DELETED>    (B) appropriate computer equipment and 
                Internet connectivity mechanisms--</DELETED>
                        <DELETED>    (i) to facilitate the exchange of 
                        Geographic Information Systems-based disease 
                        and syndrome surveillance information; 
                        and</DELETED>
                        <DELETED>    (ii) to effectively gather, 
                        analyze, and transmit public health information 
                        for infectious disease surveillance and 
                        diagnosis.</DELETED>
        <DELETED>    (4) To make available greater numbers of public 
        health professionals who are employed by the Government of the 
        United States to international regional and international 
        health organizations, international regional and international 
        health networks, and United States diplomatic missions, as 
        appropriate.</DELETED>
        <DELETED>    (5) To expand the training and outreach activities 
        of United States laboratories located in foreign countries, 
        including the Centers for Disease Control and Prevention or 
        Department of Defense laboratories, to enhance the public 
        health capabilities of developing countries.</DELETED>
        <DELETED>    (6) To provide appropriate technical assistance to 
        existing international regional and international health 
        networks and, as appropriate, seed money for new international 
        regional and international networks.</DELETED>

<DELETED>SEC. 323. DEFINITIONS.</DELETED>

<DELETED>    In this subtitle:</DELETED>
        <DELETED>    (1) Eligible developing country.--The term 
        ``eligible developing country'' means any developing country 
        that--</DELETED>
                <DELETED>    (A) has agreed to the objective of fully 
                complying with requirements of the World Health 
                Organization on reporting public health information on 
                outbreaks of infectious diseases;</DELETED>
                <DELETED>    (B) has not been determined by the 
                Secretary of State, for purposes of section 40 of the 
                Arms Export Control Act (22 U.S.C. 2780), section 620A 
                of the Foreign Assistance Act of 1961 (22 U.S.C. 2371), 
                or section 6(j) of the Export Administration Act of 
                1979 (as in effect pursuant to the International 
                Emergency Economic Powers Act; 50 U.S.C. 1701 et seq.), 
                to have repeatedly provided support for acts of 
                international terrorism, unless the Secretary of State 
                exercises a waiver certifying that it is in the 
                national interest of the United States to provide 
                assistance under the provisions of this subtitle; 
                and</DELETED>
                <DELETED>    (C) is a party to the Convention on the 
                Prohibition of the Development, Production and 
                Stockpiling of Bacteriological (Biological) and Toxin 
                Weapons and on Their Destruction, done at Washington, 
                London, and Moscow April 10, 1972 (26 UST 
                583).</DELETED>
        <DELETED>    (2) Eligible national.--The term ``eligible 
        national'' means any citizen or national of an eligible 
        developing country who--</DELETED>
                <DELETED>    (A) does not have a criminal 
                background;</DELETED>
                <DELETED>    (B) is not on any immigration or other 
                United States watch list; and</DELETED>
                <DELETED>    (C) is not affiliated with any foreign 
                terrorist organization.</DELETED>
        <DELETED>    (3) International health organization.--The term 
        ``international health organization'' includes the World Health 
        Organization, regional offices of the World Health 
        Organization, and such similar international organizations as 
        the Pan American Health Organization.</DELETED>
        <DELETED>    (4) Laboratory.--The term ``laboratory'' means a 
        facility for the biological, microbiological, serological, 
        chemical, immunohematological, hematological, biophysical, 
        cytological, pathological, or other medical examination of 
        materials derived from the human body for the purpose of 
        providing information for the diagnosis, prevention, or 
        treatment of any disease or impairment of, or the assessment of 
        the health of, human beings.</DELETED>
        <DELETED>    (5) Disease and syndrome surveillance.--The term 
        ``disease and syndrome surveillance'' means the recording of 
        clinician-reported symptoms (patient complaints) and signs 
        (derived from physical examination and laboratory data) 
        combined with simple geographic locators to track the emergence 
        of a disease in a population.</DELETED>

<DELETED>SEC. 324. ELIGIBILITY FOR ASSISTANCE.</DELETED>

<DELETED>    (a) In General.--Except as provided in subsection (b), 
assistance may be provided to an eligible developing country under any 
provision of this subtitle only if the government of the eligible 
developing country--</DELETED>
        <DELETED>    (1) permits personnel from the World Health 
        Organization and the Centers for Disease Control and Prevention 
        to investigate outbreaks of infectious diseases within the 
        borders of such country; and</DELETED>
        <DELETED>    (2) provides pathogen surveillance data to the 
        appropriate agencies and departments of the United States and 
        to international health organizations.</DELETED>
<DELETED>    (b) Waiver.--The Secretary of State may waive the 
prohibition set out in subsection (a) if the Secretary of State 
determines that it is in the national interest of the United States to 
provide such a waiver.</DELETED>
<DELETED>    (c) Prior Notice of Waivers.--A waiver pursuant to 
subsection (b) may not be executed until 15 days after the Secretary of 
State provides to the Committee on Foreign Relations of the Senate and 
the Committee on Foreign Affairs of the House of Representatives 
written notice of the intent to issue such waiver and the reasons for 
doing so.</DELETED>

<DELETED>SEC. 325. RESTRICTION.</DELETED>

<DELETED>    (a)  In General.--Notwithstanding any other provision of 
this subtitle, no foreign national participating in a program 
authorized under this subtitle shall have access, during the course of 
such participation, to a select agent or toxin described in section 
73.4 of title 42, Code of Federal Regulations (or any corresponding 
similar regulation) or an overlap select agent or toxin described in 
section 73.5 of such title (or any corresponding similar regulation) 
that may be used as, or in, a biological weapon, except in a supervised 
and controlled setting.</DELETED>
<DELETED>    (b) Relationship to Regulations.--The restriction set out 
in subsection (a) may not be construed to limit the ability of the 
Secretary of Health and Human Services to prescribe, through 
regulation, standards for the handling of a select agent or toxin or an 
overlap select agent or toxin described in such subsection.</DELETED>

<DELETED>SEC. 326. FELLOWSHIP PROGRAM.</DELETED>

<DELETED>    (a) Establishment.--There is established a fellowship 
program under which the Secretary of State, in consultation with the 
Secretary of Health and Human Services and the Secretary of Homeland 
Security and subject to the availability of appropriations, shall award 
fellowships to eligible nationals to pursue public health education or 
training, as follows:</DELETED>
        <DELETED>    (1) Master of public health degree.--Graduate 
        courses of study leading to a master of public health degree 
        with a concentration in epidemiology from an institution of 
        higher education in the United States with a Center for Public 
        Health Preparedness, as determined by the Director of the 
        Centers for Disease Control and Prevention.</DELETED>
        <DELETED>    (2) Advanced public health epidemiology 
        training.--Advanced public health training in epidemiology for 
        public health professionals from eligible developing countries 
        to be carried out at the Centers for Disease Control and 
        Prevention, an appropriate facility of a State, or an 
        appropriate facility of another agency or department of the 
        United States (other than a facility of the Department of 
        Defense or a national laboratory of the Department of Energy) 
        for a period of not less than 6 months or more than 12 
        months.</DELETED>
<DELETED>    (b) Specialization in Bioterrorism Response.--In addition 
to the education or training specified in subsection (a), each 
recipient of a fellowship under this section (in this section referred 
to as a ``fellow'') may take courses of study at the Centers for 
Disease Control and Prevention or at an equivalent facility on 
diagnosis and containment of likely bioterrorism agents.</DELETED>
<DELETED>    (c) Fellowship Agreement.--</DELETED>
        <DELETED>    (1) In general.--A fellow shall enter into an 
        agreement with the Secretary of State under which the fellow 
        agrees--</DELETED>
                <DELETED>    (A) to maintain satisfactory academic 
                progress, as determined in accordance with regulations 
                issued by the Secretary of State and confirmed in 
                regularly scheduled updates to the Secretary of State 
                from the institution providing the education or 
                training on the progress of the fellow's education or 
                training;</DELETED>
                <DELETED>    (B) upon completion of such education or 
                training, to return to the fellow's country of 
                nationality or last habitual residence (so long as it 
                is an eligible developing country) and complete at 
                least 4 years of employment in a public health position 
                in the government or a nongovernmental, not-for-profit 
                entity in that country or, with the approval of the 
                Secretary of State, complete part or all of this 
                requirement through service with an international 
                health organization without geographic restriction; 
                and</DELETED>
                <DELETED>    (C) that, if the fellow is unable to meet 
                the requirements described in subparagraph (A) or (B), 
                the fellow shall reimburse the United States for the 
                value of the assistance provided to the fellow under 
                the fellowship program, together with interest at a 
                rate that--</DELETED>
                        <DELETED>    (i) is determined in accordance 
                        with regulations issued by the Secretary of 
                        State; and</DELETED>
                        <DELETED>    (ii) is not higher than the rate 
                        generally applied in connection with other 
                        Federal loans.</DELETED>
        <DELETED>    (2) Waivers.--The Secretary of State may waive the 
        application of subparagraph (B) or (C) of paragraph (1) on a 
        case by case basis if the Secretary of State determines that--
        </DELETED>
                <DELETED>    (A) it is in the national interest of the 
                United States to provide such a waiver; or</DELETED>
                <DELETED>    (B) humanitarian considerations require 
                such a waiver.</DELETED>
<DELETED>    (d) Agreement.--The Secretary of State, in consultation 
with the Secretary of Health and Human Services and the Secretary of 
Homeland Security, is authorized to enter into an agreement with the 
government of an eligible developing country under which such 
government agrees--</DELETED>
        <DELETED>    (1) to establish a procedure for the nomination of 
        eligible nationals for fellowships under this 
        section;</DELETED>
        <DELETED>    (2) to guarantee that a fellow will be offered a 
        professional public health position within the developing 
        country upon completion of the fellow's studies; and</DELETED>
        <DELETED>    (3) to submit to the Secretary of State a 
        certification stating that a fellow has concluded the minimum 
        period of employment in a public health position required by 
        the fellowship agreement, including an explanation of how the 
        requirement was met.</DELETED>
<DELETED>    (e) Participation of United States Citizens.--On a case-
by-case basis, the Secretary of State may provide for the participation 
of a citizen of the United States in the fellowship program under the 
provisions of this section if--</DELETED>
        <DELETED>    (1) the Secretary of State determines that it is 
        in the national interest of the United States to provide for 
        such participation; and</DELETED>
        <DELETED>    (2) the citizen of the United States agrees to 
        complete, at the conclusion of such participation, at least 5 
        years of employment in a public health position in an eligible 
        developing country or at an international health 
        organization.</DELETED>
<DELETED>    (f) Use of Existing Programs.--The Secretary of State, 
with the concurrence of the Secretary of Health and Human Services, may 
elect to use existing programs of the Department of Health and Human 
Services to provide the education and training described in subsection 
(a) if the requirements of subsections (b), (c), and (d) will be 
substantially met under such existing programs.</DELETED>

<DELETED>SEC. 327. IN-COUNTRY TRAINING IN LABORATORY TECHNIQUES AND 
              DISEASE AND SYNDROME SURVEILLANCE.</DELETED>

<DELETED>    (a) Laboratory Techniques.--</DELETED>
        <DELETED>    (1) In general.--The Secretary of State, after 
        consultation with the Secretary of Health and Human Services, 
        the Secretary of Defense, and the Secretary of Homeland 
        Security and in conjunction with elements of those departments 
        that engage in activities of this type overseas, and subject to 
        the availability of appropriations, shall provide assistance 
        for short training courses for eligible nationals who are 
        laboratory technicians or other public health personnel in 
        laboratory techniques relating to the identification, 
        diagnosis, and tracking of pathogens responsible for possible 
        infectious disease outbreaks.</DELETED>
        <DELETED>    (2) Location.--The training described in paragraph 
        (1) shall be held outside the United States and may be 
        conducted in facilities of the Centers for Disease Control and 
        Prevention located in foreign countries or in Overseas Medical 
        Research Units of the Department of Defense, as 
        appropriate.</DELETED>
        <DELETED>    (3) Coordination with existing programs.--The 
        Secretary of State shall coordinate the training described in 
        paragraph (1), where appropriate, with existing programs and 
        activities of international health organizations.</DELETED>
<DELETED>    (b) Disease and Syndrome Surveillance.--</DELETED>
        <DELETED>    (1) In general.--The Secretary of State, after 
        consultation with the Secretary of Health and Human Services, 
        the Secretary of Defense, and the Secretary of Homeland 
        Security and in conjunction with elements of those departments 
        that engage in activities of this type overseas, and subject to 
        the availability of appropriations, shall establish and provide 
        assistance for short training courses for eligible nationals 
        who are health care providers or other public health personnel 
        in techniques of disease and syndrome surveillance reporting 
        and rapid analysis of syndrome information using geographic 
        information system tools.</DELETED>
        <DELETED>    (2) Location.--The training described in paragraph 
        (1) shall be conducted via the Internet or in appropriate 
        facilities located in a foreign country, as determined by the 
        Secretary of State.</DELETED>
        <DELETED>    (3) Coordination with existing programs.--The 
        Secretary of State shall coordinate the training described in 
        paragraph (1), where appropriate, with existing programs and 
        activities of international regional and international health 
        organizations.</DELETED>

<DELETED>SEC. 328. ASSISTANCE FOR THE PURCHASE AND MAINTENANCE OF 
              PUBLIC HEALTH LABORATORY EQUIPMENT AND 
              SUPPLIES.</DELETED>

<DELETED>    (a) Authorization.--The President is authorized to 
provide, on such terms and conditions as the President may determine, 
assistance to eligible developing countries to purchase and maintain 
the public health laboratory equipment and supplies described in 
subsection (b).</DELETED>
<DELETED>    (b) Equipment and Supplies Covered.--The equipment and 
supplies described in this subsection are equipment and supplies that 
are--</DELETED>
        <DELETED>    (1) appropriate, to the extent possible, for use 
        in the intended geographic area;</DELETED>
        <DELETED>    (2) necessary to collect, analyze, and identify 
        expeditiously a broad array of pathogen strains, which may 
        cause disease outbreaks or may be used in a biological 
        weapon;</DELETED>
        <DELETED>    (3) compatible with general standards set forth by 
        the World Health Organization and, as appropriate, the Centers 
        for Disease Control and Prevention, to ensure interoperability 
        with international regional and international public health 
        networks; and</DELETED>
        <DELETED>    (4) not defense articles, defense services, or 
        training, as such terms are defined in the Arms Export Control 
        Act (22 U.S.C. 2751 et seq.).</DELETED>
<DELETED>    (c) Rule of Construction.--Nothing in this section shall 
be construed to exempt the exporting of goods and technology from 
compliance with applicable provisions of the Export Administration Act 
of 1979 (as in effect pursuant to the International Emergency Economic 
Powers Act; 50 U.S.C. 1701 et seq.).</DELETED>
<DELETED>    (d) Limitation.--Amounts appropriated to carry out this 
section shall not be made available for the purchase from a foreign 
country of equipment or supplies that, if made in the United States, 
would be subject to the Arms Export Control Act (22 U.S.C. 2751 et 
seq.) or likely be barred or subject to special conditions under the 
Export Administration Act of 1979 (as in effect pursuant to the 
International Emergency Economic Powers Act; 50 U.S.C. 1701 et 
seq.).</DELETED>
<DELETED>    (e) Procurement Preference.--In the use of grant funds 
authorized under subsection (a), preference should be given to the 
purchase of equipment and supplies of United States manufacture. The 
use of amounts appropriated to carry out this section shall be subject 
to section 604 of the Foreign Assistance Act of 1961 (22 U.S.C. 
2354).</DELETED>
<DELETED>    (f) Country Commitments.--The assistance provided under 
this section for equipment and supplies may be provided only if the 
eligible developing country that receives such equipment and supplies 
agrees to provide the infrastructure, technical personnel, and other 
resources required to house, maintain, support, secure, and maximize 
use of such equipment and supplies.</DELETED>

<DELETED>SEC. 329. ASSISTANCE FOR IMPROVED COMMUNICATION OF PUBLIC 
              HEALTH INFORMATION.</DELETED>

<DELETED>    (a) Assistance for Purchase of Communication Equipment and 
Information Technology.--The President is authorized to provide, on 
such terms and conditions as the President may determine, assistance to 
eligible developing countries to purchase and maintain the 
communications equipment and information technology described in 
subsection (b), and the supporting equipment, necessary to effectively 
collect, analyze, and transmit public health information.</DELETED>
<DELETED>    (b) Covered Equipment.--The communications equipment and 
information technology described in this subsection are communications 
equipment and information technology that--</DELETED>
        <DELETED>    (1) are suitable for use under the particular 
        conditions of the geographic area of intended use;</DELETED>
        <DELETED>    (2) meet the standards set forth by the World 
        Health Organization and, as appropriate, the Secretary of 
        Health and Human Services, to ensure interoperability with like 
        equipment of other countries and international organizations; 
        and</DELETED>
        <DELETED>    (3) are not defense articles, defense services, or 
        training, as those terms are defined in the Arms Export Control 
        Act (22 U.S.C. 2751 et seq.).</DELETED>
<DELETED>    (c) Rule of Construction.--Nothing in this section shall 
be construed to exempt the exporting of goods and technology from 
compliance with applicable provisions of the Export Administration Act 
of 1979 (as in effect pursuant to the International Emergency Economic 
Powers Act; 50 U.S.C. 1701 et seq.).</DELETED>
<DELETED>    (d) Limitation.--Amounts appropriated to carry out this 
section shall not be made available for the purchase from a foreign 
country of communications equipment or information technology that, if 
made in the United States, would be subject to the Arms Export Control 
Act (22 U.S.C. 2751 et seq.) or likely be barred or subject to special 
conditions under the Export Administration Act of 1979 (as in effect 
pursuant to the International Emergency Economic Powers Act; 50 U.S.C. 
1701 et seq.).</DELETED>
<DELETED>    (e) Procurement Preference.--In the use of grant funds 
under subsection (a), preference should be given to the purchase of 
communications equipment and information technology of United States 
manufacture. The use of amounts appropriated to carry out this section 
shall be subject to section 604 of the Foreign Assistance Act of 1961 
(22 U.S.C. 2354).</DELETED>
<DELETED>    (f) Assistance for Standardization of Reporting.--The 
President is authorized to provide, on such terms and conditions as the 
President may determine, technical assistance and grant assistance to 
international health organizations to facilitate standardization in the 
reporting of public health information between and among developing 
countries and international health organizations.</DELETED>
<DELETED>    (g) Country Commitments.--The assistance provided under 
this section for communications equipment and information technology 
may be provided only if the eligible developing country that receives 
such equipment and technology agrees to provide the infrastructure, 
technical personnel, and other resources required to house, maintain, 
support, secure, and maximize use of such equipment and 
technology.</DELETED>

<DELETED>SEC. 330. ASSIGNMENT OF PUBLIC HEALTH PERSONNEL TO UNITED 
              STATES MISSIONS AND INTERNATIONAL 
              ORGANIZATIONS.</DELETED>

<DELETED>    (a) In General.--Upon the request of the chief of a 
diplomatic mission of the United States or of the head of an 
international regional or international health organization, and with 
the concurrence of the Secretary of State and of the employee 
concerned, the head of an agency or department of the United States may 
assign to the mission or the organization any officer or employee of 
the agency or department that occupies a public health position within 
the agency or department for the purpose of enhancing disease and 
pathogen surveillance efforts in developing countries.</DELETED>
<DELETED>    (b) Reimbursement.--The costs incurred by an agency or 
department of the United States by reason of the detail of personnel 
under subsection (a) may be reimbursed to that agency or department out 
of the applicable appropriations account of the Department of State if 
the Secretary of State determines that the agency or department may 
otherwise be unable to assign such personnel on a non-reimbursable 
basis.</DELETED>

<DELETED>SEC. 331. EXPANSION OF CERTAIN UNITED STATES GOVERNMENT 
              LABORATORIES ABROAD.</DELETED>

<DELETED>    (a) In General.--Subject to the availability of 
appropriations and with the concurrence of the government of each host 
country, the Director of the Centers for Disease Control and Prevention 
and the Secretary of Defense shall each--</DELETED>
        <DELETED>    (1) increase the number of personnel assigned to 
        laboratories of the Centers for Disease Control and Prevention 
        or the Department of Defense, as appropriate, located in 
        eligible developing countries that conduct research and other 
        activities with respect to infectious diseases; and</DELETED>
        <DELETED>    (2) expand the operations of such laboratories, 
        especially with respect to the implementation of on-site 
        training of foreign nationals and activities affecting the 
        region in which the country is located.</DELETED>
<DELETED>    (b) Cooperation and Coordination Between Laboratories.--
Subsection (a) shall be carried out in such a manner as to foster 
cooperation and avoid duplication between and among 
laboratories.</DELETED>

<DELETED>SEC. 332. ASSISTANCE FOR INTERNATIONAL HEALTH NETWORKS AND 
              EXPANSION OF FIELD EPIDEMIOLOGY TRAINING 
              PROGRAMS.</DELETED>

<DELETED>    (a) Authority.--The President is authorized, on such terms 
and conditions as the President may determine, to provide assistance 
for the purposes of--</DELETED>
        <DELETED>    (1) enhancing the surveillance and reporting 
        capabilities of the World Health Organization and existing 
        international regional and international health networks; 
        and</DELETED>
        <DELETED>    (2) developing new international regional and 
        international health networks.</DELETED>
<DELETED>    (b) Expansion of Field Epidemiology Training Programs.--
The Secretary of Health and Human Services is authorized to establish 
new country or regional international Field Epidemiology Training 
Programs in eligible developing countries, with the concurrence of the 
government of each host country.</DELETED>

<DELETED>SEC. 333. REPORTS.</DELETED>

<DELETED>    Not later than 90 days after the date of enactment of this 
Act, the Secretary of State, in conjunction with the Secretary of 
Health and Human Services, the Secretary of Defense, and the Secretary 
of Homeland Security, shall submit to the Committee on Foreign 
Relations and the Committee on Homeland Security and Governmental 
Affairs of the Senate and the Committee on Foreign Affairs and the 
Committee on Homeland Security of the House of Representatives a report 
on the implementation of programs under this subtitle, including an 
estimate of the level of funding required to carry out such 
programs.</DELETED>

<DELETED>SEC. 334. AUTHORIZATION OF APPROPRIATIONS.</DELETED>

<DELETED>    (a) Authorization of Appropriations.--Subject to 
subsection (c), there are authorized to be appropriated for the purpose 
of carrying out activities under this subtitle the following 
amounts:</DELETED>
        <DELETED>    (1) $40,000,000 for fiscal year 2010.</DELETED>
        <DELETED>    (2) $75,000,000 for fiscal year 2011.</DELETED>
<DELETED>    (b) Availability of Funds.--The amounts appropriated 
pursuant to subsection (a) are authorized to remain available until 
expended.</DELETED>
<DELETED>    (c) Limitation on Obligation of Funds.--Not more than 10 
percent of the amount appropriated pursuant to subsection (a)(1) may be 
obligated before the date on which a report is submitted, or required 
to be submitted, whichever first occurs, under section 333.</DELETED>

          <DELETED>TITLE IV--GOVERNMENT ORGANIZATION</DELETED>

<DELETED>SEC. 401. INTELLIGENCE ON WEAPONS OF MASS 
              DESTRUCTION.</DELETED>

<DELETED>    (a) Definitions.--In this section:</DELETED>
        <DELETED>    (1) Appropriate committees of congress.--The term 
        ``appropriate committees of Congress'' means--</DELETED>
                <DELETED>    (A) the Select Committee on Intelligence, 
                the Committee on Appropriations, the Committee on Armed 
                Services, and the Committee on Homeland Security and 
                Governmental Affairs of the Senate; and</DELETED>
                <DELETED>    (B) the Permanent Select Committee on 
                Intelligence, the Committee on Appropriations, the 
                Committee on Armed Services, and the Committee on 
                Homeland Security of the House of 
                Representatives.</DELETED>
        <DELETED>    (2) Director.--The term ``Director'' means the 
        Director of National Intelligence.</DELETED>
        <DELETED>    (3) Intelligence community.--The term 
        ``intelligence community'' has the meaning given that term in 
        section 3 of the National Security Act of 1947 (50 U.S.C. 
        401a).</DELETED>
        <DELETED>    (4) Weapons of mass destruction.--The term 
        ``weapons of mass destruction'' means--</DELETED>
                <DELETED>    (A) any weapon that is designed, intended, 
                or has the capability to cause death, illness, or 
                serious bodily injury to a significant number of 
                persons through the release, dissemination, or impact 
                of toxic or poisonous chemicals or their 
                precursors;</DELETED>
                <DELETED>    (B) any weapon involving a biological 
                agent, toxin, or vector (as such terms are defined in 
                section 178 of title 18, United States Code) that is 
                designed, intended, or has the capability to cause 
                death, illness, or serious bodily injury to a 
                significant number of persons; or</DELETED>
                <DELETED>    (C) any weapon that is designed, intended, 
                or has the capability to release radiation or 
                radioactivity causing death, illness, or serious bodily 
                injury to a significant number of persons.</DELETED>
<DELETED>    (b) Strategy for Improving Intelligence Capabilities.--
</DELETED>
        <DELETED>    (1) Requirement for strategy.--Not later than 120 
        days after the date of the enactment of this Act, the Director 
        shall develop, implement, and submit to the appropriate 
        committees of Congress a strategy for improving the 
        capabilities of the United States for the collection, analysis, 
        and dissemination of intelligence related to weapons of mass 
        destruction, including intelligence related to the relationship 
        between weapons of mass destruction and terrorism.</DELETED>
        <DELETED>    (2) Elements.--The strategy required by paragraph 
        (1) shall include a description of each of the 
        following:</DELETED>
                <DELETED>    (A) Methods for recruitment, training, and 
                retention of individuals with expertise in the 
                collection, analysis, and dissemination of intelligence 
                related to weapons of mass destruction, including 
                appropriate scientific and technical 
                expertise.</DELETED>
                <DELETED>    (B) Methods for collaboration, as 
                appropriate, with individuals with expertise described 
                in subparagraph (A) who are employed by nongovernmental 
                entities or who are foreign nationals.</DELETED>
                <DELETED>    (C) Analytic questions and gaps in 
                information related to intelligence on weapons of mass 
                destruction, including such intelligence concerning 
                state actors and nonstate actors, such as smugglers, 
                criminal enterprises, and financiers, that will be used 
                to guide intelligence collection.</DELETED>
                <DELETED>    (D) Activities for the development of 
                innovative human and technical intelligence collection 
                capabilities and techniques.</DELETED>
                <DELETED>    (E) Actions necessary to increase the 
                effectiveness and efficiency of the sharing of 
                intelligence on weapons of mass destruction throughout 
                the intelligence community, including a description of 
                statutory, regulatory, policy, technical, security, or 
                other barriers that prevent such sharing, and, as 
                appropriate, the development of uniform standards 
                across the intelligence community for such 
                sharing.</DELETED>
                <DELETED>    (F) Actions necessary to identify and 
                overcome activities by a foreign government or person 
                to deny or deceive the intelligence community 
                concerning intelligence regarding weapons of mass 
                destruction.</DELETED>
                <DELETED>    (G) Specific objectives to be accomplished 
                during each year of the first 5-year period after the 
                strategy is submitted to the appropriate committees of 
                Congress and tasks to accomplish such objectives, 
                including--</DELETED>
                        <DELETED>    (i) a list prioritizing such 
                        objectives and tasks; and</DELETED>
                        <DELETED>    (ii) a schedule for meeting such 
                        objectives and carrying out such 
                        tasks.</DELETED>
                <DELETED>    (H) Assignments of roles and 
                responsibilities to elements of the intelligence 
                community to implement the strategy.</DELETED>
                <DELETED>    (I) The personnel, financial, and other 
                resources necessary to implement the strategy and a 
                plan for obtaining such resources.</DELETED>
                <DELETED>    (J) Metrics for measuring the 
                effectiveness and efficiency of the strategy.</DELETED>
                <DELETED>    (K) A schedule for assessment, review, 
                and, as appropriate, revision of the 
                strategy.</DELETED>
        <DELETED>    (3) Requirement to consult.--In developing the 
        strategy required by paragraph (1), the Director shall consult 
        with appropriate officials of the United States including the 
        Under Secretary of Defense for Acquisition, Technology, and 
        Logistics and the Under Secretary for Science and Technology of 
        the Department of Homeland Security.</DELETED>
        <DELETED>    (4) Form.--The strategy required by paragraph (1) 
        may be submitted in a classified form.</DELETED>
<DELETED>    (c) Requirement for Reports.--</DELETED>
        <DELETED>    (1) In general.--Not less frequently than once 
        during each 180-day period after the date of the submission of 
        the strategy required by subsection (b)(1) to the appropriate 
        committees of Congress, the Director shall submit to the 
        appropriate committees of Congress a report on the 
        implementation of such strategy.</DELETED>
        <DELETED>    (2) Content.--Each report required by paragraph 
        (1) shall include the following:</DELETED>
                <DELETED>    (A) An assessment of whether the 
                objectives and tasks referred to in subsection 
                (b)(2)(G) have been accomplished in accordance with the 
                proposed schedule.</DELETED>
                <DELETED>    (B) Data corresponding to the metrics 
                required by subsection (b)(2)(J) for measuring the 
                effectiveness and efficiency of the strategy.</DELETED>
                <DELETED>    (C) An assessment of the actions of the 
                elements of the intelligence community to implement the 
                strategy.</DELETED>
                <DELETED>    (D) An assessment of whether the 
                personnel, financial, and other resources available are 
                sufficient to implement the strategy.</DELETED>
                <DELETED>    (E) A description of any revisions to, or 
                plans to revise, any component of the 
                strategy.</DELETED>
        <DELETED>    (3) Sunset date.--The requirement set forth in 
        paragraph (1) shall terminate three years after the date of the 
        submission of the strategy required by subsection (b)(1) to the 
        appropriate committees of Congress.</DELETED>

<DELETED>SEC. 402. INTELLIGENCE COMMUNITY LANGUAGE CAPABILITIES AND 
              CULTURAL KNOWLEDGE.</DELETED>

<DELETED>    (a) Definitions.--In this section, the terms ``appropriate 
committees of Congress'', ``Director'', ``intelligence community'', and 
``weapons of mass destruction'' have the meaning given such terms in 
section 401.</DELETED>
<DELETED>    (b) Strategy for Improving Language Capabilities and 
Cultural Knowledge.--</DELETED>
        <DELETED>    (1) Requirement for strategy.--Not later than 180 
        days after the date of the enactment of this Act, the Director 
        shall develop, implement, and submit to the appropriate 
        committees of Congress a strategy for improving the recruiting, 
        training, and retention of employees of the elements of the 
        intelligence community who possess critical language 
        capabilities and cultural backgrounds relevant to countering 
        terrorism or collecting, analyzing, and disseminating 
        intelligence related to weapons of mass destruction, including 
        individuals who are first or second-generation United States 
        citizens and United States citizens with immediate relatives 
        who are foreign nationals.</DELETED>
        <DELETED>    (2) Elements.--The strategy required by paragraph 
        (1) shall include a description of each of the 
        following:</DELETED>
                <DELETED>    (A) The current and projected needs of the 
                intelligence community during the ten-year periods, 
                beginning on the date the strategy is submitted to the 
                appropriate committees of Congress, for employees with 
                critical language capabilities and cultural backgrounds 
                relevant to countering terrorism or collecting, 
                analyzing, and disseminating intelligence related to 
                weapons of mass destruction.</DELETED>
                <DELETED>    (B) Actions necessary to recruit, train, 
                and retain employees with such capabilities or 
                backgrounds.</DELETED>
                <DELETED>    (C) Barriers to effective recruitment, 
                training, and retention of employees with such 
                capabilities or backgrounds, including security 
                clearance processing, and actions necessary to overcome 
                such barriers.</DELETED>
                <DELETED>    (D) Specific objectives to be accomplished 
                during each year of the first 5-year period beginning 
                on the date that the strategy is submitted to the 
                appropriate committees of Congress and tasks to 
                accomplish such objectives, including--</DELETED>
                        <DELETED>    (i) a list prioritizing such 
                        objectives and tasks; and</DELETED>
                        <DELETED>    (ii) a schedule for meeting such 
                        objectives and carrying out such 
                        tasks.</DELETED>
                <DELETED>    (E) Assignments of roles and 
                responsibilities to elements of the intelligence 
                community to carry out the strategy.</DELETED>
                <DELETED>    (F) The personnel, financial, and other 
                resources necessary to implement the strategy, and a 
                plan for obtaining such resources.</DELETED>
                <DELETED>    (G) Metrics for measuring the 
                effectiveness and efficiency of the strategy.</DELETED>
                <DELETED>    (H) A schedule for assessment, review, 
                and, as appropriate, revision of the 
                strategy.</DELETED>
<DELETED>    (c) Requirement for Reports.--</DELETED>
        <DELETED>    (1) In general.--Not less frequently than once 
        during each 180-day period after the date of the submission of 
        the strategy required by subsection (b)(1) to the appropriate 
        committees of Congress, the Director shall submit to the 
        appropriate committees of Congress a report on the 
        implementation of such strategy.</DELETED>
        <DELETED>    (2) Content.--Each report required by paragraph 
        (1) shall include the following:</DELETED>
                <DELETED>    (A) An assessment of whether the 
                objectives referred to in subsection (b)(2)(D) have 
                been accomplished in accordance with the proposed 
                schedule.</DELETED>
                <DELETED>    (B) Data corresponding to the metrics 
                required by subsection (b)(2)(G) for measuring the 
                effectiveness and efficiency of the strategy.</DELETED>
                <DELETED>    (C) An assessment of the actions by the 
                elements of the intelligence community to implement the 
                strategy.</DELETED>
                <DELETED>    (D) An assessment of whether the 
                personnel, financial, and other resources available are 
                sufficient to implement the strategy.</DELETED>
                <DELETED>    (E) A description of any revisions to, or 
                plans to revise, any component of the 
                strategy.</DELETED>
        <DELETED>    (3) Sunset date.--The requirement set forth in 
        paragraph (1) shall terminate 5 years after the date of the 
        submission of the strategy required by subsection (b)(1) to the 
        appropriate committees of Congress.</DELETED>

<DELETED>SEC. 403. COUNTERTERRORISM TECHNOLOGY ASSESSMENTS.</DELETED>

<DELETED>    (a) Agency Defined.--In this section, the term ``agency'' 
means any department, agency, or instrumentality of the executive 
branch of the Government.</DELETED>
<DELETED>    (b) Requirement for Interdisciplinary Capability of the 
Congressional Research Service.--</DELETED>
        <DELETED>    (1) In general.--The Director of the Congressional 
        Research Service shall establish an interdisciplinary 
        capability to further the Congressional Research Service's 
        responsibilities to advise Congress pursuant to section 203(d) 
        of the Legislative Reorganization Act of 1946 (2 U.S.C. 166(d)) 
        concerning technology or technological applications developed 
        or used for countering terrorism.</DELETED>
        <DELETED>    (2) Authorization of appropriations.--There is 
        authorized to be appropriated to implement this subsection the 
        following amounts:</DELETED>
                <DELETED>    (A) For fiscal year 2011, 
                $1,500,000.</DELETED>
                <DELETED>    (B) For fiscal year 2012, 
                $3,000,000.</DELETED>
                <DELETED>    (C) For fiscal year 2013, 
                $4,500,000.</DELETED>
                <DELETED>    (D) For fiscal year 2014, 
                $6,000,000.</DELETED>
                <DELETED>    (E) For fiscal year 2015 and for each 
                fiscal year thereafter, $7,500,000.</DELETED>
<DELETED>    (c) Assessments of Available Technology.--</DELETED>
        <DELETED>    (1) Requirement for assessments.--Pursuant to 
        section 717 of title 31, United States Code, the Comptroller 
        General of the United States shall conduct assessments of 
        technology or technological applications that are--</DELETED>
                <DELETED>    (A) being developed or used or are 
                available to be used for countering terrorism by a 
                program or activity that is carried out by an agency; 
                or</DELETED>
                <DELETED>    (B) proposed to be developed or used or 
                are potentially available to be used pursuant to--
                </DELETED>
                        <DELETED>    (i) a legislative proposal under 
                        consideration by a committee of the Senate or 
                        the House of Representatives; or</DELETED>
                        <DELETED>    (ii) a recommendation submitted to 
                        Congress by the President or an 
                        agency.</DELETED>
        <DELETED>    (2) Scope of assessment.--Each assessment of a 
        technology or technological application carried out under 
        paragraph (1) shall evaluate the actual or anticipated impact, 
        effectiveness, or efficiency of the technology or technological 
        application for countering terrorism, including evaluating--
        </DELETED>
                <DELETED>    (A) any test results related to the 
                technology or technological application;</DELETED>
                <DELETED>    (B) any alternatives to the technology or 
                technological application;</DELETED>
                <DELETED>    (C) the actual or anticipated operational 
                requirements of the technology or technological 
                application, including the logistical needs, personnel 
                training, and procedures for utilizing the technology 
                or technological application;</DELETED>
                <DELETED>    (D) the actual or anticipated costs, as 
                compared to the actual or anticipated benefits of the 
                technology or technological application;</DELETED>
                <DELETED>    (E) any actual or anticipated 
                countermeasures to the technology or technological 
                application by terrorists; and</DELETED>
                <DELETED>    (F) technology assessments or related 
                reports prepared by or for an agency for the technology 
                or technological application.</DELETED>
        <DELETED>    (3) Technology assessment capability.--</DELETED>
                <DELETED>    (A) Requirement to establish.--The 
                Comptroller General of the United States shall 
                establish an interdisciplinary capability to perform 
                the assessments required by paragraph (1) that includes 
                officers and employees who have expertise in science, 
                engineering, technology, homeland security, 
                counterterrorism, or other fields that the Comptroller 
                General considers appropriate to conduct such 
                assessments.</DELETED>
                <DELETED>    (B) Appointment and procurement.--The 
                Comptroller General shall appoint, pay, and assign 
                officers and employees pursuant to subsection (a) of 
                section 731 of title 31, United States Code, and may 
                procure the services or assistance of experts and 
                consultants pursuant to subsection (e) of such section, 
                in order to acquire the expertise in science, 
                technology, or other fields necessary to conduct the 
                assessments required by paragraph (1).</DELETED>
        <DELETED>    (4) Authorization of appropriations.--There is 
        authorized to be appropriated to implement this subsection the 
        following amounts:</DELETED>
                <DELETED>    (A) For fiscal year 2011, 
                $2,000,000.</DELETED>
                <DELETED>    (B) For fiscal year 2012, 
                $5,000,000.</DELETED>
                <DELETED>    (C) For fiscal year 2013, 
                $8,000,000.</DELETED>
                <DELETED>    (D) For fiscal year 2014, 
                $12,000,000.</DELETED>
                <DELETED>    (E) For fiscal year 2015 and for each 
                fiscal year thereafter, $15,000,000.</DELETED>
<DELETED>    (d) Assessments of Future Technology.--</DELETED>
        <DELETED>    (1) Requirement for assessments.--The Comptroller 
        General of the United States shall, as appropriate, enter into 
        arrangements with the National Academy of Sciences to assess 
        technology and technological applications that are being 
        developed or could be developed for purposes of countering 
        terrorism.</DELETED>
        <DELETED>    (2) Scope of assessments.--Each assessment carried 
        out under paragraph (1) shall include--</DELETED>
                <DELETED>    (A) determining trends related to the 
                development of technology or technological applications 
                and their implications for countering 
                terrorism;</DELETED>
                <DELETED>    (B) identifying particular technology or 
                technological applications that potentially may become 
                available or are necessary for countering terrorism; 
                and</DELETED>
                <DELETED>    (C) recommending investments to be made by 
                an agency in the development of particular technology 
                or technological applications.</DELETED>
        <DELETED>    (3) Authorization of appropriations.--There is 
        authorized to be appropriated to implement this subsection the 
        following amounts:</DELETED>
                <DELETED>    (A) For fiscal year 2011, 
                $1,000,000.</DELETED>
                <DELETED>    (B) For fiscal year 2012, 
                $2,000,000.</DELETED>
                <DELETED>    (C) For fiscal year 2013, 
                $3,000,000.</DELETED>
                <DELETED>    (D) For fiscal year 2014, 
                $4,000,000.</DELETED>
                <DELETED>    (E) For fiscal year 2015 and for each 
                fiscal year thereafter, $5,000,000.</DELETED>

<DELETED>TITLE V--EMERGENCY MANAGEMENT AND CITIZEN ENGAGEMENT</DELETED>

<DELETED>SEC. 501. COMMUNICATION OF THREAT INFORMATION AND 
              ALERTS.</DELETED>

<DELETED>    (a) Finding.--Congress finds that the Commission on the 
Prevention of Weapons of Mass Destruction Proliferation and Terrorism 
recommended that ``the Federal Government should practice greater 
openness of public information so that citizens better understand the 
threat and the risk this threat poses to them.''.</DELETED>
<DELETED>    (b) Terrorism Threat Awareness.--Section 203 of the 
Homeland Security Act of 2002 (6 U.S.C. 124) is amended by adding at 
the end the following:</DELETED>
<DELETED>    ``(c) Terrorism Threat Awareness.--</DELETED>
        <DELETED>    ``(1) Terrorism threat awareness.--The Secretary, 
        in coordination with the Director of the Federal Bureau of 
        Investigation, shall ensure that information concerning 
        terrorist threats is available to the general public within the 
        United States.</DELETED>
        <DELETED>    ``(2) Threat bulletins.--</DELETED>
                <DELETED>    ``(A) In general.--Consistent with the 
                requirements of subsection (b), the Secretary shall on 
                a timely basis prepare unclassified terrorism-related 
                threat and risk assessments.</DELETED>
                <DELETED>    ``(B) Requirements.--Each assessment 
                required under subparagraph (A) shall--</DELETED>
                        <DELETED>    ``(i) include guidance to the 
                        general public for preventing and responding to 
                        acts of terrorism; and</DELETED>
                        <DELETED>    ``(ii) be made available on the 
                        website of the Department and other publicly 
                        accessible websites, communication systems, and 
                        information networks.</DELETED>
        <DELETED>    ``(3) Guidance to state, local, and tribal 
        governments.--The Secretary shall provide to State, local, and 
        tribal governments written guidance on how to disseminate 
        information about terrorism-related threats and risks to the 
        general public within their jurisdictions.</DELETED>
        <DELETED>    ``(4) Use of existing resources.--The Secretary 
        shall use websites, communication systems, and information 
        networks in operation on the date of an assessment under this 
        subsection to satisfy the requirements of paragraph 
        (2)(B)(ii).''.</DELETED>
<DELETED>    (c) Responsibilities of the Secretary.--Section 201(d)(8) 
of the Homeland Security Act of 2002 (6 U.S.C. 121(d)(8)) is amended by 
striking ``and to agencies of State'' and all that follows and 
inserting ``to State, local, tribal, and private entities with such 
responsibilities, and, as appropriate, to the general public, in order 
to assist in deterring, preventing, or responding to acts of terrorism 
against the United States.''.</DELETED>
<DELETED>    (d) Reporting Requirement.--Not later than 180 days after 
the date of enactment of this Act, the Secretary of Homeland Security 
shall submit to the Committee on Homeland Security and Governmental 
Affairs of the Senate and the Committee on Homeland Security of the 
House of Representatives a report on the implementation of section 203 
of the Homeland Security Act of 2002, as amended by subsection 
(b).</DELETED>

<DELETED>SEC. 502. GUIDELINES CONCERNING WEAPONS OF MASS 
              DESTRUCTION.</DELETED>

<DELETED>    (a) Establishment of Guidelines.--Not later than 1 year 
after the date of enactment of this Act, the Secretary of Homeland 
Security shall--</DELETED>
        <DELETED>    (1) develop guidelines, in coordination with 
        State, local, and tribal governments and representatives of 
        emergency response provider organizations, for police, fire, 
        emergency medical services, emergency management, and public 
        health personnel, for responding to an explosion or release of 
        nuclear, biological, radiological, or chemical material; 
        and</DELETED>
        <DELETED>    (2) make the guidelines developed under paragraph 
        (1) available to State, local, and tribal governments, 
        nongovernmental organizations, and the private 
        sector.</DELETED>
<DELETED>    (b) Contents.--The guidelines developed under subsection 
(a)(1) shall contain, at a minimum--</DELETED>
        <DELETED>    (1) protective action guidelines for ensuring the 
        health and safety of emergency response providers;</DELETED>
        <DELETED>    (2) information regarding the effects of the 
        biological, chemical, or radiological agent on those exposed to 
        the agent; and</DELETED>
        <DELETED>    (3) information regarding how emergency response 
        providers and mass care facilities may most effectively deal 
        with individuals affected by an incident involving a nuclear, 
        biological, radiological, or chemical material.</DELETED>
<DELETED>    (c) Review and Revision of Guidelines.--The Secretary of 
Homeland Security shall--</DELETED>
        <DELETED>    (1) not less frequently than every 2 years, review 
        the guidelines developed under subsection (a)(1);</DELETED>
        <DELETED>    (2) make revisions to the guidelines as 
        appropriate; and</DELETED>
        <DELETED>    (3) make the revised guidelines available to 
        State, local, and tribal governments, nongovernmental 
        organizations, the private sector, and the general 
        public.</DELETED>
<DELETED>    (d) Procedures for Developing and Revising Guidelines.--In 
carrying out the requirements of this section, the Secretary of 
Homeland Security shall establish procedures--</DELETED>
        <DELETED>    (1) to inventory any existing relevant hazardous 
        material response guidelines;</DELETED>
        <DELETED>    (2) to enable the public to submit recommendations 
        of areas for which guidelines could be developed under 
        subsection (a)(1);</DELETED>
        <DELETED>    (3) to determine which entities should be 
        consulted in developing or revising the guidelines;</DELETED>
        <DELETED>    (4) to prioritize, on a regular basis, guidelines 
        that should be developed or revised; and</DELETED>
        <DELETED>    (5) to develop and disseminate the guidelines in 
        accordance with the prioritization under paragraph 
        (4).</DELETED>
<DELETED>    (e) Consultations.--The Secretary of Homeland Security 
shall develop and revise the guidelines developed under subsection 
(a)(1), and the procedures required under subsection (d), in 
consultation with--</DELETED>
        <DELETED>    (1) the Secretary of Energy;</DELETED>
        <DELETED>    (2) the Secretary of Health and Human 
        Services;</DELETED>
        <DELETED>    (3) other Federal departments and agencies, as 
        appropriate;</DELETED>
        <DELETED>    (4) the National Advisory Council established 
        under section 508 of the Homeland Security Act of 2002 (6 
        U.S.C. 318);</DELETED>
        <DELETED>    (5) State, local, and tribal governments; 
        and</DELETED>
        <DELETED>    (6) nongovernmental organizations and private 
        industry.</DELETED>
<DELETED>    (f) Reporting Requirements.--Not later than 180 days after 
the date of enactment of this Act, 1 year after such date of enactment, 
and annually thereafter, the Secretary of Homeland Security shall 
provide the Committee on Homeland Security and Governmental Affairs of 
the Senate and the Committee on Homeland Security of the House of 
Representatives with--</DELETED>
        <DELETED>    (1) a description of the procedures established 
        under subsection (d);</DELETED>
        <DELETED>    (2) any guidelines in effect on the date of the 
        report;</DELETED>
        <DELETED>    (3) a list of entities that to which the 
        guidelines described in paragraph (2) were 
        disseminated;</DELETED>
        <DELETED>    (4) a plan for reviewing the guidelines described 
        in paragraph (2), in accordance with subsection (e);</DELETED>
        <DELETED>    (5) the prioritized list of the guidelines 
        required under subsection (d)(4), and the methodology used by 
        the Secretary of Homeland Security for such prioritization; 
        and</DELETED>
        <DELETED>    (6) a plan for developing, revising, and 
        disseminating the guidelines.</DELETED>
<DELETED>    (g) Definition.--In this section, the term ``emergency 
response provider'' has the meaning given that term in section 2 of the 
Homeland Security Act of 2002 (6 U.S.C. 101).</DELETED>

<DELETED>SEC. 503. INDIVIDUAL AND COMMUNITY PREPAREDNESS.</DELETED>

<DELETED>    (a) Individual and Community Preparedness.--Title V of the 
Homeland Security Act of 2002 (6 U.S.C. 311 et seq.), as amended by 
section 221, is amended by adding at the end the following:</DELETED>

<DELETED>``SEC. 526. INDIVIDUAL AND COMMUNITY PREPAREDNESS.</DELETED>

<DELETED>    ``(a) In General.--The Administrator shall assist State, 
local, and tribal governments in improving and promoting individual and 
community preparedness for natural disasters, acts of terrorism, and 
other man-made disasters, including incidents involving the use of 
weapons of mass destruction and other potentially catastrophic events, 
by--</DELETED>
        <DELETED>    ``(1) developing guidelines and checklists of 
        recommended actions for individual and community prevention and 
        preparedness efforts and disseminating such guidelines and 
        checklists to communities and individuals;</DELETED>
        <DELETED>    ``(2) disseminating the guidelines developed under 
        section 502 of the Weapons of Mass Destruction Prevention and 
        Preparedness Act of 2009 to communities and individuals, as 
        appropriate;</DELETED>
        <DELETED>    ``(3) compiling and disseminating information on 
        best practices in individual and community 
        preparedness;</DELETED>
        <DELETED>    ``(4) providing information and training materials 
        in support of individual and community preparedness 
        efforts;</DELETED>
        <DELETED>    ``(5) conducting individual and community 
        preparedness outreach efforts; and</DELETED>
        <DELETED>    ``(6) such other actions as the Administrator 
        determines appropriate.</DELETED>
<DELETED>    ``(b) Coordination.--Where appropriate, the Administrator 
shall coordinate with private sector and nongovernmental organizations 
to promote individual and community preparedness.</DELETED>
<DELETED>    ``(c) Support for Voluntary Programs.--In carrying out the 
responsibilities described in subsection (a), the Administrator shall, 
where appropriate, work with and provide support to individual and 
community preparedness programs, such as the Community Emergency 
Response Team Program, Fire Corps, Medical Reserve Corps Program, 
Volunteers in Police Service, USAonWatch-Neighborhood Watch, and other 
voluntary programs.</DELETED>
<DELETED>    ``(d) Director.--The Administrator shall appoint a 
Director of Community Preparedness to coordinate and oversee the 
individual and community preparedness efforts of the Agency.</DELETED>
<DELETED>    ``(e) Grants.--</DELETED>
        <DELETED>    ``(1) In general.--The Administrator may make 
        grants to States to support individual and community 
        preparedness efforts, including through the Citizen Corps 
        Program.</DELETED>
        <DELETED>    ``(2) Appropriations.--There are authorized to be 
        appropriated for grants under this section--</DELETED>
                <DELETED>    ``(A) $15,000,000 for fiscal year 
                2010;</DELETED>
                <DELETED>    ``(B) $20,000,000 for fiscal year 
                2011;</DELETED>
                <DELETED>    ``(C) $25,000,000 for fiscal year 
                2012;</DELETED>
                <DELETED>    ``(D) $30,000,000 for fiscal year 
                2013;</DELETED>
                <DELETED>    ``(E) $35,000,000 for fiscal year 2014; 
                and</DELETED>
                <DELETED>    ``(F) $40,000,000 for fiscal year 
                2015.''.</DELETED>
<DELETED>    (b) Enhancing Preparedness.--Section 504(a) of the 
Homeland Security Act of 2002 (6 U.S.C. 314(a)) is amended--</DELETED>
        <DELETED>    (1) by redesignating paragraphs (20) and (21) as 
        paragraphs (21) and (22), respectively; and</DELETED>
        <DELETED>    (2) by inserting after paragraph (19) the 
        following:</DELETED>
        <DELETED>    ``(20) enhancing and promoting the preparedness of 
        individuals and communities for natural disasters, acts of 
        terrorism, and other man-made disasters;''.</DELETED>
<DELETED>    (c) Table of Contents.--The table of contents in section 
1(b) of the Homeland Security Act of 2002 (6 U.S.C. 101 et seq.), as 
amended by section 221, is amended by inserting after the item relating 
to section 525 the following:</DELETED>

<DELETED>``Sec. 526. Individual and community preparedness.''.

</DELETED>SECTION 1. SHORT TITLE; AND TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Weapons of Mass 
Destruction Prevention and Preparedness Act of 2009'' or the ``WMD 
Prevention and Preparedness Act of 2009''.
    (b) Table of Contents.--The table of contents is as follows:

Sec. 1. Short title; and table of contents.

                     TITLE I--ENHANCED BIOSECURITY

Sec. 101. Designation of Tier I agents.
Sec. 102. Enhanced biosecurity measures.
Sec. 103. Laboratory and facility registration and database.
Sec. 104. Background checks.
Sec. 105. Biological laboratory protection.
Sec. 106. Biosecurity information sharing.
Sec. 107. Research with the Variola virus genome.

       TITLE II--RESPONSE TO A WEAPON OF MASS DESTRUCTION ATTACK

     Subtitle A--Ensuring Access to Medical Countermeasures During 
                              Emergencies

Sec. 201. National Medical Countermeasure Dispensing Strategy.
Sec. 202. Tailoring of the national medical countermeasure dispensing 
                            strategy.
Sec. 203. Expansion in the use of the U.S. Postal Service to deliver 
                            medical countermeasures.
Sec. 204. Dispensing medical countermeasures through employers.
Sec. 205. Personal medkits for emergency response providers and members 
                            of preparedness organizations.
Sec. 206. General public medkit pilot program.
Sec. 207. Report on the use of expiring countermeasures.

           Subtitle B--Bioforensics Capabilities and Strategy

Sec. 211. Bioforensics capabilities and strategy.

                  Subtitle C--Communications Planning

Sec. 221. Communications planning.
Sec. 222. Plume modeling.

   TITLE III--INTERNATIONAL MEASURES TO PREVENT BIOLOGICAL TERRORISM

Subtitle A--Prevention and Protection Against International Biological 
                                Threats

Sec. 301. International Threat Assessment: Tier I Pathogen Facilities.
Sec. 302. Strengthening international biosecurity.
Sec. 303. Promoting secure biotechnology advancement.

                Subtitle B--Global Pathogen Surveillance

Sec. 321. Short title.
Sec. 322. Findings; purpose.
Sec. 323. Definitions.
Sec. 324. Eligibility for assistance.
Sec. 325. Restriction.
Sec. 326. Fellowship program.
Sec. 327. In-country training in laboratory techniques and disease and 
                            syndrome surveillance.
Sec. 328. Assistance for the purchase and maintenance of public health 
                            laboratory equipment and supplies.
Sec. 329. Assistance for improved communication of public health 
                            information.
Sec. 330. Assignment of public health personnel to United States 
                            missions and international organizations.
Sec. 331. Expansion of certain United States Government laboratories 
                            abroad.
Sec. 332. Assistance for international health networks and expansion of 
                            Field Epidemiology Training Programs.
Sec. 333. Reports.
Sec. 334. Authorization of appropriations.

  Subtitle C--Strengthening the Oversight of Nuclear Nonproliferation

Sec. 351. Definitions.
Sec. 352. Report on United States nuclear nonproliferation efforts.
Sec. 353. Report on United States work with IAEA on nuclear 
                            nonproliferation.
Sec. 354. Authorization of appropriations.

         Subtitle D--Energy Development Program Implementation

Sec. 361. Findings.
Sec. 362. Definitions.
Sec. 363. Energy development program implementation.
Sec. 364. Reports.

                   TITLE IV--GOVERNMENT ORGANIZATION

Sec. 401. Intelligence on weapons of mass destruction.
Sec. 402. Intelligence community language capabilities and cultural 
                            knowledge.
Sec. 403. Counterterrorism technology assessments.

          TITLE V--EMERGENCY MANAGEMENT AND CITIZEN ENGAGEMENT

Sec. 501. Communication of threat information and alerts.
Sec. 502. Guidelines concerning weapons of mass destruction.
Sec. 503. Individual and community preparedness.

                     TITLE I--ENHANCED BIOSECURITY

SEC. 101. DESIGNATION OF TIER I AGENTS.

    (a) Amendments to the Public Health Service Act.--Section 351A of 
the Public Health Service Act (42 U.S.C. 262a) is amended in subsection 
(a)--
            (1) by redesignating paragraph (2) as paragraph (3);
            (2) by inserting after paragraph (1) the following:
            ``(2) Tier i agents.--
                    ``(A) Designation of tier i agents.--Not later than 
                180 days after the date of enactment of the Weapons of 
                Mass Destruction Prevention and Preparedness Act of 
                2009, the Secretary, in coordination with the Secretary 
                of Homeland Security, shall by regulation designate as 
                `Tier I agents' those agents and toxins--
                            ``(i) for which the Secretary of Homeland 
                        Security has issued a Material Threat 
                        Determination under section 319F-2(c)(2) 
                        regarding the agent or toxin, unless the 
                        Secretary of Health and Human Services 
                        determines, in coordination with the Secretary 
                        of Homeland Security, that such designation is 
                        unwarranted; or
                            ``(ii) that meet the criteria under 
                        subparagraph (B).
                    ``(B) Criteria.--In determining whether to 
                designate an agent or toxin as a Tier I agent under 
                subparagraph (A), the Secretary, in coordination with 
                the Secretary of Homeland Security, shall consider--
                            ``(i) whether the agent or toxin has clear 
                        potential to be used effectively in a 
                        biological attack that causes significant 
                        casualties;
                            ``(ii) information available from any 
                        biological or bioterrorism risk assessments 
                        conducted by the Department of Homeland 
                        Security or relevant assessments by other 
                        agencies; and
                            ``(iii) such other criteria and information 
                        that the Secretary determines appropriate and 
                        relevant.
                    ``(C) Inclusion of agents and toxins not previously 
                listed.--All agents or toxins designated by the 
                Secretary as Tier I agents shall be included on the 
                list maintained by the Secretary pursuant to paragraph 
                (1).
                    ``(D) Evaluation of tier i agents.--The Secretary, 
                in coordination with the Secretary of Homeland 
                Security, shall--
                            ``(i) on an ongoing basis, consider the 
                        inclusion of additional agents or toxins on the 
                        list of Tier I agents, as appropriate; and
                            ``(ii) at least biennially, review the list 
                        of Tier I agents to determine whether any 
                        agents or toxins should be removed from the 
                        list.''; and
            (3) in paragraph (3), as so redesignated, by striking 
        ``list under paragraph (1)'' and inserting ``lists under 
        paragraphs (1) and (2)''.
    (b) Amendments to the Agricultural Bioterrorism Protection Act of 
2002.--Section 212(a) of the Agricultural Bioterrorism Protection Act 
of 2002 (7 U.S.C. 8401(a)) is amended--
            (1) by redesignating paragraph (2) as paragraph (3);
            (2) by inserting after paragraph (1) the following:
            ``(2) Tier i agents.--
                    ``(A) Designation of tier i agents.--Not later than 
                180 days after the date of enactment of the Weapons of 
                Mass Destruction Prevention and Preparedness Act of 
                2009, the Secretary, in coordination with the Secretary 
                of Homeland Security, shall by regulation designate as 
                `Tier I agents' those agents and toxins--
                            ``(i) for which the Secretary of Homeland 
                        Security has issued a Material Threat 
                        Determination under section 319F-2(c)(2) of the 
                        Public Health Service Act (42 U.S.C. 247d-
                        6b(c)(2)) regarding the agent or toxin, unless 
                        the Secretary of Agriculture determines, in 
                        coordination with the Secretary of Homeland 
                        Security, that such designation is unwarranted; 
                        or
                            ``(ii) that meet the criteria under 
                        subparagraph (B).
                    ``(B) Criteria.--In determining whether to 
                designate an agent or toxin as a Tier I agent under 
                subparagraph (A), the Secretary, in coordination with 
                the Secretary of Homeland Security, shall consider--
                            ``(i) whether the agent or toxin has clear 
                        potential to be used effectively in a 
                        biological attack that causes catastrophic 
                        consequences;
                            ``(ii) information available from any 
                        biological or bioterrorism risk assessments 
                        conducted by the Department of Homeland 
                        Security or relevant assessments by other 
                        agencies; and
                            ``(iii) such other criteria and information 
                        that the Secretary determines appropriate and 
                        relevant.
                    ``(C) Inclusion of agents and toxins not previously 
                listed.--All agents or toxins designated by the 
                Secretary as Tier I agents shall be included on the 
                list maintained by the Secretary pursuant to paragraph 
                (1).
                    ``(D) Evaluation of tier i agents.--The Secretary, 
                in coordination with the Secretary of Homeland 
                Security, shall--
                            ``(i) on an ongoing basis, consider the 
                        inclusion of additional agents or toxins on the 
                        list of Tier I agents, as appropriate; and
                            ``(ii) at least biennially, review the list 
                        of Tier I agents to determine whether any 
                        agents or toxins should be removed from the 
                        list.''; and
            (3) by striking ``list under paragraph (1)'' and inserting 
        ``lists under paragraphs (1) and (2)''.

SEC. 102. ENHANCED BIOSECURITY MEASURES.

    (a) In General.--Title III of the Homeland Security Act (6 U.S.C. 
181 et seq.) is amended by adding at the end the following:

``SEC. 318. ENHANCED BIOSECURITY MEASURES.

    ``(a) Definitions.--In this section:
            ``(1) Listed agent.--The term `listed agent' means an agent 
        or toxin included on--
                    ``(A) the list established and maintained by the 
                Secretary of Health and Human Services under section 
                351A(a)(1) of the Public Health Service Act (42 U.S.C. 
                262a(a)(1)); or
                    ``(B) the list established and maintained by the 
                Secretary of Agriculture under section 212(a)(1) of the 
                Agricultural Bioterrorism Protection Act of 2002 (7 
                U.S.C. 8401(a)(1)).
            ``(2) Person.--The term `person' has the meaning given that 
        term in section 351A(l)(6) of the Public Health Service Act (42 
        U.S.C. 262a(l)(6)).
            ``(3) Tier i agent.--The term `Tier I agent' means an agent 
        or toxin designated as a Tier I agent under section 351A(a)(2) 
        of the Public Health Service Act (42 U.S.C. 262a(a)(2)) or 
        section 212(a)(2) of the Agricultural Bioterrorism Protection 
        Act of 2002 (7 U.S.C. 8401(a)(2)).
    ``(b) Regulations.--The Secretary, in consultation with the 
Secretary of Health and Human Services and the Secretary of 
Agriculture, shall through a negotiated rulemaking under subchapter III 
of chapter 5 of title 5, United States Code, establish enhanced 
biosecurity measures for persons that possess, use, or transfer Tier I 
agents, which shall include--
            ``(1) standards for personnel reliability programs;
            ``(2) standards for biosecurity training of responsible 
        officials, laboratory personnel, and support personnel employed 
        by such persons;
            ``(3) standards for performing laboratory risk assessments;
            ``(4) risk-based laboratory security performance standards; 
        and
            ``(5) any other security standards jointly determined 
        necessary by the Secretary and the Secretary of Health and 
        Human Services.
    ``(c) Negotiated Rulemaking Committee.--The negotiated rulemaking 
committee established by the Secretary under subsection (b) shall 
include representatives from--
            ``(1) the Department;
            ``(2) the Department of Health and Human Services;
            ``(3) the Department of Agriculture;
            ``(4) the Department of Defense;
            ``(5) the Department of Energy;
            ``(6) the Department of Justice;
            ``(7) for profit research institutions;
            ``(8) academic research institutions;
            ``(9) nonprofit research institutions; and
            ``(10) other interested parties, as the Secretary 
        determines appropriate.
    ``(d) Time Requirement.--The procedures for the negotiated 
rulemaking conducted under subsection (b) shall be conducted in a 
timely manner to ensure that--
            ``(1) any recommendations with respect to proposed 
        regulations are provided to the Secretary not later than 6 
        months after the date of enactment of this section; and
            ``(2) a final rule is promulgated not later than 12 months 
        after the date of enactment of this section.
    ``(e) Factors To Be Considered.--In developing proposed and final 
standards under subsection (b), the Secretary and the negotiated 
rulemaking committee shall consider factors including--
            ``(1) the recommendations of the Commission on the 
        Prevention of Weapons of Mass Destruction Proliferation and 
        Terrorism (established under section 1851 of the Implementing 
        Recommendations of the 9/11 Commission Act of 2007 (Public Law 
        110-53; 121 Stat. 501)), the National Science Advisory Board 
        for Biosecurity (established under section 205 of the Pandemic 
        and All-Hazards Preparedness Act (Public Law 109-417; 120 Stat. 
        2851)), the Trans-Federal Task Force on Optimizing Biosafety 
        and Biocontainment Oversight, and any working group established 
        under Executive Order 13486 (74 Fed. Reg. 2289) relating to 
        strengthening laboratory biosecurity; and
            ``(2) how any disincentives to biological research arising 
        from enhanced biosecurity measures can be minimized.
    ``(f) Implementation of Enhanced Biosecurity Measures.--
            ``(1) Enforcement.--The Secretary, in consultation as 
        appropriate with the Secretary of Health and Human Services and 
        the Secretary of Agriculture, shall enforce the standards 
        promulgated under subsection (b).
            ``(2) Training programs.--The Secretary of Health and Human 
        Services, in consultation with the Secretary, shall develop or 
        approve training programs that meet the standards promulgated 
        under subsection (b).
            ``(3) Harmonization of regulations.--
                    ``(A) Regulations under public health service 
                act.--Not later than 120 days after the Secretary 
                promulgates regulations or amendments thereto pursuant 
                to this section, the Secretary of Health and Human 
                Services shall amend regulations promulgated under the 
                Select Agent Program under section 351A(b)(1) of the 
                Public Health Service Act (42 U.S.C. 262a(b)(1)) to 
                ensure that such regulations do not overlap or conflict 
                with the regulations promulgated by the Secretary under 
                this section.
                    ``(B) Regulations under agriculture bioterrorism 
                protection act of 2002.--Not later than 120 days after 
                the Secretary promulgates regulations or amendments 
                thereto pursuant to this section, the Secretary of 
                Agriculture shall amend regulations promulgated under 
                the Select Agent Program under section 212(b)(1) of the 
                Agricultural Bioterrorism Protection Act of 2002 (7 
                U.S.C. 8401(b)(1)) to ensure that such regulations do 
                not overlap or conflict with the regulations 
                promulgated by the Secretary under this section.
            ``(4) Penalties.--
                    ``(A) Civil money penalty.--In addition to any 
                other penalties that may apply under law, any person 
                who violates any provision of regulations promulgated 
                under subsection (b) shall be subject to a civil money 
                penalty in an amount not exceeding $250,000 in the case 
                of an individual and $500,000 in the case of any other 
                person that possesses, uses, or transfers a Tier I 
                agent.
                    ``(B) Intermediate sanctions.--
                            ``(i) In general.--If the Secretary 
                        determines that a person has violated any 
                        provision of regulations promulgated under this 
                        section, the Secretary may impose intermediate 
                        sanctions in lieu of the actions authorized by 
                        subsection (A).
                            ``(ii) Types of sanctions.--The 
                        intermediate sanctions which may be imposed 
                        under paragraph (1) shall consist of--
                                    ``(I) directed plans of correction;
                                    ``(II) civil money penalties in an 
                                amount not to exceed $10,000 for each 
                                violation of, or for each day of 
                                substantial noncompliance with, the 
                                regulations promulgated under this 
                                section;
                                    ``(III) payment for the costs of 
                                onsite monitoring; or
                                    ``(IV) any combination of the 
                                actions described in subclauses (I), 
                                (II), and (III).
                    ``(C) Suspension of research and funding.--
                            ``(i) In general.--If the Secretary 
                        determines that a person has violated any 
                        provision of the regulations promulgated under 
                        subsection (b) and that the violation has 
                        endangered security, the Secretary may suspend 
                        the authority of the person to possess, use, or 
                        transfer Tier I agents until the violation has 
                        been remedied.
                            ``(ii) Notice.--If the Secretary suspends 
                        the authority of a person to possess, use, or 
                        transfer Tier I agents under clause (i), the 
                        Secretary shall notify each executive agency 
                        that provides funding for research on Tier I 
                        agents by the person.
                            ``(iii) Suspension.--If the head of an 
                        executive agency receives notice under clause 
                        (ii), the head of the executive agency may 
                        suspend the provision of funds to the person 
                        for research on Tier I agents.
                            ``(iv) Rule of construction.--Nothing in 
                        this subparagraph shall be construed to limit 
                        or modify the authority to suspend the 
                        authority of a person to possess, use, or 
                        transfer Tier I agents, or to suspend funding 
                        for research under any other provision of law.
                    ``(D) Procedures.--The Secretary shall develop and 
                implement procedures with respect to when and how 
                penalties or intermediate sanctions are to be imposed 
                under this paragraph. Such procedures shall provide for 
                notice to the person, a reasonable opportunity to 
                respond to the proposed penalty or intermediate 
                sanction, and appropriate procedures for appealing 
                determinations relating to the imposition of a penalty 
                or intermediate sanction.
            ``(5) Simultaneous laboratory inspections.--
                    ``(A) Inspections by the department of homeland 
                security.--The Secretary shall have the authority to 
                inspect persons subject to the regulations promulgated 
                under subsection (b) to ensure compliance with the 
                regulations by such persons.
                    ``(B) Simultaneous inspections.--All Federal 
                agencies conducting inspections of a person to ensure 
                compliance with regulations promulgated under 
                subsection (b), regulations promulgated under section 
                351A(b)(1) of the Public Health Service Act (42 U.S.C. 
                262a(b)(1)), regulations promulgated under section 
                212(b)(1) of the Agricultural Bioterrorism Protection 
                Act of 2002 (7 U.S.C. 8401(b)(1)), or security 
                standards applicable under a contract between a Federal 
                agency and the person shall be conducted simultaneously 
                to the extent practicable.
                    ``(C) Joint inspection procedures.--Federal 
                agencies conducting simultaneous inspections of a 
                person under this paragraph shall cooperate, to the 
                maximum extent practicable, to ensure that the 
                inspections are conducted efficiently and in a manner 
                that minimizes the administrative burden on the person.
                    ``(D) Inspection reports.--Any report of inspection 
                of a person conducted by a Federal agency to enforce 
                regulations promulgated under subsection (b), 
                regulations promulgated under section 351A(b)(1) of the 
                Public Health Service Act (42 U.S.C. 262a(b)(1)), 
                regulations promulgated under section 212(b)(1) of the 
                Agricultural Bioterrorism Protection Act of 2002 (7 
                U.S.C. 8401(b)(1)), or security standards applicable 
                under a contract between the Federal agency and the 
                person shall be made available to any other Federal 
                agency that enforces any such regulations with respect 
                to the person or that funds research of a Tier I agent 
                or a listed agent by the person.''.
    (b) Authorization of Appropriations.--There are authorized to be 
appropriated such sums as may be necessary to carry out this section 
and the amendments made by this section.
    (c) Technical and Conforming Amendment.--The table of contents in 
section 1(b) of the Homeland Security Act of 2002 (6 U.S.C. 101 et 
seq.) is amended by inserting after the item relating to section 317 
the following:

``Sec. 318. Enhanced biosecurity measures.''.

SEC. 103. LABORATORY AND FACILITY REGISTRATION AND DATABASE.

    (a) In General.--Section 351A of the Public Health Service Act (42 
U.S.C. 262a) is amended--
            (1) by redesignating subsections (f) through (m) as (g) 
        through (n) respectively; and
            (2) by inserting after subsection (e) the following:
    ``(f) Laboratory and Facility Registration and Database.--
            ``(1) In general.--The Secretary, in coordination with the 
        Secretary of Homeland Security and the Secretary of 
        Agriculture, shall by regulation establish criteria defining 
        characteristics, features, or equipment that could facilitate 
        the misuse of a laboratory or other facility for the purposes 
        of developing a biological weapon, which may include--
                    ``(A) technology that is particularly suitable to 
                the development of an effective biological weapon, such 
                as technology that would enable synthesis of Tier I 
                agents;
                    ``(B) features that would enable an individual to 
                develop a biological weapon while escaping detection; 
                and
                    ``(C) such other characteristics as the Secretary 
                determines appropriate.
            ``(2) Registry agents.--
                    ``(A) In general.--The Secretary, in coordination 
                with the Secretary of Agriculture and the Secretary of 
                Homeland Security, shall establish and maintain by 
                regulation a list of biological agents and toxins that 
                have the potential to pose a severe threat to public, 
                animal, or plant health but for which the potential to 
                be used in a biological attack has not been 
                established.
                    ``(B) Designation.--Agents listed pursuant to 
                subparagraph (A) shall be designated as `Registry 
                Agents'.
                    ``(C) Exclusion of select agents.--In determining 
                whether to designate a biological agent or toxin as a 
                Registry Agent, the Secretary shall exclude agents or 
                toxins listed pursuant to subsection (a)(1) of this 
                section and section 212(a)(1) of the Agricultural 
                Bioterrorism Protection Act of 2002.
            ``(3) Regulations governing registration and database.--
                    ``(A) Regulations requiring registration.--The 
                Secretary shall by regulation require the registration 
                with the Secretary of laboratories or other facilities 
                that--
                            ``(i) meet the criteria established 
                        pursuant to paragraph (1); or
                            ``(ii) possess, use, or transfer Registry 
                        Agents designated under paragraph (2).
                    ``(B) Database.--The Secretary shall maintain a 
                national database that includes the locations of each 
                laboratory or other facility required to be registered 
                under this subsection, the criteria established 
                pursuant to paragraph (1) that are applicable to the 
                laboratory or facility, the Registry Agents that are 
                possessed or used at or transferred by the laboratory 
                or facility, and the name of the person that owns or 
                controls the laboratory or facility.
                    ``(C) Additional registration requirements.--An 
                individual who possesses, uses, or transfers Registry 
                Agents at a location other than a laboratory or other 
                facility shall be required to register with the 
                Secretary pursuant to this subsection.
            ``(4) Penalties.--In addition to any other penalties that 
        may apply under law, any person who violates any provision of 
        this subsection shall be subject to the United States for a 
        civil penalty in an amount not to exceed $25,000 in the case of 
        an individual and $50,000 in the case of any other person.
            ``(5) Access to database.--The Secretary shall make the 
        database established under paragraph (3) available to the 
        Secretary of Homeland Security, the Secretary of Agriculture, 
        the Secretary of Defense, the Attorney General, and such 
        agencies as the Secretary determines appropriate.
            ``(6) Biosecurity and biosafety best practices.--The 
        Secretary, in consultation with the Secretary of Homeland 
        Security and the Secretary of Agriculture, shall promote 
        biosecurity and biosafety best practices to entities registered 
        under paragraph (3).
            ``(7) Disclosure of information.--No Federal agency shall 
        disclose under section 552 of title 5, United States Code, any 
        information contained in the database established pursuant to 
        paragraph (3).''.
    (b) Revision of the List of Biological Agents and Toxins.--
            (1) Review of listed agents.--
                    (A) Review by the secretary of health and human 
                services.--Not later than 180 days after the 
                establishment of the list pursuant to subsection (f)(2) 
                of section 351A of the Public Health Service Act (as 
                added by subsection (a)), the Secretary of Health and 
                Human Services shall conduct a comprehensive review of 
                the list of biological agents and toxins maintained 
                pursuant to subsection (a)(1) of such section to 
                determine which listed agents and toxins should instead 
                be listed as Registry Agents (as described under such 
                subsection (f)(2)).
                    (B) Review by the secretary of agriculture.--Not 
                later than 180 days after the establishment of the list 
                pursuant to subsection (f)(2) of section 351A of the 
                Public Health Service Act (as amended by subsection 
                (a)), the Secretary of Agriculture shall conduct a 
                comprehensive review of the list of biological agents 
                and toxins maintained pursuant to section 212(a)(1) of 
                the Agricultural Bioterrorism Protection Act of 2002 (7 
                U.S.C. 8401(a)(1)) to determine which listed agents and 
                toxins should instead be listed as Registry Agents (as 
                described under such subsection (f)(2)).
            (2) Amendments to the public health service act.--
                    (A) Criteria.--Section 351A(a)(1)(B)(i) of the 
                Public Health Service Act (42 U.S.C. 262a(a)(1)(B)(i)) 
                is amended--
                            (i) by redesignating subclauses (III) and 
                        (IV) as subclauses (IV) and (V), respectively; 
                        and
                            (ii) by inserting after subclause (II) the 
                        following:
                                    ``(III) the suitability of the 
                                agent or toxin to be used in a 
                                biological attack;''.
                    (B) Exemptions for clinical or diagnostic 
                laboratories.--Section 351A(h)(1) of the Public Health 
                Service Act (42 U.S.C. 262a(h)(1)), as redesignated by 
                subsection (a), is amended by striking ``subsections 
                (b) and (c)'' and inserting ``subsections (b), (c), and 
                (f)''.
            (3) Amendments to the agricultural bioterrorism protection 
        act.--Section 212(a)(1)(B)(i) of the Agricultural Bioterrorism 
        Protection Act of 2002 (7 U.S.C. 8401(a)(1)(B)(i)) is amended--
                    (A) by redesignating subclauses (III) and (IV) as 
                subclauses (IV) and (V), respectively; and
                    (B) by inserting after subclause (II) the 
                following:
                                    ``(III) the suitability of the 
                                agent or toxin to be used in a 
                                biological attack;''.
    (c) Authorization of Appropriations.--There are authorized to be 
appropriated such sums as may be necessary to carry out this section.
    (d) Conforming Amendments.--
            (1) Public health service act.--Section 351A of the Public 
        Health Service Act (42 U.S.C. 262a) is amended--
                    (A) in subsection (e)(7)(B)(ii) by striking 
                ``subsection (h)'' and inserting ``subsection (i)'';
                    (B) in subsection (i)(1)(E), as redesignated by 
                subsection (a), by striking ``subsection (f)'' and 
                inserting ``subsection (g)'';
                    (C) in subsection (k), as so redesignated, by 
                striking ``subsection (l)'' and inserting ``subsection 
                (m)''; and
                    (D) in subsection (l), as so redesignated, by 
                striking ``subsection (j)'' and inserting ``subsection 
                (k)''.
            (2) Agricultural bioterrorism protection act of 2002.--
        Section 212(g)(1)(E) of the Agricultural Bioterrorism 
        Protection Act of 2002 (7 U.S.C. 8401(g)(1)(E)) is amended by 
        striking ``351A(g)(3)'' and inserting ``351A(h)(3)''.

SEC. 104. BACKGROUND CHECKS.

    Section 351A(e)(3)(A) of the Public Health Service Act (42 U.S.C. 
262a(e)(3)(A)) is amended by adding at the end the following: ``In 
identifying whether an individual is within a category specified in 
subparagraph (B)(ii)(II), the Attorney General shall consult with the 
Secretary of Homeland Security to determine if the Department of 
Homeland Security possesses any information relevant to the 
identification of such an individual by the Attorney General.''.

SEC. 105. BIOLOGICAL LABORATORY PROTECTION.

    (a) Academic and Nonprofit High Containment Biological Laboratory 
Protection Grants.--
            (1) Grants authorized.--The Secretary of Homeland Security, 
        acting through the Administrator of the Federal Emergency 
        Management Agency, may award grants to academic and nonprofit 
        organizations and to State, local, and tribal governments to 
        implement security improvements at laboratories of such 
        organizations and governments that possess, use, or transfer 
        Tier I agents or toxins, as so designated under section 
        351A(a)(2) of the Public Health Service Act or section 
        212(a)(2) of the Agricultural Bioterrorism Protection Act of 
        2002, as amended by this Act.
            (2) Authorization of appropriations.--There are authorized 
        to be appropriated to the Department of Homeland Security to 
        carry out this subsection, $50,000,000 for each of fiscal years 
        2011 through 2014.
    (b) Voluntary Vulnerability Assessments.--In carrying out section 
201(d)(2) of the Homeland Security Act of 2002 (6 U.S.C. 121(d)(2)), 
the Secretary of Homeland Security shall encourage the voluntary 
participation of laboratories working with biological agents and 
toxins, as so designated under section 351A(a)(1) of the Public Health 
Service Act (42 U.S.C. 262a(a)(1)) or section 212(a)(1) of the 
Agricultural Bioterrorism Protection Act of 2002 (7 U.S.C. 8401(a)(1)), 
commensurate with the risks such agents and toxins pose.

SEC. 106. BIOSECURITY INFORMATION SHARING.

    (a) Amendment to the Public Health Service Act.--Section 351A(d) of 
the Public Health Service Act (42 U.S.C. 262a(d)) is amended by 
inserting after paragraph (2) the following:
            ``(3) Federal agency access.--The Secretary shall ensure 
        access to the database established pursuant to paragraph (2) by 
        the Secretary of Agriculture, the Secretary of Homeland 
        Security, the Attorney General, the Secretary of Energy, the 
        Secretary of Defense, and any other Federal agency that the 
        Secretary determines appropriate.''.
    (b) Amendment to the Agricultural Bioterrorism Protection Act of 
2002.--Section 212(d) of the Agricultural Bioterrorism Protection Act 
of 2002 (7 U.S.C. 8401(d)) is amended by inserting after paragraph (2) 
the following:
            ``(3) Federal agency access.--The Secretary shall ensure 
        access to the database established pursuant to paragraph (2) by 
        the Secretary of Health and Human Services, the Secretary of 
        Homeland Security, the Attorney General, the Secretary of 
        Energy, the Secretary of Defense, and any other Federal agency 
        that the Secretary determines appropriate.''.
    (c) Amendment to the Homeland Security Act of 2002.--Title III of 
the Homeland Security Act of 2002 (6 U.S.C. 181 et seq.), as amended by 
section 102, is amended by adding at the end the following:

``SEC. 319. BIOSECURITY INFORMATION SHARING.

    ``(a) In General.--Consistent with the responsibilities under 
section 201(d), the Secretary shall ensure that State, local, and 
tribal governments have access to relevant safety and security 
information relating to biological laboratories and facilities in or in 
close proximity to the jurisdiction of the State, local, or tribal 
government, as the Secretary determines appropriate.
    ``(b) Access to Information in Databases.--In carrying out this 
section, the Secretary may utilize information from the national 
databases established under subsections (d)(2) and (f)(3) of section 
351A of the Public Health Service Act (42 U.S.C. 262a) and section 
212(d)(2) of the Agricultural Bioterrorism Protection Act of 2002 (7 
U.S.C. 8401(d)(2)).
    ``(c) Classified and Sensitive Information.--The Secretary shall 
ensure that any information disseminated under this section is 
disseminated consistent with--
            ``(1) the authority of the Director of National 
        Intelligence to protect intelligence sources and methods under 
        the National Security Act of 1947 (50 U.S.C. 401 et seq.) and 
        related procedures or similar authorities of the Attorney 
        General concerning sensitive law enforcement information;
            ``(2) section 552a of title 5, United States Code (commonly 
        referred to as the Privacy Act of 1974); and
            ``(3) other relevant laws.''.
    (d) Technical and Conforming Amendment.--The table of contents in 
section 1(b) of the Homeland Security Act of 2002 (6 U.S.C. 101 et 
seq.) is amended by inserting after the item relating to section 318, 
as added by section 102, the following:

``Sec. 319. Biosecurity information sharing.''.

SEC. 107. RESEARCH WITH THE VARIOLA VIRUS GENOME.

    (a) Regulations.--For the purposes of preventing a reengineering of 
the live Variola virus from Variola virus DNA fragments or parts of the 
Variola virus genome, not later than 180 days after the date of 
enactment of this Act, the Secretary of Health and Human Services, in 
consultation with the Secretary of Homeland Security, shall promulgate 
regulations governing the distribution, synthesis, and handling of 
Variola virus DNA.
    (b) Considerations.--The regulations promulgated under subsection 
(a) shall take into account--
            (1) the recommendations issued by the World Health 
        Organization concerning the distribution, handling, and 
        synthesis or Variola virus DNA in May 2008; and
            (2) the continuing importance of research by the legitimate 
        scientific community with fragments of the Variola virus genome 
        for the purposes of preventing smallpox or developing vaccines 
        or treatments against smallpox.
    (c) Inclusions.--The regulations promulgated under subsection (a) 
shall include regulations regarding--
            (1) which research entities are qualified to receive 
        Variola virus DNA fragments taking into account adequate 
        security and safety measures;
            (2) the rules under which distribution to qualifying 
        research entities may occur;
            (3) the appropriate limits on the numbers of and length of 
        base pairs of Variola virus DNA that can be handled by a 
        qualifying laboratory;
            (4) the appropriate limits on the total genome size of 
        Variola virus DNA fragments that may be handled by a qualifying 
        laboratory;
            (5) the appropriate limits on synthesizing Variola virus 
        DNA; and
            (6) any other matters determined necessary by the Secretary 
        to carry out the purposes of section 351A(a) of the Public 
        Health Service Act (as amended by this Act).

       TITLE II--RESPONSE TO A WEAPON OF MASS DESTRUCTION ATTACK

     Subtitle A--Ensuring Access to Medical Countermeasures During 
                              Emergencies

SEC. 201. NATIONAL MEDICAL COUNTERMEASURE DISPENSING STRATEGY.

    Title III of the Public Health Service Act (42 U.S.C. 241 et seq.) 
is amended by inserting after section 319M the following:

``SEC. 319N. NATIONAL MEDICAL COUNTERMEASURE DISPENSING STRATEGY.

    ``(a) Definitions.--In this section--
            ``(1) the term `appropriate committees of Congress' means--
                    ``(A) the Committee on Homeland Security and 
                Governmental Affairs and the Committee on Health, 
                Education, Labor, and Pensions of the Senate; and
                    ``(B) the Committee on Homeland Security, the 
                Committee on Energy and Commerce, and the Committee on 
                Oversight and Government Reform of the House of 
                Representatives;
            ``(2) the term `dispense' means to provide medical 
        countermeasures to an affected population in response to a 
        threat or incident;
            ``(3) the term `medical countermeasure' means a drug (as 
        that term is defined in section 201(g)(1) of the Federal Food, 
        Drug, and Cosmetic Act), a device (as that term is defined in 
        section 201(h) of such Act), or a biological product (as that 
        term is defined in section 351 of this Act), to--
                    ``(A) diagnose, mitigate, prevent, or treat harm 
                from any biological agent (including organisms that 
                cause an infectious disease) or toxin, chemical, 
                radiological, or nuclear agent that may cause a public 
                health emergency; or
                    ``(B) diagnose, mitigate, prevent, or treat harm 
                from a condition that may result in adverse health 
                consequences or death and may be caused by 
                administering a drug, biological product, or device; 
                and
            ``(4) the term `public health emergency' means a public 
        health emergency declared by the Secretary under section 319.
    ``(b) Strategy.--The Secretary, in coordination with the Secretary 
of Homeland Security and the Postmaster General, shall develop, 
coordinate, and maintain a National Medical Countermeasure Dispensing 
Strategy (referred to in this section as the `National MCM Dispensing 
Strategy').
    ``(c) Contents.--The National MCM Dispensing Strategy shall--
            ``(1) encompass all aspects of the Federal role in 
        dispensing medical countermeasures (referred to in this section 
        as `MCMs') and describe methods by which the Federal Government 
        may assist State, local, and tribal governments to dispense 
        MCMs;
            ``(2) address a variety of geographical areas, population 
        densities, and demographics;
            ``(3) create a multilayered approach for the dispensing of 
        MCMs that includes redundancies;
            ``(4) address--
                    ``(A) a staffing plan for dispensing MCMs, 
                including--
                            ``(i) for MCM dispensing locations; and
                            ``(ii) for dispensing through the United 
                        States Postal Service;
                    ``(B) requirements for timeliness of MCM 
                dispensing;
                    ``(C) appropriateness, effectiveness, and 
                efficiency of differing methods of MCM dispensing;
                    ``(D) measures and evaluations of MCM dispensing 
                effectiveness and efficiency;
                    ``(E) liability issues associated with MCM 
                dispensing, considering--
                            ``(i) the volunteer force;
                            ``(ii) medical personnel;
                            ``(iii) potential adverse reactions to 
                        medications;
                            ``(iv) participating employees of the 
                        United States Postal Service; and
                            ``(v) security personnel;
                    ``(F) security issues, including--
                            ``(i) partnerships with law enforcement; 
                        and
                            ``(ii) necessary levels of security to 
                        protect MCM dispensing locations and related 
                        personnel, participating employees of the 
                        United States Postal Service, and 
                        transportation of MCMs;
                    ``(G) communications issues, including--
                            ``(i) communications between the Federal, 
                        State, local, and tribal government officials 
                        that may be involved in dispensing MCMs;
                            ``(ii) communications between the 
                        government and private sector; and
                            ``(iii) the creation of prescripted 
                        messages or message templates so that 
                        information about how people can acquire MCMs 
                        can be disseminated quickly in anticipation of 
                        or in the immediate aftermath of a biological 
                        attack or a naturally occurring disease 
                        outbreak;
                    ``(H) transportation of MCMs to dispensing 
                locations;
                    ``(I) implementation and operations of dispensing 
                plans;
                    ``(J) necessary levels of Federal technical 
                assistance in developing MCM dispensing capabilities;
                    ``(K) measures that are necessary in order so that 
                actions taken pursuant to the National MCM Dispensing 
                Strategy will comply with applicable requirements of 
                the Federal Food, Drug, and Cosmetic Act and of section 
                351 of this Act; and
                    ``(L) any other topics that the Secretary 
                determines appropriate; and
            ``(5) be exercised regularly in various jurisdictions.
    ``(d) Coordination.--Where appropriate, the Secretary, in 
coordination with the Secretary of Homeland Security and the Postmaster 
General, shall coordinate with State, local, and tribal government 
officials, private sector, and nongovernmental organizations in 
development of the National MCM Dispensing Strategy.
    ``(e) Reports to Congress.--
            ``(1) In general.--The Secretary, in coordination with the 
        Secretary of Homeland Security and the Postmaster General, 
        shall--
                    ``(A) not later than 180 days after the date of 
                enactment of this section, submit the National MCM 
                Dispensing Strategy to the appropriate committees of 
                Congress; and
                    ``(B) not later than 180 days after the submission 
                of the Strategy under subparagraph (A), submit an 
                implementation plan for such Strategy to the 
                appropriate committees of Congress.
            ``(2) Status report.--Not later than 1 year after the 
        submission of the implementation plan under paragraph (1)(B), 
        the Secretary, in coordination with the Secretary of Homeland 
        Security and the Postmaster General, shall submit to the 
        appropriate committees of Congress a report describing the 
        status of the activities taken pursuant to the implementation 
        plan.''.

SEC. 202. TAILORING OF THE NATIONAL MEDICAL COUNTERMEASURE DISPENSING 
              STRATEGY.

    (a) In General.--
            (1) Plans.--The Secretary of Health and Human Services, in 
        coordination with the Secretary of Homeland Security and, where 
        appropriate, the Postmaster General, shall tailor 
        implementation of the National MCM Dispensing Strategy 
        established under section 319N of the Public Health Service Act 
        (as added by section 201) for--
                    (A) Cities Readiness Initiative jurisdictions and 
                other densely populated metropolitan areas deemed at 
                highest risk of being the target of a terrorist attack;
                    (B) representative localities of varying geographic 
                sizes, population densities, and demographics; and
                    (C) any other unique or specific local needs the 
                Secretary of Health and Human Services deems 
                appropriate.
            (2) Consultation with state, local, and tribal 
        governments.--In fulfilling the requirements of paragraph (1), 
        the Secretary of Health and Human Services, in coordination 
        with the Secretary of Homeland Security and, where appropriate, 
        the Postmaster General, shall consult with State, local, and 
        tribal officials.
            (3) Review.--The Secretary of Homeland Security, during and 
        in conjunction with the creation of tailored National MCM 
        Dispensing Strategy plans under paragraph (1), shall--
                    (A) provide a review of transportation and 
                logistics capabilities for moving medical 
                countermeasures from State, local, and tribal 
                receiving, staging, and storing sites to dispensing 
                locations;
                    (B) review security plans and capabilities for 
                protecting transportation of medical countermeasures 
                and dispensing locations;
                    (C) work in coordination with the Postmaster 
                General to review security for protecting United States 
                Postal Service employees performing dispensing;
                    (D) assist State, local, and tribal governments in 
                building partnerships with law enforcement to perform 
                security for medical countermeasure transportation and 
                dispensing;
                    (E) assist State, local, and tribal governments in 
                working with emergency response providers to create 
                appropriate roles for their participation in the 
                tailored Strategy plans; and
                    (F) determine other assistance that may be offered 
                to State, local, and tribal governments with respect to 
                logistics, transportation, security, or other issues 
                that the Secretary of Homeland Security determines 
                appropriate.
    (b) Definition.--In this section, the term ``emergency response 
provider'' has the meaning given that term in section 2 of the Homeland 
Security Act of 2002 (6 U.S.C. 101).

SEC. 203. EXPANSION IN THE USE OF THE U.S. POSTAL SERVICE TO DELIVER 
              MEDICAL COUNTERMEASURES.

    (a) In General.--The Secretary of Health and Human Services, in 
coordination with the Postmaster General and the Secretary of Homeland 
Security, and in a manner that complies with the applicable 
requirements of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 
et seq.) and of section 351 of the Public Health Service Act (42 U.S.C. 
262), shall expand existing pilot programs to utilize the United States 
Postal Service to deliver medical countermeasures in an emergency.
    (b) Timeline.--The Postmaster General shall increase the ability of 
the United States Postal Service, contingent on the voluntary 
participation of additional jurisdictions, to deliver medical 
countermeasures to homes in--
            (1) 5 additional Cities Readiness Initiative jurisdictions 
        not later than 1 year after the date of enactment of this Act; 
        and
            (2) 15 additional Cities Readiness Initiative jurisdictions 
        not later than 2 years after the date of enactment of this Act.
    (c) USPS Medkits.--The Secretary of Health and Human Services, in 
coordination with the Postmaster General and the Secretary of Homeland 
Security, shall, on a biennial basis, reevaluate the contents of 
medkits provided to enrolled United States Postal Service employees and 
immediate family members of those employees under the U.S. Postal 
Service Dispensing Plan.
    (d) Content Consideration.--In establishing the appropriate 
contents for medkits under subsection (c), the Secretary of Health and 
Human Services shall--
            (1) consider information available from any biological or 
        bioterrorism risk assessments conducted by the Department of 
        Homeland Security or other relevant assessments by other 
        departments or the intelligence community;
            (2) consider the criteria described in section 
        351A(a)(1)(B) of the Public Health Service Act (42 U.S.C. 
        262a(a)(1)(B));
            (3) consult with private and public organizations, as 
        appropriate;
            (4) comply with applicable requirements of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and of 
        section 351 of the Public Health Service Act (42 U.S.C. 262); 
        and
            (5) consider such other criteria and information that the 
        Secretary of Health and Human Services determines appropriate.
    (e) Report.--Not later than 18 months after the date of enactment 
of this Act, the Secretary of Health and Human Services, the Postmaster 
General, and the Secretary of Homeland Security shall submit to the 
appropriate committees of Congress a report on the implementation of 
this section.
    (f) Definitions.--In this section--
            (1) the term ``appropriate committees of Congress'' means--
                    (A) the Committee on Homeland Security and 
                Governmental Affairs and the Committee on Health, 
                Education, Labor, and Pensions of the Senate; and
                    (B) the Committee on Homeland Security, the 
                Committee on Energy and Commerce, and the Committee on 
                Oversight and Government Reform of the House of 
                Representatives;
            (2) the term ``medkit'' means a cache of antibiotics and 
        other medical countermeasures to be used during a public health 
        emergency; and
            (3) the term ``public health emergency'' means a public 
        health emergency declared by the Secretary of Health and Human 
        Services under section 319 of the Public Health Service Act (42 
        U.S.C. 247d).
    (g) Authorization of Appropriations.--There are authorized to be 
appropriated such sums as may be necessary to carry out this section.

SEC. 204. DISPENSING MEDICAL COUNTERMEASURES THROUGH EMPLOYERS.

    (a) Definitions.--In this section--
            (1) the term ``appropriate committees of Congress'' means--
                    (A) the Committee on Homeland Security and 
                Governmental Affairs and the Committee on Health, 
                Education, Labor, and Pensions of the Senate; and
                    (B) the Committee on Homeland Security and the 
                Committee on Energy and Commerce of the House of 
                Representatives;
            (2) the terms ``biological agent'' and ``toxin'' have the 
        meanings given those terms in section 178 of title 18, United 
        States Code;
            (3) the term ``covered Federal facility'' means a Federal 
        facility determined by the Secretary of Health and Human 
        Services, in coordination with the Secretary of Homeland 
        Security, to be of sufficient size, workforce level, and 
        geographic location to warrant developing a plan for receiving 
        and dispensing medical countermeasures to employees working in 
        the Federal facility;
            (4) the term ``dispense'' means to provide medical 
        countermeasures to an affected population in response to a 
        threat or incident;
            (5) the term ``medical countermeasure'' means a drug (as 
        that term is defined in section 201(g)(1) of the Federal Food, 
        Drug, and Cosmetic Act), a device (as that term is defined in 
        section 201(h) of such Act), or a biological product (as that 
        term is defined in section 351 of this Act), to--
                    (A) diagnose, mitigate, prevent, or treat harm from 
                any biological agent (including organisms that cause an 
                infectious disease) or toxin, chemical, radiological, 
                or nuclear agent that may cause a public health 
                emergency; or
                    (B) diagnose, mitigate, prevent, or treat harm from 
                a condition that may result in adverse health 
                consequences or death and may be caused by 
                administering a drug, biological product, or device; 
                and
            (6) the term ``public health emergency'' means a public 
        health emergency declared by the Secretary of Health and Human 
        Services under section 319 of the Public Health Service Act (42 
        U.S.C. 247d).
    (b) Federal Plan.--
            (1) In general.--The head of each executive agency, in 
        consultation with the Secretary of Health and Human Services 
        and the Secretary of Homeland Security, and in a manner that 
        complies with the applicable requirements of the Federal Food, 
        Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and of section 
        351 of the Public Health Service Act (42 U.S.C. 262), shall 
        develop a plan to receive and dispense medical countermeasures 
        to individuals employed by the executive agency--
                    (A) if the individuals work in a covered Federal 
                facility that is likely the target, or located in an 
                area that is likely a target, of an act of terrorism 
                involving a biological agent or toxin; or
                    (B) in the event of a naturally occurring outbreak 
                of an infectious disease that may result in a national 
                epidemic.
            (2) Contents.--The plans developed under paragraph (1) 
        shall identify individuals in the covered Federal facility who 
        will be performing receiving and dispensing of medical 
        countermeasures to employees.
            (3) Review.--The Secretary of Health and Human Services, in 
        coordination with the Secretary of Homeland Security, shall 
        review and approve the plans developed under paragraph (1).
            (4) Exercises.--On a biennial basis, the head of each 
        executive agency shall conduct exercises of the plan developed 
        by the head of the executive agency under paragraph (1).
    (c) Other Employers.--The Secretary of Health and Human Services, 
in coordination with Secretary of Homeland Security, shall establish a 
set of best practices to guide and promote medical countermeasure 
dispensing capabilities among private sector entities.
    (d) Report.--Not later than 180 days after the date of enactment of 
this Act, the Secretary of Health and Human Services, in coordination 
with the Secretary of Homeland Security, shall submit to the 
appropriate committees of Congress a report on the implementation of 
this section.

SEC. 205. PERSONAL MEDKITS FOR EMERGENCY RESPONSE PROVIDERS AND MEMBERS 
              OF PREPAREDNESS ORGANIZATIONS.

    (a) In General.--Title III of the Homeland Security Act of 2002 (6 
U.S.C. 181 et seq.), as amended by section 106, is further amended by 
adding at the end the following:

``SEC. 320. PERSONAL MEDKITS FOR EMERGENCY RESPONSE PROVIDERS AND 
              MEMBERS OF PREPAREDNESS ORGANIZATIONS.

    ``(a) Definitions.--In this section--
            ``(1) the term `appropriate committees of Congress' means--
                    ``(A) the Committee on Homeland Security and 
                Governmental Affairs and the Committee on Health, 
                Education, Labor, and Pensions of the Senate; and
                    ``(B) the Committee on Homeland Security and the 
                Committee on Energy and Commerce of the House of 
                Representatives;
            ``(2) the term `immediate family member' means an 
        individual who is a cohabitating family member or domestic 
        partner;
            ``(3) the term `preparedness organization' means an 
        organization that contributes to State or local preparedness 
        for an emergency or major disaster (as those terms are defined 
        in section 102 of the Robert T. Stafford Disaster Relief and 
        Emergency Assistance Act (42 U.S.C. 5122)), including Community 
        Emergency Response Teams, the Medical Reserve Corps, the Fire 
        Corps, and the citizen preparedness programs of the American 
        Red Cross;
            ``(4) the term `medkit' means a cache of antibiotics and 
        other medical countermeasures to be used during a public health 
        emergency;
            ``(5) the term `medkit program' means the program 
        established under subsection (b); and
            ``(6) the term `public health emergency' means a public 
        health emergency declared by the Secretary of Health and Human 
        Services under section 319 of the Public Health Service Act (42 
        U.S.C. 247d).
    ``(b) Establishment.--The Secretary, in coordination with the 
Secretary of Health and Human Services and in a manner that complies 
with applicable requirements of the Federal Food, Drug, and Cosmetic 
Act (21 U.S.C. 301 et seq.) and of section 351 of the Public Health 
Service Act (42 U.S.C. 262), shall establish a program to distribute 
medkits to emergency response providers, members of preparedness 
organizations, and immediate family members of an emergency response 
provider or member of a preparedness organization.
    ``(c) Medkit Program Components.--
            ``(1) In general.--An emergency response provider, member 
        of a preparedness organization, or immediate family member of 
        an emergency response provider or member of a preparedness 
        organization participating in the medkit program shall--
                    ``(A) register with the Secretary;
                    ``(B) before the distribution of a medkit, receive 
                training regarding--
                            ``(i) the proper use and dosing of medical 
                        countermeasures;
                            ``(ii) reporting of the use of a medkit;
                            ``(iii) the proper storage of a medkit; and
                            ``(iv) any other topic determined 
                        appropriate by the Secretary;
                    ``(C) before the distribution of a medkit, undergo 
                appropriate medical screening; and
                    ``(D) report the use of a medkit within a 
                reasonable time period, as established by the 
                Secretary.
            ``(2) Inventory.--The Secretary shall conduct an annual 
        inventory of medkits distributed under the medkit program.
    ``(d) Authorization and Contents.--
            ``(1) In general.--The Secretary shall coordinate with the 
        Secretary of Health and Human Services and the Commissioner of 
        Food and Drugs to--
                    ``(A) seek an emergency use authorization under 
                section 564 of the Federal Food, Drug, and Cosmetic Act 
                (21 U.S.C. 360bbb-3), if needed, to allow distribution 
                and use of medkits under the medkit program; and
                    ``(B) establish the appropriate contents for 
                medkits distributed under the medkit program.
            ``(2) Content consideration.--In establishing the 
        appropriate contents for medkits under paragraph (1)(B), the 
        Secretary, in coordination with the Secretary of Health and 
        Human Services, shall--
                    ``(A) consider information available from any 
                biological or bioterrorism risk assessments conducted 
                by the Department of Homeland Security or other 
                relevant assessments by other departments or the 
                intelligence community;
                    ``(B) consider the criteria described in section 
                351A(a)(1)(B) of the Public Health Service Act (42 
                U.S.C. 262a(a)(1)(B));
                    ``(C) consult with relevant private and public 
                organizations; and
                    ``(D) consider such other criteria and information 
                that the Secretary, in coordination with the Secretary 
                of Health and Human Services, determines appropriate.
    ``(e) Report.--Not later than 180 days after the date of enactment 
of this section, the Secretary shall submit to the appropriate 
committees of Congress a report on the implementation of this section.
    ``(f) Authorization of Appropriations.--There is authorized to be 
appropriated to the Secretary to carry out this section, $20,000,000 
for each of fiscal years 2011 through 2013.''.
    (b) Technical and Conforming Amendment.--The table of contents in 
section 1(b) of the Homeland Security Act of 2002 (6 U.S.C. 101 et 
seq.) is amended by inserting after the item relating to section 319, 
as added by section 106 of this Act, the following:

``Sec. 320. Personal medkits for emergency response providers and 
                            members of preparedness organizations.''.

SEC. 206. GENERAL PUBLIC MEDKIT PILOT PROGRAM.

    (a) Definitions.--In this section--
            (1) the term ``medical countermeasures'' means a drug or 
        biological product used to mitigate, prevent, or treat harm 
        from any biological agent (including organisms that cause an 
        infectious disease) or toxin or chemical, radiological, or 
        nuclear agent that may cause a public health emergency; and
            (2) the term ``medkit'' means a cache of antibiotics and 
        other medical countermeasures to be used during a public health 
        emergency declared by the Secretary of Health and Human 
        Services under section 319 of the Public Health Service Act (42 
        U.S.C. 247d).
    (b) Pilot Program.--The Secretary of Health and Human Services, in 
coordination with the Secretary of Homeland Security, shall conduct a 
pilot program to study the feasibility of providing personal medkits to 
the public.
    (c) Requirements.--In carrying out the pilot program, the Secretary 
of Health and Human Services, in coordination with the Secretary of 
Homeland Security and in a manner that complies with applicable 
requirements of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 
et seq.) and of section 351 of the Public Health Service Act (42 U.S.C. 
262), shall ensure that--
            (1) enrollment of participants in the pilot program 
        encompasses a diverse range of municipality sizes, various 
        geographic locations, and different socioeconomic statuses;
            (2) the number of enrolled participants in the program 
        shall be expanded significantly beyond the number of those 
        enrolled in the 2006 St. Louis Medkit evaluation study, 
        conducted by the Centers for Disease Control and Prevention;
            (3) the program shall evaluate the ability of households to 
        maintain medkits in the home as directed and reserve for 
        emergency use; and
            (4) prior to obtaining a medkit, participants are required 
        to receive training regarding--
                    (A) proper use and dosing of medical 
                countermeasures;
                    (B) reporting of use of medkits;
                    (C) proper storage of medkits; and
                    (D) any other information that the Secretary of 
                Health and Human Services and the Secretary of Homeland 
                Security determine appropriate.
    (d) Authorization and Content.--The Secretary of Health and Human 
Services and the Secretary of Homeland Security shall coordinate with 
the Commissioner of Food and Drugs--
            (1) to seek an emergency use authorization under section 
        564 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
        360bbb-3), if needed, to allow distribution of medkits for the 
        purpose of the pilot program; and
            (2) to establish the appropriate contents of medkits to the 
        public for the pilot program.
    (e) Report.--
            (1) Appropriate committees of congress.--In this 
        subsection, the term ``appropriate committees of Congress'' 
        means--
                    (A) the Committee on Homeland Security and 
                Governmental Affairs and the Committee on Health, 
                Education, Labor, and Pensions of the Senate; and
                    (B) the Committee on Homeland Security and the 
                Committee on Energy and Commerce of the House of 
                Representatives.
            (2) Report.--Not later than 90 days after completion of the 
        program under this section, the Secretary of Health and Human 
        Services, in coordination with the Secretary of Homeland 
        Security, shall submit to the appropriate committees of 
        Congress a report on the conclusions of such program. The 
        report shall include recommendations and conclusions on the 
        feasibility of creating a national medkit program, through 
        which medkits would be distributed widely to the public.
    (f) Authorization of Appropriations.--There are authorized to be 
appropriated such sums as may be necessary to carry out this section.

SEC. 207. REPORT ON THE USE OF EXPIRING COUNTERMEASURES.

    (a) In General.--The Secretary of Health and Human Services shall 
contract with the Director of the Institute of Medicine to conduct a 
study to be completed not later than 1 year after the date of enactment 
of this Act that examines the feasibility and effectiveness of 
alternative uses of medical countermeasures (as defined in section 319N 
of the Public Health Service Act, as added by section 201 of this Act), 
including vaccines, in the Strategic National Stockpile before the 
expiration of the medical countermeasures.
    (b) Areas.--The study under subsection (a) shall include the 
examination of--
            (1) the effectiveness of allowing States to access medical 
        countermeasures approaching expiration in a timely way to allow 
        emergency response providers (as defined in section 2 of the 
        Homeland Security Act of 2002 (6 U.S.C. 101)) in those States 
        to voluntarily choose pre-event or post-event vaccination or 
        treatment; and
            (2) the ability of States to effectively determine which 
        personnel should receive pre-event treatment using the medical 
        countermeasures approaching expiration from the Strategic 
        National Stockpile.

           Subtitle B--Bioforensics Capabilities and Strategy

SEC. 211. BIOFORENSICS CAPABILITIES AND STRATEGY.

    (a) In General.--Title III of the Homeland Security Act of 2002 (6 
U.S.C. 181 et seq.), as amended by section 205, is further amended by 
adding at the end the following:

``SEC. 321. BIOFORENSICS CAPABILITIES AND STRATEGY.

    ``(a) Definitions.--In this section--
            ``(1) the term `appropriate committees of Congress' means--
                    ``(A) the Committee on Homeland Security and 
                Governmental Affairs, the Committee on the Judiciary, 
                the Committee on Health, Education, Labor, and 
                Pensions, the Committee on Agriculture, Nutrition, and 
                Forestry, and the Committee on Armed Services of the 
                Senate; and
                    ``(B) the Committee on Homeland Security, the 
                Committee on the Judiciary, the Committee on Energy and 
                Commerce, the Committee on Agriculture, and the 
                Committee on Armed Services of the House of 
                Representatives;
            ``(2) the term `bioforensic' means the scientific 
        discipline dedicated to analyzing evidence from a bioterrorism 
        act, biological agent or toxin based criminal act, or 
        inadvertent biological agent or toxin release for attribution 
        purposes;
            ``(3) the term `National Bioforensics Analysis Center' 
        means the National Bioforensics Analysis Center established 
        under subsection (b);
            ``(4) the term `national bioforensics repository 
        collection' means the national bioforensics repository 
        collection established under subsection (c)(1); and
            ``(5) the term `national bioforensics strategy' means the 
        national bioforensics strategy developed under subsection 
        (d)(1).
    ``(b) National Bioforensics Analysis Center.--There is in the 
Department a National Bioforensics Analysis Center which shall--
            ``(1) serve as the lead Federal facility to conduct and 
        facilitate bioforensic analysis in support of the executive 
        agency with primary responsibility for responding to the 
        biological incident;
            ``(2) maintain the national bioforensics repository 
        collection as a reference collection of biological agents and 
        toxins for comparative bioforensic identifications; and
            ``(3) support threat agent characterization studies and 
        bioforensic assay development.
    ``(c) National Bioforensic Repository Collection.--
            ``(1) In general.--The National Bioforensics Analysis 
        Center shall maintain a national bioforensics repository 
        collection.
            ``(2) Activities.--The national bioforensics repository 
        collection shall--
                    ``(A) receive, store, and distribute biological 
                threat agents and toxins and related biological agents 
                and toxins;
                    ``(B) serve as a reference collection for 
                comparative bioforensic identifications; and
                    ``(C) support threat agent characterization studies 
                and bioforensic assay development.
            ``(3) Participation.--
                    ``(A) In general.--The Secretary, the Attorney 
                General, the Secretary of Health and Human Services, 
                the Secretary of Agriculture, the Secretary of Defense, 
                and the head of any other appropriate executive agency 
                with a biological agent or toxin collection that is 
                useful for the bioforensic analysis of biological 
                incidents, performance of biological threat agent 
                characterization studies, or development of bioforensic 
                assays shall provide samples of relevant biological 
                agents and toxins, as determined by the Secretary, in 
                consultation with the head of the executive agency 
                possessing the agent or toxin, which shall not include 
                any variola virus, to the national bioforensics 
                repository collection.
                    ``(B) Other biological agents and toxins.--The 
                Secretary shall encourage the contribution of public 
                and private biological agent and toxin collections to 
                the national bioforensics repository collection that 
                were collected or created with support from a Federal 
                grant or contract and that support the functions 
                described in paragraph (2).
            ``(4) Access.--The Secretary shall--
                    ``(A) provide an executive agency that submits a 
                biological agent or toxin to the national bioforensics 
                repository collection with access to the national 
                bioforensics repository collection; and
                    ``(B) establish a mechanism to provide public and 
                private entities with access to the national 
                bioforensics repository collection, as appropriate, for 
                scientific analysis of a biological agent or toxin in 
                the national bioforensics repository collection, with 
                appropriate protection for intellectual property 
                rights.
            ``(5) Report.--
                    ``(A) In general.--Not later than 180 days after 
                the date of enactment of this section, the Secretary, 
                in consultation with the Attorney General, the 
                Secretary of Health and Human Services, the Secretary 
                of Agriculture, the Secretary of Defense, and the head 
                of any other appropriate executive agency that will 
                participate in or contribute to the national 
                bioforensics repository collection, shall submit to the 
                appropriate committees of Congress a report regarding 
                the national bioforensics repository collection.
                    ``(B) Contents.--The report submitted under 
                subparagraph (A) shall--
                            ``(i) discuss the status of the 
                        establishment of the national bioforensics 
                        repository collection;
                            ``(ii) identify domestic and international 
                        biological agent and toxin collections that 
                        would prove useful in carrying out the 
                        functions of the national bioforensics 
                        repository collection;
                            ``(iii) examine any access or participation 
                        issues affecting the establishment of the 
                        national bioforensics repository collection or 
                        the ability to support bioforensic analysis, 
                        threat characterization studies, or bioforensic 
                        assay development, including--
                                    ``(I) intellectual property 
                                concerns;
                                    ``(II) access to collected or 
                                created biological agent or toxin 
                                collections funded by a Federal grant 
                                or contract;
                                    ``(III) costs for the national 
                                bioforensics repository collection 
                                associated with accessing domestic and 
                                international biological agent and 
                                toxin collections;
                                    ``(IV) costs incurred by domestic 
                                and international biological agent and 
                                toxin collections to allow broad access 
                                or contribute biological agents or 
                                toxins to the national bioforensics 
                                repository collection; and
                                    ``(V) access to the national 
                                bioforensics repository collection by 
                                public and private researchers to 
                                support threat characterization studies 
                                and bioforensic assay development; and
                            ``(iv) other issues determined appropriate 
                        by the Secretary.
    ``(d) National Bioforensic Strategy.--
            ``(1) In general.--The Secretary, in coordination with the 
        Attorney General, the Secretary of Health and Human Services, 
        the Secretary of Agriculture, the Secretary of Defense, and the 
        head of any other appropriate executive agency, as determined 
        by the Secretary, shall develop, coordinate, and maintain a 
        national bioforensics strategy.
            ``(2) Contents.--The national bioforensics strategy shall--
                    ``(A) provide for a coordinated approach across all 
                executive agencies with responsibilities for analyzing 
                evidence from a bioterrorism act, biological agent or 
                toxin based criminal act, or inadvertent biological 
                agent or toxin release for attribution purposes;
                    ``(B) describe the roles and responsibilities of 
                all relevant executive agencies;
                    ``(C) establish mechanisms, in coordination with 
                State, local, and tribal governments, for coordinating 
                with law enforcement agencies in analyzing bioforensic 
                evidence;
                    ``(D) include guidance for collecting, processing, 
                and analyzing samples; and
                    ``(E) provide for a coordinated approach across all 
                executive agencies to support threat agent 
                characterization research, funding, and assay 
                development.
            ``(3) Report.--Not later than 180 days after the date of 
        enactment of this section, the Secretary, in consultation with 
        the Attorney General, the Secretary of Health and Human 
        Services, the Secretary of Agriculture, the Secretary of 
        Defense, and the head of any other appropriate executive 
        agency, as determined by the Secretary, shall submit to the 
        appropriate committees of Congress the national bioforensics 
        strategy.
    ``(e) Authorization of Appropriations.--There are authorized to be 
appropriated such sums as may be necessary to carry out this 
section.''.
    (b) Technical and Conforming Amendment.--The table of contents in 
section 1(b) of the Homeland Security Act of 2002 (6 U.S.C. 101 et 
seq.) is amended by inserting after the item relating to section 320, 
as added by section 205 of this Act, the following:

``Sec. 321. Bioforensics capabilities and strategy.''.

                  Subtitle C--Communications Planning

SEC. 221. COMMUNICATIONS PLANNING.

    (a) In General.--Title V of the Homeland Security Act of 2002 (6 
U.S.C. 311 et seq.) is amended by adding at the end the following:

``SEC. 525. COMMUNICATIONS PLANNING.

    ``(a) Incorporation of Communications Plans.--
            ``(1) In general.--The Secretary, acting through the 
        Administrator of the Federal Emergency Management Agency, shall 
        incorporate into each operational plan developed under sections 
        653(a)(4) and 653(b) of the Post-Katrina Emergency Management 
        Reform Act of 2006 (6 U.S.C. 701 note) a communications plan 
        for providing information to the public related to preventing, 
        preparing for, protecting against, and responding to imminent 
        natural disasters, acts of terrorism, and other man-made 
        disasters, including incidents involving the use of weapons of 
        mass destruction and other potentially catastrophic events.
            ``(2) Consultation.--In developing communications plans 
        under paragraph (1), the Administrator shall consult with 
        State, local, and tribal governments and coordinate, as the 
        Administrator considers appropriate, with other Federal 
        departments and agencies that have responsibilities under the 
        National Response Framework and other relevant Federal 
        departments and agencies.
    ``(b) Prescripted Messages and Message Templates.--
            ``(1) In general.--As part of the communication plans, the 
        Administrator shall develop prescripted messages or message 
        templates, as appropriate, to be included in the plans to be 
        provided to State, local, and tribal officials so that those 
        officials can quickly and rapidly disseminate critical 
        information to the public in anticipation or in the immediate 
        aftermath of a disaster or incident.
            ``(2) Development and design.--The prescripted messages or 
        message templates shall--
                    ``(A) be developed, as the Administrator determines 
                appropriate, in consultation with State, local, and 
                tribal governments and in coordination with other 
                Federal departments and agencies that have 
                responsibilities under the National Response Framework 
                and other relevant Federal departments and agencies;
                    ``(B) be designed to provide accurate, essential, 
                and appropriate information and instructions to the 
                population directly affected by a disaster or incident, 
                including information related to evacuation, sheltering 
                in place, and issues of immediate health and safety; 
                and
                    ``(C) be designed to provide accurate, essential, 
                and appropriate technical information and instructions 
                to emergency response providers and medical personnel 
                responding to a disaster or incident.
    ``(c) Communications Formats.--In developing the prescripted 
messages or message templates required under subsection (b), the 
Administrator shall develop each such prescripted message or message 
template in multiple formats to ensure delivery--
            ``(1) in cases where the usual communications 
        infrastructure is unusable as a result of the nature of a 
        disaster or incident; and
            ``(2) to individuals with disabilities or other special 
        needs and individuals with limited English proficiency in 
        accordance with section 616 of the Post-Katrina Emergency 
        Management Reform Act of 2006 (6 U.S.C. 701 note).
    ``(d) Dissemination and Technical Assistance.--The Administrator 
shall ensure that all prescripted messages and message templates 
developed under this section are made available to State, local, and 
tribal governments so that those governments may incorporate them, as 
appropriate, into their emergency plans. The Administrator shall also 
make available relevant technical assistance to those governments to 
support communications planning.
    ``(e) Exercises.--To ensure that the prescripted messages or 
message templates developed under this section can be effectively 
utilized in a disaster or incident, the Administrator shall incorporate 
such prescripted messages or message templates into exercises conducted 
under the National Exercise Program described in section 648 of the 
Post-Katrina Emergency Management Reform Act of 2006 (6 U.S.C. 701 
note).
    ``(f) Report.--Not later than 1 year after the date of the 
enactment of this section, the Administrator shall submit to the 
Committee on Homeland Security and Governmental Affairs of the Senate 
and the Committee on Homeland Security of the House of Representatives 
a copy of the communications plans required to be developed under this 
section, including prescripted messages or message templates developed 
in conjunction with the plans and a description of the means that will 
be used to deliver such messages in a natural disaster, act of 
terrorism, or other man-made disaster.''.
    (b) Table of Contents.--The table of contents in section 1(b) of 
the Homeland Security Act of 2002 (6 U.S.C. 101) is amended by 
inserting after the item relating to section 524 the following:

``Sec. 525. Communications planning.''.

SEC. 222. PLUME MODELING.

    (a) Definitions.--In this section--
            (1) the term ``appropriate committees of Congress'' means--
                    (A) the Committee on Homeland Security and 
                Governmental Affairs, the Committee on Energy and 
                Natural Resources, the Committee on Armed Services, and 
                the Committee on Health, Education, Labor, and Pensions 
                of the Senate; and
                    (B) the Committee on Homeland Security, the 
                Committee on Energy and Commerce, and the Committee on 
                Armed Services of the House of Representatives;
            (2) the term ``executive agency'' has the meaning given 
        that term in section 2 of the Homeland Security Act of 2002 (6 
        U.S.C. 101);
            (3) the term ``integrated plume model'' means a plume model 
        that integrates protective action guidance and other 
        information as the Secretary of Homeland Security determines 
        appropriate; and
            (4) the term ``plume model'' means the assessment of the 
        location and prediction of the spread of nuclear, radioactive, 
        or chemical fallout and biological pathogens resulting from an 
        explosion or release of nuclear, radioactive, chemical, or 
        biological substances.
    (b) Development.--
            (1) In general.--The Secretary of Homeland Security shall 
        develop and disseminate integrated plume models to enable rapid 
        response activities following a nuclear, radiological, 
        chemical, or biological explosion or release.
            (2) Scope.--The Secretary of Homeland Security shall--
                    (A) ensure the rapid development and distribution 
                of integrated plume models to appropriate officials of 
                the Federal Government and State, local, and tribal 
                governments to enable immediate response to a nuclear, 
                radiological, chemical, or biological incident; and
                    (B) establish mechanisms for dissemination by 
                appropriate emergency response officials of the 
                integrated plume models described in paragraph (1) to 
                nongovernmental organizations and the public to enable 
                appropriate response activities by individuals.
            (3) Consultation with other departments and agencies.--In 
        developing the integrated plume models described in this 
        section, the Secretary of Homeland Security shall consult, as 
        appropriate, with--
                    (A) the Secretary of Energy, the Secretary of 
                Defense, the Secretary of Health and Human Services, 
                the Secretary of Commerce, and the heads of other 
                executive agencies determined appropriate by the 
                Secretary of Homeland Security; and
                    (B) State, local, and tribal governments and 
                nongovernmental organizations.
    (c) Exercises.--The Secretary of Homeland Security shall ensure 
that the development and dissemination of integrated plume models are 
assessed during exercises administered by the Department of Homeland 
Security.
    (d) Reporting.--Not later than 180 days after the date of enactment 
of this Act, and every year thereafter for 3 years , the Secretary of 
Homeland Security shall submit to the appropriate committees of 
Congress a report regarding--
            (1) the development and dissemination of integrated plume 
        models under this section; and
            (2) lessons learned from assessing the development and 
        dissemination of integrated plume models during exercises 
        administered by the Department of Homeland Security, and plans 
        for improving the development and dissemination of integrated 
        plume models, as appropriate.

   TITLE III--INTERNATIONAL MEASURES TO PREVENT BIOLOGICAL TERRORISM

Subtitle A--Prevention and Protection Against International Biological 
                                Threats

SEC. 301. INTERNATIONAL THREAT ASSESSMENT: TIER I PATHOGEN FACILITIES.

    (a) Review.--Not later than 6 months after the date of the 
enactment of this Act, the Director of National Intelligence, in 
consultation with the Secretary of State, the Secretary of Defense, the 
Secretary of Homeland Security, the Secretary of Health and Human 
Services, the Secretary of Agriculture, and the heads of other 
appropriate Federal agencies, shall complete a global review of 
international biological security threats to the United States.
    (b) Content.--The review under this section shall--
            (1) assess global biological risks, including by describing 
        regions or countries with the greatest biological security 
        risk, taking into account factors such as--
                    (A) the presence and capabilities of a foreign 
                terrorist organization;
                    (B) the location of highest risk pathogen 
                collections; and
                    (C) the location of biological laboratories 
                operating with inadequate security measures; and
            (2) assess any gaps in knowledge about international 
        biosecurity threats.
    (c) Updates.--The Director shall update the review under this 
section as new or revised intelligence becomes available, but not less 
frequently than biennially.
    (d) Submission of Review or Update.--Not later than 6 months after 
the date of the enactment of this Act, and biennially thereafter, the 
Director shall submit the classified review or update to--
            (1) the Select Committee on Intelligence of the Senate;
            (2) the Committee on Armed Services of the Senate;
            (3) the Committee on Foreign Relations of the Senate;
            (4) the Permanent Select Committee on Intelligence of the 
        House of Representatives
            (5) the Committee on Armed Services of the House of 
        Representatives; and
            (6) the Committee on Foreign Affairs of the House of 
        Representatives.
    (e) Submission of Unclassified Summary and Classified Annex.--Not 
later than 6 months after the date of the enactment of this Act, and 
biennially thereafter, the Director shall submit an unclassified report 
and a classified annex summarizing the review or update to--
            (1) the Committee on Agriculture of the Senate;
            (2) the Committee on Health, Education, Labor, and Pensions 
        of the Senate;
            (3) the Committee on Homeland Security and Governmental 
        Affairs of the Senate;
            (4) the Committee on Agriculture of the House of the 
        Representatives;
            (5) the Committee on Energy and Commerce of the House of 
        Representatives; and
            (6) the Committee on Homeland Security of the House of 
        Representatives.
    (f) Sunset Date.--The requirements specified in subsections (c), 
(d), and (e) of this section shall terminate five years after the date 
of the enactment of this Act.

SEC. 302. STRENGTHENING INTERNATIONAL BIOSECURITY.

    (a) Technical and Financial Assistance Authorized.--The Secretary 
of State, in coordination with the Secretary of Health and Human 
Services, the Secretary of Defense, the Secretary of Agriculture, the 
Secretary of Homeland Security, and other appropriate agencies, shall 
provide technical and financial assistance, including the activities 
described in subsection (b), to countries or regions identified by the 
Threat Assessment mandated in section 301.
    (b) Authorized Activities.--
            (1) Reducing and securing dangerous pathogen collections.--
        The Secretary of State shall--
                    (A) provide assistance to remove or consolidate an 
                agent or toxin designated as a Tier I agent under 
                section 351A(a)(2) of the Public Health Service Act or 
                section 212(a)(2) of the Agricultural Bioterrorism 
                Protection Act of 2002 (in this subtitle referred to as 
                a ``Tier I agent'') and other dangerous pathogen 
                collections spread among multiple locations within a 
                country or region into facilities with appropriate 
                safety and security;
                    (B) provide assistance to replace dangerous or 
                obsolete pathogen isolation techniques with modern 
                diagnostic tools to improve safety and security and to 
                reduce the number and size of dangerous pathogen 
                collections in high risk regions and countries;
                    (C) encourage countries to eliminate stores of Tier 
                I agents and other dangerous pathogen collections in 
                exchange for facilitating access to state-of-the-art 
                civilian research at international facilities;
                    (D) provide assistance to identify and secure Tier 
                I agents and other dangerous pathogen collections in 
                high risk regions and countries; and
                    (E) carry out such other activities as the 
                Secretary of State considers necessary to achieve the 
                purposes of this subtitle.
            (2) Prevention and protection.--The Secretary of State 
        shall--
                    (A) raise awareness of international biological 
                threats with foreign governments, academic 
                institutions, and industrial laboratories that possess, 
                use, or transfer Tier I agents and other dangerous 
                pathogen collections through conferences, seminars and 
                workshops;
                    (B) provide biosecurity upgrades at high risk 
                laboratories;
                    (C) train foreign partners in high risk regions on 
                best laboratory biosecurity practices within facilities 
                that possess, use, or transfer Tier I agents and other 
                dangerous pathogen collections;
                    (D) assist foreign countries in establishing 
                personnel reliability measures, as part of a 
                comprehensive laboratory management system;
                    (E) partner with foreign governments, laboratories, 
                and scientists in activities that strengthen and 
                reinforce best biological safety and security practices 
                within facilities that possess, use, or transfer Tier I 
                agents and other dangerous pathogen collections;
                    (F) enhance information sharing through regular 
                meetings of relevant United States and foreign 
                government agencies with subject matter expertise on 
                pathogen security and laboratory best practices in high 
                risk regions;
                    (G) increase support for United States science and 
                technology agreements and initiatives in high risk 
                regions and countries, including collaborative projects 
                in the areas of bioterrorism prevention, infectious 
                disease control, disease surveillance, bioforensics, 
                laboratory biosafety, and hazardous waste management; 
                and
                    (H) develop laboratory biosafety and biosecurity 
                standards and guidelines, including personnel 
                reliability measures, for facilities that possess, use, 
                or transfer Tier I agents and other dangerous pathogen 
                collections.
            (3) Science and technology exchange.--The Secretary of 
        State shall--
                    (A) promote research and development collaboration 
                on highly infectious human, animal and plant disease 
                agents in facilities with appropriate safety and 
                security measures;
                    (B) provide opportunities for foreign scientists, 
                particularly those located in highest risk countries 
                identified in section 301, to receive training in the 
                United States on biological safety and security best 
                practices, standard operating procedures, and 
                maintenance for high containment facilities; and
                    (C) facilitate the secure exchange of research 
                samples between laboratories in the United States and 
                foreign national laboratories for the development of 
                vaccines and diagnostics for Tier I agents and other 
                dangerous pathogens.

SEC. 303. PROMOTING SECURE BIOTECHNOLOGY ADVANCEMENT.

    (a) Plan To Promote International Adherence to International 
Agreements.--The Secretary of State, in coordination with appropriate 
agencies, shall produce and implement a plan for promoting 
international adherence to, and implementation of, frameworks, 
treaties, and other international agreements regarding weapons of mass 
destruction, including the Biological Weapons Convention, World Health 
Organization International Health Regulations, and United Nations 
Security Council Resolution 1540.
    (b) Biotechnology Discussions.--
            (1) In general.--The Secretary of State, in coordination 
        with appropriate agencies, shall pursue discussions with 
        government, academic, and industry representatives in countries 
        that possess established or emerging biotechnology sectors or 
        are identified as high-risk countries in the Threat Assessment 
        required under section 301.
            (2) Topics.--Topics to be discussed under paragraph (1) 
        shall include--
                    (A) multilateral initiatives intended to promote 
                safe and secure biotechnology;
                    (B) norms and safeguards necessary to prevent the 
                misuse of biotechnology;
                    (C) multilateral initiatives intended to counter 
                the threat of biological terrorism; and
                    (D) other topics on international biosecurity that 
                the Secretary of State considers to be relevant.

                Subtitle B--Global Pathogen Surveillance

SEC. 321. SHORT TITLE.

    This subtitle may be cited as the ``Global Pathogen Surveillance 
Act of 2009''.

SEC. 322. FINDINGS; PURPOSE.

    (a) Findings.--Congress makes the following findings:
            (1) The frequency of the occurrence of biological events 
        that could threaten the national security of the United States 
        has increased and is likely increasing. The threat to the 
        United States from such events includes threats from diseases 
        that infect humans, animals, or plants regardless of whether 
        such diseases are introduced naturally, accidentally, or 
        intentionally.
            (2) Bioterrorism poses a grave national security threat to 
        the United States. The insidious nature of a bioterrorist 
        attack, the likelihood that the recognition of such an attack 
        would be delayed, and the underpreparedness of the domestic 
        public health infrastructure to respond to such an attack could 
        result in catastrophic consequences following a biological 
        weapons attack against the United States.
            (3) The ability to recognize that a country or organization 
        is carrying out a covert biological weapons program is 
        dependent on a number of indications and warnings. A critical 
        component of this recognition is the timely detection of 
        sentinel events such as community-level outbreaks that could be 
        the earliest indication of an emerging bioterrorist program in 
        a foreign country. Early detection of such events may enable 
        earlier counterproliferation intervention.
            (4) A contagious pathogen engineered as a biological weapon 
        and developed, tested, produced, or released in a foreign 
        country could quickly spread to the United States. Considering 
        the realities of international travel, trade, and migration 
        patterns, a dangerous pathogen appearing naturally, 
        accidentally, or intentionally anywhere in the world can spread 
        to the United States in a matter of days, before any effective 
        quarantine or isolation measures could be implemented.
            (5) To combat bioterrorism effectively and ensure that the 
        United States is fully prepared to prevent, recognize, and 
        contain a biological weapons attack or emerging infectious 
        disease, measures to strengthen the domestic public health 
        infrastructure and improve domestic event detection, 
        surveillance, and response, while absolutely essential, are not 
        sufficient.
            (6) The United States should enhance cooperation with the 
        World Health Organization, regional international health 
        organizations, and individual countries, including data sharing 
        with appropriate agencies and departments of the United States, 
        to help detect and quickly contain infectious disease outbreaks 
        or a bioterrorism agent before such a disease or agent is 
        spread.
            (7) The World Health Organization has done an impressive 
        job in monitoring infectious disease outbreaks around the 
        world, notably in the April 2000 establishment and subsequent 
        operation of the Global Outbreak Alert and Response Network.
            (8) The capabilities of the World Health Organization 
        depend on the timeliness and quality of the data and 
        information the Organization receives from the countries that 
        are members of the Organization, pursuant to the 2005 revision 
        of the International Health Regulations. Developing countries, 
        in particular, often lack the necessary resources to build and 
        maintain effective public health infrastructures.
            (9) Developing countries could benefit from--
                    (A) better trained public health professionals and 
                epidemiologists to recognize disease patterns;
                    (B) appropriate laboratory equipment for diagnosis 
                of pathogens;
                    (C) disease reporting systems that--
                            (i) are based on disease and syndrome 
                        surveillance; and
                            (ii) could enable an effective response to 
                        a biological event to begin at the earliest 
                        possible opportunity;
                    (D) a narrowing of the existing technology gap in 
                disease and syndrome surveillance capabilities, based 
                on reported symptoms, and real-time information 
                dissemination to public health officials; and
                    (E) appropriate communications equipment and 
                information technology to efficiently transmit 
                information and data within national, international 
                regional, and international health networks, including 
                inexpensive, Internet-based geographic information 
                systems and relevant telephone-based systems for early 
                recognition and diagnosis of diseases.
            (10) An effective international capability to detect, 
        monitor, and quickly diagnose infectious disease outbreaks will 
        offer dividends not only in the event of biological weapons 
        development, testing, production, and attack, but also in the 
        more likely cases of naturally occurring infectious disease 
        outbreaks that could threaten the United States. Furthermore, a 
        robust surveillance system will serve to deter or contain 
        terrorist use of biological weapons, mitigating the intended 
        effects of such malevolent uses.
    (b) Purposes.--The purposes of this subtitle are as follows:
            (1) To enhance the capability of the international 
        community, through international health organizations and 
        individual countries, to detect, identify, and contain 
        infectious disease outbreaks, whether the cause of those 
        outbreaks is intentional human action or natural in origin.
            (2) To enhance the training of public health professionals 
        and epidemiologists from eligible developing countries in 
        advanced Internet-based disease and syndrome surveillance 
        systems, in addition to traditional epidemiology methods, so 
        that such professionals and epidemiologists may better detect, 
        diagnose, and contain infectious disease outbreaks, especially 
        such outbreaks caused by the pathogens that may be likely to be 
        used in a biological weapons attack.
            (3) To provide assistance to eligible developing countries 
        to purchase appropriate communications equipment and 
        information technology to detect, analyze, and report 
        biological threats, including--
                    (A) relevant computer equipment, Internet 
                connectivity mechanisms, and telephone-based 
                applications to effectively gather, analyze, and 
                transmit public health information for infectious 
                disease surveillance and diagnosis; and
                    (B) appropriate computer equipment and Internet 
                connectivity mechanisms--
                            (i) to facilitate the exchange of 
                        Geographic Information Systems-based disease 
                        and syndrome surveillance information; and
                            (ii) to effectively gather, analyze, and 
                        transmit public health information for 
                        infectious disease surveillance and diagnosis.
            (4) To make available greater numbers of public health 
        professionals who are employed by the Government of the United 
        States to international regional and international health 
        organizations, international regional and international health 
        networks, and United States diplomatic missions, as 
        appropriate.
            (5) To expand the training and outreach activities of 
        United States laboratories located in foreign countries, 
        including the Centers for Disease Control and Prevention or 
        Department of Defense laboratories, to enhance the public 
        health capabilities of developing countries.
            (6) To provide appropriate technical assistance to existing 
        international regional and international health networks and, 
        as appropriate, seed money for new international regional and 
        international networks.

SEC. 323. DEFINITIONS.

    In this subtitle:
            (1) Eligible developing country.--The term ``eligible 
        developing country'' means any developing country that--
                    (A) has agreed to the objective of fully complying 
                with requirements of the World Health Organization on 
                reporting public health information on outbreaks of 
                infectious diseases;
                    (B) has not been determined by the Secretary of 
                State, for purposes of section 40 of the Arms Export 
                Control Act (22 U.S.C. 2780), section 620A of the 
                Foreign Assistance Act of 1961 (22 U.S.C. 2371), or 
                section 6(j) of the Export Administration Act of 1979 
                (as in effect pursuant to the International Emergency 
                Economic Powers Act; 50 U.S.C. 1701 et seq.), to have 
                repeatedly provided support for acts of international 
                terrorism, unless the Secretary of State exercises a 
                waiver certifying that it is in the national interest 
                of the United States to provide assistance under the 
                provisions of this subtitle; and
                    (C) is a party to the Convention on the Prohibition 
                of the Development, Production and Stockpiling of 
                Bacteriological (Biological) and Toxin Weapons and on 
                Their Destruction, done at Washington, London, and 
                Moscow April 10, 1972 (26 UST 583).
            (2) Eligible national.--The term ``eligible national'' 
        means any citizen or national of an eligible developing country 
        who--
                    (A) does not have a criminal background;
                    (B) is not on any immigration or other United 
                States watch list; and
                    (C) is not affiliated with any foreign terrorist 
                organization.
            (3) International health organization.--The term 
        ``international health organization'' includes the World Health 
        Organization, regional offices of the World Health 
        Organization, and such similar international organizations as 
        the Pan American Health Organization.
            (4) Laboratory.--The term ``laboratory'' means a facility 
        for the biological, microbiological, serological, chemical, 
        immunohematological, hematological, biophysical, cytological, 
        pathological, or other medical examination of materials derived 
        from the human body for the purpose of providing information 
        for the diagnosis, prevention, or treatment of any disease or 
        impairment of, or the assessment of the health of, human 
        beings.
            (5) Disease and syndrome surveillance.--The term ``disease 
        and syndrome surveillance'' means the recording of clinician-
        reported symptoms (patient complaints) and signs (derived from 
        physical examination and laboratory data) combined with simple 
        geographic locators to track the emergence of a disease in a 
        population.

SEC. 324. ELIGIBILITY FOR ASSISTANCE.

    (a) In General.--Except as provided in subsection (b), assistance 
may be provided to an eligible developing country under any provision 
of this subtitle only if the government of the eligible developing 
country--
            (1) permits personnel from the World Health Organization 
        and the Centers for Disease Control and Prevention to 
        investigate outbreaks of infectious diseases within the borders 
        of such country; and
            (2) provides pathogen surveillance data to the appropriate 
        agencies and departments of the United States and to 
        international health organizations.
    (b) Waiver.--The Secretary of State may waive the prohibition set 
out in subsection (a) if the Secretary of State determines that it is 
in the national interest of the United States to provide such a waiver.
    (c) Prior Notice of Waivers.--A waiver pursuant to subsection (b) 
may not be executed until 15 days after the Secretary of State provides 
to the Committee on Foreign Relations of the Senate and the Committee 
on Foreign Affairs of the House of Representatives written notice of 
the intent to issue such waiver and the reasons for doing so.

SEC. 325. RESTRICTION.

    (a)  In General.--Notwithstanding any other provision of this 
subtitle, no foreign national participating in a program authorized 
under this subtitle shall have access, during the course of such 
participation, to a select agent or toxin described in section 73.4 of 
title 42, Code of Federal Regulations (or any corresponding similar 
regulation) or an overlap select agent or toxin described in section 
73.5 of such title (or any corresponding similar regulation) that may 
be used as, or in, a biological weapon, except in a supervised and 
controlled setting.
    (b) Relationship to Regulations.--The restriction set out in 
subsection (a) may not be construed to limit the ability of the 
Secretary of Health and Human Services to prescribe, through 
regulation, standards for the possession, use, or transfer of a select 
agent or toxin or an overlap select agent or toxin described in such 
subsection.

SEC. 326. FELLOWSHIP PROGRAM.

    (a) Establishment.--There is established a fellowship program under 
which the Secretary of State, in consultation with the Secretary of 
Health and Human Services and the Secretary of Homeland Security and 
subject to the availability of appropriations, shall award fellowships 
to eligible nationals to pursue public health education or training, as 
follows:
            (1) Master of public health degree.--Graduate courses of 
        study leading to a master of public health degree with a 
        concentration in epidemiology from an institution of higher 
        education in the United States with a Center for Public Health 
        Preparedness, as determined by the Director of the Centers for 
        Disease Control and Prevention.
            (2) Advanced public health epidemiology training.--Advanced 
        public health training in epidemiology for public health 
        professionals from eligible developing countries to be carried 
        out at the Centers for Disease Control and Prevention, an 
        appropriate facility of a State, or an appropriate facility of 
        another agency or department of the United States (other than a 
        facility of the Department of Defense or a national laboratory 
        of the Department of Energy) for a period of not less than 6 
        months or more than 12 months.
    (b) Specialization in Bioterrorism Response.--In addition to the 
education or training specified in subsection (a), each recipient of a 
fellowship under this section (in this section referred to as a 
``fellow'') may take courses of study at the Centers for Disease 
Control and Prevention or at an equivalent facility on diagnosis and 
containment of likely bioterrorism agents.
    (c) Fellowship Agreement.--
            (1) In general.--A fellow shall enter into an agreement 
        with the Secretary of State under which the fellow agrees--
                    (A) to maintain satisfactory academic progress, as 
                determined in accordance with regulations issued by the 
                Secretary of State and confirmed in regularly scheduled 
                updates to the Secretary of State from the institution 
                providing the education or training on the progress of 
                the fellow's education or training;
                    (B) upon completion of such education or training, 
                to return to the fellow's country of nationality or 
                last habitual residence (so long as it is an eligible 
                developing country) and complete at least 4 years of 
                employment in a public health position in the 
                government or a nongovernmental, not-for-profit entity 
                in that country or, with the approval of the Secretary 
                of State, complete part or all of this requirement 
                through service with an international health 
                organization without geographic restriction; and
                    (C) that, if the fellow is unable to meet the 
                requirements described in subparagraph (A) or (B), the 
                fellow shall reimburse the United States for the value 
                of the assistance provided to the fellow under the 
                fellowship program, together with interest at a rate 
                that--
                            (i) is determined in accordance with 
                        regulations issued by the Secretary of State; 
                        and
                            (ii) is not higher than the rate generally 
                        applied in connection with other Federal loans.
            (2) Waivers.--The Secretary of State may waive the 
        application of subparagraph (B) or (C) of paragraph (1) on a 
        case by case basis if the Secretary of State determines that--
                    (A) it is in the national interest of the United 
                States to provide such a waiver; or
                    (B) humanitarian considerations require such a 
                waiver.
    (d) Agreement.--The Secretary of State, in consultation with the 
Secretary of Health and Human Services and the Secretary of Homeland 
Security, is authorized to enter into an agreement with the government 
of an eligible developing country under which such government agrees--
            (1) to establish a procedure for the nomination of eligible 
        nationals for fellowships under this section;
            (2) to guarantee that a fellow will be offered a 
        professional public health position within the developing 
        country upon completion of the fellow's studies; and
            (3) to submit to the Secretary of State a certification 
        stating that a fellow has concluded the minimum period of 
        employment in a public health position required by the 
        fellowship agreement, including an explanation of how the 
        requirement was met.
    (e) Participation of United States Citizens.--On a case-by-case 
basis, the Secretary of State may provide for the participation of a 
citizen of the United States in the fellowship program under the 
provisions of this section if--
            (1) the Secretary of State determines that it is in the 
        national interest of the United States to provide for such 
        participation; and
            (2) the citizen of the United States agrees to complete, at 
        the conclusion of such participation, at least 5 years of 
        employment in a public health position in an eligible 
        developing country or at an international health organization.
    (f) Use of Existing Programs.--The Secretary of State, with the 
concurrence of the Secretary of Health and Human Services, may elect to 
use existing programs of the Department of Health and Human Services to 
provide the education and training described in subsection (a) if the 
requirements of subsections (b), (c), and (d) will be substantially met 
under such existing programs.

SEC. 327. IN-COUNTRY TRAINING IN LABORATORY TECHNIQUES AND DISEASE AND 
              SYNDROME SURVEILLANCE.

    (a) Laboratory Techniques.--
            (1) In general.--The Secretary of State, after consultation 
        with the Secretary of Health and Human Services, the Secretary 
        of Defense, and the Secretary of Homeland Security and in 
        conjunction with elements of those departments that engage in 
        activities of this type overseas, and subject to the 
        availability of appropriations, shall provide assistance for 
        short training courses for eligible nationals who are 
        laboratory technicians or other public health personnel in 
        laboratory techniques relating to the identification, 
        diagnosis, and tracking of pathogens responsible for possible 
        infectious disease outbreaks.
            (2) Location.--The training described in paragraph (1) 
        shall be held outside the United States and may be conducted in 
        facilities of the Centers for Disease Control and Prevention 
        located in foreign countries or in Overseas Medical Research 
        Units of the Department of Defense, as appropriate.
            (3) Coordination with existing programs.--The Secretary of 
        State shall coordinate the training described in paragraph (1), 
        where appropriate, with existing programs and activities of 
        international health organizations.
    (b) Disease and Syndrome Surveillance.--
            (1) In general.--The Secretary of State, after consultation 
        with the Secretary of Health and Human Services, the Secretary 
        of Defense, and the Secretary of Homeland Security and in 
        conjunction with elements of those departments that engage in 
        activities of this type overseas, and subject to the 
        availability of appropriations, shall establish and provide 
        assistance for short training courses for eligible nationals 
        who are health care providers or other public health personnel 
        in techniques of disease and syndrome surveillance reporting 
        and rapid analysis of syndrome information using geographic 
        information system tools.
            (2) Location.--The training described in paragraph (1) 
        shall be conducted via the Internet or in appropriate 
        facilities located in a foreign country, as determined by the 
        Secretary of State.
            (3) Coordination with existing programs.--The Secretary of 
        State shall coordinate the training described in paragraph (1), 
        where appropriate, with existing programs and activities of 
        international regional and international health organizations.

SEC. 328. ASSISTANCE FOR THE PURCHASE AND MAINTENANCE OF PUBLIC HEALTH 
              LABORATORY EQUIPMENT AND SUPPLIES.

    (a) Authorization.--The President is authorized to provide, on such 
terms and conditions as the President may determine, assistance to 
eligible developing countries to purchase and maintain the public 
health laboratory equipment and supplies described in subsection (b).
    (b) Equipment and Supplies Covered.--The equipment and supplies 
described in this subsection are equipment and supplies that are--
            (1) appropriate, to the extent possible, for use in the 
        intended geographic area;
            (2) necessary to collect, analyze, and identify 
        expeditiously a broad array of pathogen strains, which may 
        cause disease outbreaks or may be used in a biological weapon;
            (3) compatible with general standards set forth by the 
        World Health Organization and, as appropriate, the Centers for 
        Disease Control and Prevention, to ensure interoperability with 
        international regional and international public health 
        networks; and
            (4) not defense articles, defense services, or training, as 
        such terms are defined in the Arms Export Control Act (22 
        U.S.C. 2751 et seq.).
    (c) Rule of Construction.--Nothing in this section shall be 
construed to exempt the exporting of goods and technology from 
compliance with applicable provisions of the Export Administration Act 
of 1979 (as in effect pursuant to the International Emergency Economic 
Powers Act; 50 U.S.C. 1701 et seq.).
    (d) Limitation.--Amounts appropriated to carry out this section 
shall not be made available for the purchase from a foreign country of 
equipment or supplies that, if made in the United States, would be 
subject to the Arms Export Control Act (22 U.S.C. 2751 et seq.) or 
likely be barred or subject to special conditions under the Export 
Administration Act of 1979 (as in effect pursuant to the International 
Emergency Economic Powers Act; 50 U.S.C. 1701 et seq.).
    (e) Procurement Preference.--In the use of grant funds authorized 
under subsection (a), preference should be given to the purchase of 
equipment and supplies of United States manufacture. The use of amounts 
appropriated to carry out this section shall be subject to section 604 
of the Foreign Assistance Act of 1961 (22 U.S.C. 2354).
    (f) Country Commitments.--The assistance provided under this 
section for equipment and supplies may be provided only if the eligible 
developing country that receives such equipment and supplies agrees to 
provide the infrastructure, technical personnel, and other resources 
required to house, maintain, support, secure, and maximize use of such 
equipment and supplies.

SEC. 329. ASSISTANCE FOR IMPROVED COMMUNICATION OF PUBLIC HEALTH 
              INFORMATION.

    (a) Assistance for Purchase of Communication Equipment and 
Information Technology.--The President is authorized to provide, on 
such terms and conditions as the President may determine, assistance to 
eligible developing countries to purchase and maintain the 
communications equipment and information technology described in 
subsection (b), and the supporting equipment, necessary to effectively 
collect, analyze, and transmit public health information.
    (b) Covered Equipment.--The communications equipment and 
information technology described in this subsection are communications 
equipment and information technology that--
            (1) are suitable for use under the particular conditions of 
        the geographic area of intended use;
            (2) meet the standards set forth by the World Health 
        Organization and, as appropriate, the Secretary of Health and 
        Human Services, to ensure interoperability with like equipment 
        of other countries and international organizations; and
            (3) are not defense articles, defense services, or 
        training, as those terms are defined in the Arms Export Control 
        Act (22 U.S.C. 2751 et seq.).
    (c) Rule of Construction.--Nothing in this section shall be 
construed to exempt the exporting of goods and technology from 
compliance with applicable provisions of the Export Administration Act 
of 1979 (as in effect pursuant to the International Emergency Economic 
Powers Act; 50 U.S.C. 1701 et seq.).
    (d) Limitation.--Amounts appropriated to carry out this section 
shall not be made available for the purchase from a foreign country of 
communications equipment or information technology that, if made in the 
United States, would be subject to the Arms Export Control Act (22 
U.S.C. 2751 et seq.) or likely be barred or subject to special 
conditions under the Export Administration Act of 1979 (as in effect 
pursuant to the International Emergency Economic Powers Act; 50 U.S.C. 
1701 et seq.).
    (e) Procurement Preference.--In the use of grant funds under 
subsection (a), preference should be given to the purchase of 
communications equipment and information technology of United States 
manufacture. The use of amounts appropriated to carry out this section 
shall be subject to section 604 of the Foreign Assistance Act of 1961 
(22 U.S.C. 2354).
    (f) Assistance for Standardization of Reporting.--The President is 
authorized to provide, on such terms and conditions as the President 
may determine, technical assistance and grant assistance to 
international health organizations to facilitate standardization in the 
reporting of public health information between and among developing 
countries and international health organizations.
    (g) Country Commitments.--The assistance provided under this 
section for communications equipment and information technology may be 
provided only if the eligible developing country that receives such 
equipment and technology agrees to provide the infrastructure, 
technical personnel, and other resources required to house, maintain, 
support, secure, and maximize use of such equipment and technology.

SEC. 330. ASSIGNMENT OF PUBLIC HEALTH PERSONNEL TO UNITED STATES 
              MISSIONS AND INTERNATIONAL ORGANIZATIONS.

    (a) In General.--Upon the request of the chief of a diplomatic 
mission of the United States or of the head of an international 
regional or international health organization, and with the concurrence 
of the Secretary of State and of the employee concerned, the head of an 
agency or department of the United States may assign to the mission or 
the organization any officer or employee of the agency or department 
that occupies a public health position within the agency or department 
for the purpose of enhancing disease and pathogen surveillance efforts 
in developing countries.
    (b) Reimbursement.--The costs incurred by an agency or department 
of the United States by reason of the detail of personnel under 
subsection (a) may be reimbursed to that agency or department out of 
the applicable appropriations account of the Department of State if the 
Secretary of State determines that the agency or department may 
otherwise be unable to assign such personnel on a non-reimbursable 
basis.

SEC. 331. EXPANSION OF CERTAIN UNITED STATES GOVERNMENT LABORATORIES 
              ABROAD.

    (a) In General.--Subject to the availability of appropriations and 
with the concurrence of the government of each host country, the 
Director of the Centers for Disease Control and Prevention and the 
Secretary of Defense shall each--
            (1) increase the number of personnel assigned to 
        laboratories of the Centers for Disease Control and Prevention 
        or the Department of Defense, as appropriate, located in 
        eligible developing countries that conduct research and other 
        activities with respect to infectious diseases; and
            (2) expand the operations of such laboratories, especially 
        with respect to the implementation of on-site training of 
        foreign nationals and activities affecting the region in which 
        the country is located.
    (b) Cooperation and Coordination Between Laboratories.--Subsection 
(a) shall be carried out in such a manner as to foster cooperation and 
avoid duplication between and among laboratories.

SEC. 332. ASSISTANCE FOR INTERNATIONAL HEALTH NETWORKS AND EXPANSION OF 
              FIELD EPIDEMIOLOGY TRAINING PROGRAMS.

    (a) Authority.--The President is authorized, on such terms and 
conditions as the President may determine, to provide assistance for 
the purposes of--
            (1) enhancing the surveillance and reporting capabilities 
        of the World Health Organization and existing international 
        regional and international health networks; and
            (2) developing new international regional and international 
        health networks.
    (b) Expansion of Field Epidemiology Training Programs.--The 
Secretary of Health and Human Services is authorized to establish new 
country or regional international Field Epidemiology Training Programs 
in eligible developing countries, with the concurrence of the 
government of each host country.

SEC. 333. REPORTS.

    Not later than 90 days after the date of enactment of this Act, the 
Secretary of State, in conjunction with the Secretary of Health and 
Human Services, the Secretary of Defense, and the Secretary of Homeland 
Security, shall submit to the Committee on Foreign Relations and the 
Committee on Homeland Security and Governmental Affairs of the Senate 
and the Committee on Foreign Affairs and the Committee on Homeland 
Security of the House of Representatives a report on the implementation 
of programs under this subtitle, including an estimate of the level of 
funding required to carry out such programs.

SEC. 334. AUTHORIZATION OF APPROPRIATIONS.

    (a) Authorization of Appropriations.--Subject to subsection (b), 
there are authorized to be appropriated such sums as may be necessary 
to carry out this section and the amendments made by this section.
    (b) Limitation on Obligation of Funds.--Not more than 10 percent of 
the amount appropriated pursuant to subsection (a)(1) may be obligated 
before the date on which a report is submitted, or required to be 
submitted, whichever first occurs, under section 333.

  Subtitle C--Strengthening the Oversight of Nuclear Nonproliferation

SEC. 351. DEFINITIONS.

    In this title:
            (1) Appropriate congressional committees.--The term 
        ``appropriate congressional committees'' means--
                    (A) the Committee on Foreign Relations, the 
                Committee on Homeland Security and Governmental 
                Affairs, the Committee on Armed Services, the Select 
                Committee on Intelligence, the Committee on Energy and 
                Natural Resources, and the Committee on Environment and 
                Public Works of the Senate; and
                    (B) the Committee on Foreign Affairs, the Committee 
                on Oversight and Government Reform, the Committee on 
                Armed Services, the Permanent Select Committee on 
                Intelligence, and the Committee on Energy and Commerce 
                of the House of Representatives.
            (2) Commission.--The term ``Commission'' means the 
        Commission on the Prevention of Weapons of Mass Destruction 
        Proliferation and Terrorism established by section 1851 of the 
        Implementing Recommendation of the 9/11 Commission Act of 2007 
        (Public Law 110-53; 121 Stat. 501).
            (3) Coordinator.--The term ``Coordinator'' means the 
        President's Coordinator for the Prevention of Weapons of Mass 
        Destruction Proliferation and Terrorism established by section 
        1841(b)(1) of the Implementing Recommendations of the 9/11 
        Commission Act of 2007 (50 U.S.C. 2931(b)(1)).
            (4) Deputy coordinator.--The term ``Deputy Coordinator'' 
        means the Deputy United States Coordinator for the Prevention 
        of Weapons of Mass Destruction Proliferation and Terrorism 
        established under section 1841(b)(2) of the Implementing 
        Recommendations of the 9/11 Commission Act of 2007 (50 U.S.C. 
        2931(b)(2)).
            (5) Highly enriched uranium.--The term ``highly enriched 
        uranium'' means uranium that contains at least 20 percent of 
        the uranium isotope 235.
            (6) IAEA.--The term ``IAEA'' means the International Atomic 
        Energy Agency.
            (7) Special nuclear material.--The term ``special nuclear 
        material'' has the meaning given the term in section 11(aa) of 
        the Atomic Energy Act of 1954 (42 U.S.C. 2014(aa)).

SEC. 352. REPORT ON UNITED STATES NUCLEAR NONPROLIFERATION EFFORTS.

    (a) In General.--Not later than 1 year after the date of the 
enactment of this Act, and annually thereafter, the Coordinator shall 
submit to the appropriate congressional committees an unclassified 
report, with classified annexes as necessary, on the findings and 
recommendations of the Commission described in subsection (b).
    (b) Content.--The report required under subsection (a) shall 
include the following:
            (1) A description of the financial incentives the United 
        States Government used during the previous year to promote 
        civilian nuclear energy abroad, including the types, amounts, 
        and recipients of such financial incentives.
            (2) A description of the actions the United States 
        Government has taken for improving the secure civilian storage 
        of, and minimizing the use and export of, weapons useable 
        highly enriched uranium during the previous year, and the 
        amount the United States Government spends annually to fuel 
        United States civilian reactors that use highly enriched 
        uranium.
            (3) A description of the actions that have been taken by 
        the United States Government to implement title V of the 
        Nuclear Non-Proliferation Act of 1978 (22 U.S.C. 3261 et seq.) 
        during the previous year and any obstacles pertaining to its 
        implementation with recommended actions.
            (4) A description of the steps the United States Government 
        has taken during the previous year to upgrade the physical 
        security of civilian nuclear reactors in the United States that 
        store or handle special nuclear material.
            (5) A United States Government assessment of the 
        capabilities of the IAEA, completed in consultation with all 
        relevant United States Government agencies, including the 
        Office of the Director of National Intelligence, including--
                    (A) the ability of IAEA to meet its own timely 
                detection inspection goals;
                    (B) the ability of IAEA to afford timely detection 
                of possible military diversions and whether or not the 
                IAEA has met its own timely detection inspection goals;
                    (C) recommendations for whether and how the IAEA 
                should update its definitions of how much special 
                nuclear material is needed to create a nuclear bomb and 
                how long it takes to convert such special nuclear 
                material into nuclear bombs; and
                    (D) recommendations regarding how the United States 
                could improve the capabilities of the IAEA.
    (c) Absence of the Coordinator and the Deputy Coordinator.--The 
President shall submit the report required under this section if 
neither the Coordinator nor the Deputy Coordinator have been appointed 
pursuant to section 1841(b)(3) of the Implementing Recommendation of 
the 9/11 Commission Act of 2007 (50 U.S.C. 2931(b)(3)).

SEC. 353. REPORT ON UNITED STATES WORK WITH IAEA ON NUCLEAR 
              NONPROLIFERATION.

    (a) In General.--Not later than 1 year after the date of the 
enactment of this Act, the Coordinator shall submit to the appropriate 
congressional committees an unclassified report, with classified 
annexes as necessary, on the findings and recommendations of the 
Commission under subsection (b).
    (b) Content.--The report required under subsection (a) shall 
include details about the progress of the work of the United States 
Government with the IAEA Director General to--
            (1) establish a safeguards user fee, whereby countries with 
        inspected facilities would be assessed a fee to help cover the 
        costs of IAEA inspections;
            (2) assess whether the IAEA can meet its own inspection 
        goals, whether those goals afford timely detection to account 
        for a bomb's worth of special nuclear material, whether there 
        are situations in which achieving those goals is not possible, 
        and what corrective actions, if any, might help the IAEA to 
        achieve its inspection goals;
            (3) promote transparency at suspect sites and to encourage 
        IAEA member states to maintain a registry, made available to 
        other IAEA members upon request, of all foreign visitors at 
        safeguarded sites;
            (4) provide for the acquisition and implementation of near-
        real-time surveillance equipment in the use of safeguards, 
        including at sites where nuclear fuel rods are located;
            (5) require that the transfer of all items on the Nuclear 
        Suppliers Group dual-use and trigger lists be reported to the 
        IAEA in advance and develop a system to process and analyze the 
        information; and
            (6) provide recommendations on how the United States could 
        improve the capabilities of the IAEA.
    (c) Absence of the Coordinator and the Deputy Coordinator.--The 
President shall submit the report required under this section if 
neither the Coordinator nor the Deputy Coordinator have been appointed 
pursuant to section 1841(b)(3) of the Implementing Recommendation of 
the 9/11 Commission Act of 2007 (50 U.S.C. 2931(b)(3)).

SEC. 354. AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated such sums as may be 
necessary to carry out the reporting requirements under sections 352 
and 353 for fiscal year 2010 and each subsequent year thereafter.

         Subtitle D--Energy Development Program Implementation

SEC. 361. FINDINGS.

    Congress finds that--
            (1) title V of the Nuclear Non-Proliferation Act of 1978 
        (22 U.S.C. 3261 et seq.) requires the United States to work 
        with developing countries in assessing and finding ways to meet 
        their energy needs through alternatives to nuclear energy that 
        are consistent with economic factors, material resources, and 
        environmental protection; and
            (2) in December 2008, the Commission on the Prevention of 
        Weapons of Mass Destruction Proliferation and Terrorism noted 
        that the Federal Government had failed to implement title V of 
        that Act and recommended that the Federal Government implement 
        title V of that Act to help reduce the risk of nuclear 
        proliferation.

SEC. 362. DEFINITIONS.

    In this title:
            (1) Appropriate congressional committees.--The term 
        ``appropriate congressional committees'' means--
                    (A) the Committee on Homeland Security and 
                Governmental Affairs, the Committee on Foreign 
                Relations, the Committee on Energy and Natural 
                Resources, and the Committee on Appropriations of the 
                Senate; and
                    (B) the Committee on Oversight and Government 
                Reform, the Committee on Foreign Affairs, the Committee 
                on Energy and Commerce, and the Committee on 
                Appropriations of the House of Representatives.
            (2) Energy development program.--The term ``energy 
        development program'' means the program established under title 
        V of the Nuclear Non-Proliferation Act of 1978 (22 U.S.C. 3261 
        et seq.).
            (3) Secretary.--The term ``Secretary'' means the Secretary 
        of Energy, in cooperation with the Secretary of State and the 
        Administrator of the United States Agency for International 
        Development.

SEC. 363. ENERGY DEVELOPMENT PROGRAM IMPLEMENTATION.

    (a) Strategic and Implementation Plans.--
            (1) In general.--Not later than 180 days after the date of 
        enactment of this Act, the Secretary shall develop--
                    (A) strategic plans for the energy development 
                program consistent with title V of the Nuclear Non-
                Proliferation Act of 1978 (22 U.S.C. 3261 et seq.); and
                    (B) implementation plans for the energy development 
                program consistent with title V of that Act.
            (2) Review of plans.--Not later than 180 days after the 
        date of enactment of this Act, the Secretary shall submit the 
        strategic and implementation plans to the appropriate 
        congressional committees for review.
    (b) Implementation.--Not later than 180 days after the date on 
which the plans are submitted to the appropriate congressional 
committees for review under subsection (a), the Secretary shall 
implement the plans.
    (c) Allowances, Privileges, and Other Benefits.--
            (1) In general.--A Federal employee serving in an exchange 
        capacity in the energy development program shall be considered 
        to be detailed.
            (2) Employing agency.--For the purpose of preserving 
        allowance, privileges, rights, seniority, and other benefits 
        with respect to the Federal employee, the employee shall be--
                    (A) considered an employee of the original 
                employing agency; and
                    (B) entitled to the pay, allowances, and benefits 
                from funds available to the original employing agency.
    (d) Authorization of Appropriations.--There are authorized to be 
appropriated such sums as are necessary to carry out this section for 
fiscal year 2010 and each fiscal year thereafter.

SEC. 364. REPORTS.

    (a) Annual Report.--Not later than 1 year after the date of 
implementation of the plans under section 363(b) and every year 
thereafter, the Secretary shall report annually to the appropriate 
congressional committees on the plans consistent with section 501 of 
the Nuclear Non-Proliferation Act of 1978 (22 U.S.C. 3261).
    (b) Report on the Alternative Energy Corps.--
            (1) Cooperative activities.--Not later than 1 year after 
        the date of implementation of the plans under section 363(b), 
        the Secretary shall report to the appropriate congressional 
        committees on the feasibility of expanding the cooperative 
        activities established pursuant to section 502(c) of the 
        Nuclear Non-Proliferation Act of 1978 (22 U.S.C. 3262) into an 
        international cooperative effort.
            (2) Requirements.--The report required under paragraph (1) 
        shall include an analysis and description of--
                    (A) an Alternative Energy Corps that is designed to 
                encourage large numbers of technically trained 
                volunteers to live and work in developing countries for 
                varying periods of time for the purpose of engaging in 
                projects to aid in meeting the energy needs of those 
                countries through--
                            (i) the search for and use of non-nuclear 
                        indigenous energy resources; and
                            (ii) the application of suitable 
                        technology, including the widespread use of 
                        renewable and unconventional energy 
                        technologies; and
                    (B) other mechanisms that are available to 
                coordinate an international effort to develop, 
                demonstrate, and encourage the use of suitable 
                technologies in developing countries.

                   TITLE IV--GOVERNMENT ORGANIZATION

SEC. 401. INTELLIGENCE ON WEAPONS OF MASS DESTRUCTION.

    (a) Definitions.--In this section:
            (1) Appropriate committees of congress.--The term 
        ``appropriate committees of Congress'' means--
                    (A) the Select Committee on Intelligence, the 
                Committee on Appropriations, the Committee on Armed 
                Services, and the Committee on Homeland Security and 
                Governmental Affairs of the Senate; and
                    (B) the Permanent Select Committee on Intelligence, 
                the Committee on Appropriations, the Committee on Armed 
                Services, and the Committee on Homeland Security of the 
                House of Representatives.
            (2) Director.--The term ``Director'' means the Director of 
        National Intelligence.
            (3) Intelligence community.--The term ``intelligence 
        community'' has the meaning given that term in section 3 of the 
        National Security Act of 1947 (50 U.S.C. 401a).
            (4) Weapon of mass destruction.--The term ``weapon of mass 
        destruction'' has the meaning given that term in section 1403 
        of the Defense Against Weapons of Mass Destruction Act of 1996 
        (50 U.S.C. 2302).
    (b) Strategy for Improving Intelligence Capabilities.--
            (1) Requirement for strategy.--Not later than 120 days 
        after the date of the enactment of this Act, the Director shall 
        develop, implement, and submit to the appropriate committees of 
        Congress a strategy for improving the capabilities of the 
        United States for the collection, analysis, and dissemination 
        of intelligence related to weapons of mass destruction, 
        including intelligence related to the relationship between 
        weapons of mass destruction and terrorism.
            (2) Elements.--The strategy required by paragraph (1) shall 
        include a description of each of the following:
                    (A) Methods for recruitment, training, and 
                retention of individuals with expertise in the 
                collection, analysis, and dissemination of intelligence 
                related to weapons of mass destruction, including 
                appropriate scientific and technical expertise.
                    (B) Methods for collaboration, as appropriate, with 
                individuals with expertise described in subparagraph 
                (A) who are employed by nongovernmental entities or who 
                are foreign nationals.
                    (C) Analytic questions and gaps in information 
                related to intelligence on weapons of mass destruction, 
                including such intelligence concerning state actors and 
                nonstate actors, such as smugglers, criminal 
                enterprises, and financiers, that will be used to guide 
                intelligence collection.
                    (D) Activities for the development of innovative 
                human and technical intelligence collection 
                capabilities and techniques.
                    (E) Actions necessary to increase the effectiveness 
                and efficiency of the sharing of intelligence on 
                weapons of mass destruction throughout the intelligence 
                community, including a description of statutory, 
                regulatory, policy, technical, security, or other 
                barriers that prevent such sharing, and, as 
                appropriate, the development of uniform standards 
                across the intelligence community for such sharing.
                    (F) Actions necessary to identify and overcome 
                activities by a foreign government or person to deny or 
                deceive the intelligence community concerning 
                intelligence regarding weapons of mass destruction.
                    (G) Specific objectives to be accomplished during 
                each year of the first 5-year period after the strategy 
                is submitted to the appropriate committees of Congress 
                and tasks to accomplish such objectives, including--
                            (i) a list prioritizing such objectives and 
                        tasks; and
                            (ii) a schedule for meeting such objectives 
                        and carrying out such tasks.
                    (H) Assignments of roles and responsibilities to 
                elements of the intelligence community to implement the 
                strategy.
                    (I) The personnel, financial, and other resources 
                necessary to implement the strategy and a plan for 
                obtaining such resources.
                    (J) Metrics for measuring the effectiveness and 
                efficiency of the strategy.
                    (K) A schedule for assessment, review, and, as 
                appropriate, revision of the strategy.
            (3) Requirement to consult.--In developing the strategy 
        required by paragraph (1), the Director shall consult with the 
        Secretary of Homeland Security, the Secretary of Defense, and 
        other officials as the Director determines appropriate.
            (4) Form.--The strategy required by paragraph (1) may be 
        submitted in a classified form.
    (c) Requirement for Reports.--
            (1) In general.--Not less frequently than once during each 
        180-day period after the date of the submission of the strategy 
        required by subsection (b)(1) to the appropriate committees of 
        Congress, the Director shall submit to the appropriate 
        committees of Congress a report on the implementation of such 
        strategy.
            (2) Content.--Each report required by paragraph (1) shall 
        include the following:
                    (A) An assessment of whether the objectives and 
                tasks referred to in subsection (b)(2)(G) have been 
                accomplished in accordance with the proposed schedule.
                    (B) Data corresponding to the metrics required by 
                subsection (b)(2)(J) for measuring the effectiveness 
                and efficiency of the strategy.
                    (C) An assessment of the actions of the elements of 
                the intelligence community to implement the strategy.
                    (D) An assessment of whether the personnel, 
                financial, and other resources available are sufficient 
                to implement the strategy.
                    (E) A description of any revisions to, or plans to 
                revise, any component of the strategy.
            (3) Sunset date.--The requirement set forth in paragraph 
        (1) shall terminate three years after the date of the 
        submission of the strategy required by subsection (b)(1) to the 
        appropriate committees of Congress.

SEC. 402. INTELLIGENCE COMMUNITY LANGUAGE CAPABILITIES AND CULTURAL 
              KNOWLEDGE.

    (a) Definitions.--In this section, the terms ``appropriate 
committees of Congress'', ``Director'', ``intelligence community'', and 
``weapons of mass destruction'' have the meaning given such terms in 
section 401.
    (b) Strategy for Improving Language Capabilities and Cultural 
Knowledge.--
            (1) Requirement for strategy.--Not later than 180 days 
        after the date of the enactment of this Act, the Director shall 
        develop, implement, and submit to the appropriate committees of 
        Congress a strategy for improving the recruiting, training, and 
        retention of employees of the elements of the intelligence 
        community who possess critical language capabilities and 
        cultural backgrounds relevant to countering terrorism or 
        collecting, analyzing, and disseminating intelligence related 
        to weapons of mass destruction, including individuals who are 
        first or second-generation United States citizens and United 
        States citizens with immediate relatives who are foreign 
        nationals.
            (2) Elements.--The strategy required by paragraph (1) shall 
        include a description of each of the following:
                    (A) The current and projected needs of the 
                intelligence community during the ten-year period, 
                beginning on the date the strategy is submitted to the 
                appropriate committees of Congress, for employees with 
                critical language capabilities and cultural backgrounds 
                relevant to countering terrorism or collecting, 
                analyzing, and disseminating intelligence related to 
                weapons of mass destruction.
                    (B) Actions necessary to recruit, train, and retain 
                employees with such capabilities or backgrounds.
                    (C) Barriers to effective recruitment, training, 
                and retention of employees with such capabilities or 
                backgrounds, including security clearance processing, 
                and actions necessary to overcome such barriers.
                    (D) Specific objectives to be accomplished during 
                each year of the first 5-year period beginning on the 
                date that the strategy is submitted to the appropriate 
                committees of Congress and tasks to accomplish such 
                objectives, including--
                            (i) a list prioritizing such objectives and 
                        tasks; and
                            (ii) a schedule for meeting such objectives 
                        and carrying out such tasks.
                    (E) Assignments of roles and responsibilities to 
                elements of the intelligence community to carry out the 
                strategy.
                    (F) The personnel, financial, and other resources 
                necessary to implement the strategy, and a plan for 
                obtaining such resources.
                    (G) Metrics for measuring the effectiveness and 
                efficiency of the strategy.
                    (H) A schedule for assessment, review, and, as 
                appropriate, revision of the strategy.
    (c) Requirement for Reports.--
            (1) In general.--Not less frequently than once during each 
        180-day period after the date of the submission of the strategy 
        required by subsection (b)(1) to the appropriate committees of 
        Congress, the Director shall submit to the appropriate 
        committees of Congress a report on the implementation of such 
        strategy.
            (2) Content.--Each report required by paragraph (1) shall 
        include the following:
                    (A) An assessment of whether the objectives 
                referred to in subsection (b)(2)(D) have been 
                accomplished in accordance with the proposed schedule.
                    (B) Data corresponding to the metrics required by 
                subsection (b)(2)(G) for measuring the effectiveness 
                and efficiency of the strategy.
                    (C) An assessment of the actions by the elements of 
                the intelligence community to implement the strategy.
                    (D) An assessment of whether the personnel, 
                financial, and other resources available are sufficient 
                to implement the strategy.
                    (E) A description of any revisions to, or plans to 
                revise, any component of the strategy.
            (3) Sunset date.--The requirement set forth in paragraph 
        (1) shall terminate 5 years after the date of the submission of 
        the strategy required by subsection (b)(1) to the appropriate 
        committees of Congress.

SEC. 403. COUNTERTERRORISM TECHNOLOGY ASSESSMENTS.

    (a) Agency Defined.--In this section, the term ``agency'' means any 
department, agency, or instrumentality of the executive branch of the 
Government.
    (b) Requirement for Interdisciplinary Capability of the 
Congressional Research Service.--
            (1) In general.--The Director of the Congressional Research 
        Service shall establish an interdisciplinary capability to 
        further the Congressional Research Service's responsibilities 
        to advise Congress pursuant to section 203(d) of the 
        Legislative Reorganization Act of 1946 (2 U.S.C. 166(d)) 
        concerning technology or technological applications developed 
        or used for countering terrorism.
            (2) Authorization of appropriations.--There is authorized 
        to be appropriated to implement this subsection $2,000,000 for 
        each of fiscal years 2011 through 2013.
    (c) Assessments of Available Technology.--
            (1) Requirement for assessments.--Pursuant to section 717 
        of title 31, United States Code, the Comptroller General of the 
        United States shall conduct assessments of technology or 
        technological applications that are--
                    (A) being developed or used or are available to be 
                used for countering terrorism by a program or activity 
                that is carried out by an agency; or
                    (B) proposed to be developed or used or are 
                potentially available to be used pursuant to--
                            (i) a legislative proposal under 
                        consideration by a committee of the Senate or 
                        the House of Representatives; or
                            (ii) a recommendation submitted to Congress 
                        by the President or an agency.
            (2) Scope of assessment.--Each assessment of a technology 
        or technological application carried out under paragraph (1) 
        shall evaluate the actual or anticipated impact, effectiveness, 
        or efficiency of the technology or technological application 
        for countering terrorism, including evaluating--
                    (A) any test results related to the technology or 
                technological application;
                    (B) any alternatives to the technology or 
                technological application;
                    (C) the actual or anticipated operational 
                requirements of the technology or technological 
                application, including the logistical needs, personnel 
                training, and procedures for utilizing the technology 
                or technological application;
                    (D) the actual or anticipated costs, as compared to 
                the actual or anticipated benefits of the technology or 
                technological application;
                    (E) any actual or anticipated countermeasures to 
                the technology or technological application by 
                terrorists; and
                    (F) technology assessments or related reports 
                prepared by or for an agency for the technology or 
                technological application.
            (3) Technology assessment capability.--
                    (A) Requirement to establish.--The Comptroller 
                General of the United States shall establish an 
                interdisciplinary capability to perform the assessments 
                required by paragraph (1) that includes officers and 
                employees who have expertise in science, engineering, 
                technology, homeland security, counterterrorism, or 
                other fields that the Comptroller General considers 
                appropriate to conduct such assessments.
                    (B) Appointment and procurement.--The Comptroller 
                General shall appoint, pay, and assign officers and 
                employees pursuant to subsection (a) of section 731 of 
                title 31, United States Code, and may procure the 
                services or assistance of experts and consultants 
                pursuant to subsection (e) of such section, in order to 
                acquire the expertise in science, technology, or other 
                fields necessary to conduct the assessments required by 
                paragraph (1).
            (4) Authorization of appropriations.--There is authorized 
        to be appropriated to implement this subsection $2,000,000 for 
        each of fiscal years 2011 through 2013.
    (d) Assessments of Future Technology.--
            (1) Requirement for assessments.--The Comptroller General 
        of the United States shall, as appropriate, enter into 
        arrangements with the National Academy of Sciences to assess 
        technology and technological applications that are being 
        developed or could be developed for purposes of countering 
        terrorism.
            (2) Scope of assessments.--Each assessment carried out 
        under paragraph (1) shall include--
                    (A) determining trends related to the development 
                of technology or technological applications and their 
                implications for countering terrorism;
                    (B) identifying particular technology or 
                technological applications that potentially may become 
                available or are necessary for countering terrorism; 
                and
                    (C) recommending investments to be made by an 
                agency in the development of particular technology or 
                technological applications.
            (3) Authorization of appropriations.--There is authorized 
        to be appropriated to implement this subsection $2,000,000 for 
        each of fiscal years 2011 through 2013.

          TITLE V--EMERGENCY MANAGEMENT AND CITIZEN ENGAGEMENT

SEC. 501. COMMUNICATION OF THREAT INFORMATION AND ALERTS.

    (a) Finding.--Congress finds that the Commission on the Prevention 
of Weapons of Mass Destruction Proliferation and Terrorism recommended 
that ``the Federal Government should practice greater openness of 
public information so that citizens better understand the threat and 
the risk this threat poses to them.''.
    (b) Terrorism Threat Awareness.--Section 203 of the Homeland 
Security Act of 2002 (6 U.S.C. 124) is amended by adding at the end the 
following:
    ``(c) Terrorism Threat Awareness.--
            ``(1) Terrorism threat awareness.--The Secretary, in 
        coordination with the Attorney General, shall ensure that 
        information concerning terrorist threats is available to the 
        general public within the United States.
            ``(2) Threat bulletins.--
                    ``(A) In general.--Consistent with the requirements 
                of subsection (b), the Secretary shall on a timely 
                basis prepare unclassified terrorism-related threat and 
                risk assessments.
                    ``(B) Requirements.--Each assessment required under 
                subparagraph (A) shall--
                            ``(i) include guidelines for the general 
                        public for preventing and responding to acts of 
                        terrorism; and
                            ``(ii) be made available on the website of 
                        the Department and other publicly accessible 
                        websites, communication systems, and 
                        information networks.
            ``(3) Guidelines for state, local, and tribal 
        governments.--The Secretary shall provide to State, local, and 
        tribal governments written guidelines on how to disseminate 
        information about terrorism-related threats and risks to the 
        general public within their jurisdictions.
            ``(4) Use of existing resources.--The Secretary shall use 
        websites, communication systems, and information networks in 
        operation on the date of an assessment under this subsection to 
        satisfy the requirements of paragraph (2)(B)(ii).''.
    (c) Responsibilities of the Secretary.--Section 201(d)(8) of the 
Homeland Security Act of 2002 (6 U.S.C. 121(d)(8)) is amended by 
striking ``and to agencies of State'' and all that follows and 
inserting ``to State, local, tribal, and private entities with such 
responsibilities, and, as appropriate, to the general public, in order 
to assist in deterring, preventing, or responding to acts of terrorism 
against the United States.''.
    (d) Reporting Requirement.--Not later than 180 days after the date 
of enactment of this Act, the Secretary of Homeland Security shall 
submit to the Committee on Homeland Security and Governmental Affairs 
of the Senate and the Committee on Homeland Security of the House of 
Representatives a report on the implementation of section 203 of the 
Homeland Security Act of 2002, as amended by subsection (b).

SEC. 502. GUIDELINES CONCERNING WEAPONS OF MASS DESTRUCTION.

    (a) Establishment of Guidelines.--Not later than 1 year after the 
date of enactment of this Act, the Secretary of Homeland Security 
shall--
            (1) develop guidelines, in coordination with State, local, 
        and tribal governments and representatives of emergency 
        response provider organizations, for police, fire, emergency 
        medical services, emergency management, and public health 
        personnel, for responding to an explosion or release of 
        nuclear, biological, radiological, or chemical material; and
            (2) make the guidelines developed under paragraph (1) 
        available to State, local, and tribal governments, 
        nongovernmental organizations, and the private sector.
    (b) Contents.--The guidelines developed under subsection (a)(1) 
shall contain, at a minimum--
            (1) protective action guidelines for ensuring the health 
        and safety of emergency response providers;
            (2) information regarding the effects of the biological, 
        chemical, or radiological agent on those exposed to the agent; 
        and
            (3) information regarding how emergency response providers 
        and mass care facilities may most effectively deal with 
        individuals affected by an incident involving a nuclear, 
        biological, radiological, or chemical material.
    (c) Review and Revision of Guidelines.--The Secretary of Homeland 
Security shall--
            (1) not less frequently than every 2 years, review the 
        guidelines developed under subsection (a)(1);
            (2) make revisions to the guidelines as appropriate; and
            (3) make the revised guidelines available to State, local, 
        and tribal governments, nongovernmental organizations, the 
        private sector, and the general public.
    (d) Procedures for Developing and Revising Guidelines.--In carrying 
out the requirements of this section, the Secretary of Homeland 
Security shall establish procedures--
            (1) to inventory any existing relevant hazardous material 
        response guidelines;
            (2) to enable the public to submit recommendations of areas 
        for which guidelines could be developed under subsection 
        (a)(1);
            (3) to determine which entities should be consulted in 
        developing or revising the guidelines;
            (4) to prioritize, on a regular basis, guidelines that 
        should be developed or revised; and
            (5) to develop and disseminate the guidelines in accordance 
        with the prioritization under paragraph (4).
    (e) Consultations.--The Secretary of Homeland Security shall 
develop and revise the guidelines developed under subsection (a)(1), 
and the procedures required under subsection (d), in consultation 
with--
            (1) the Secretary of Energy;
            (2) the Secretary of Health and Human Services;
            (3) the Secretary of Defense;
            (4) other Federal departments and agencies, as appropriate;
            (5) the National Advisory Council established under section 
        508 of the Homeland Security Act of 2002 (6 U.S.C. 318);
            (6) State, local, and tribal governments; and
            (7) nongovernmental organizations and private industry.
    (f) Reporting Requirements.--Not later than 180 days after the date 
of enactment of this Act, 1 year after such date of enactment, and 
annually thereafter, the Secretary of Homeland Security shall provide 
the Committee on Homeland Security and Governmental Affairs of the 
Senate and the Committee on Homeland Security of the House of 
Representatives with--
            (1) a description of the procedures established under 
        subsection (d);
            (2) any guidelines in effect on the date of the report;
            (3) a list of entities that to which the guidelines 
        described in paragraph (2) were disseminated;
            (4) a plan for reviewing the guidelines described in 
        paragraph (2), in accordance with subsection (e);
            (5) the prioritized list of the guidelines required under 
        subsection (d)(4), and the methodology used by the Secretary of 
        Homeland Security for such prioritization; and
            (6) a plan for developing, revising, and disseminating the 
        guidelines.
    (g) Definition.--In this section, the term ``emergency response 
provider'' has the meaning given that term in section 2 of the Homeland 
Security Act of 2002 (6 U.S.C. 101).

SEC. 503. INDIVIDUAL AND COMMUNITY PREPAREDNESS.

    (a) Individual and Community Preparedness.--Title V of the Homeland 
Security Act of 2002 (6 U.S.C. 311 et seq.), as amended by section 221, 
is amended by adding at the end the following:

``SEC. 526. INDIVIDUAL AND COMMUNITY PREPAREDNESS.

    ``(a) In General.--The Administrator shall assist State, local, and 
tribal governments in improving and promoting individual and community 
preparedness for natural disasters, acts of terrorism, and other man-
made disasters, including incidents involving the use of weapons of 
mass destruction and other potentially catastrophic events, by--
            ``(1) developing guidelines and checklists of recommended 
        actions for individual and community prevention and 
        preparedness efforts and disseminating such guidelines and 
        checklists to communities and individuals;
            ``(2) disseminating the guidelines developed under section 
        502 of the Weapons of Mass Destruction Prevention and 
        Preparedness Act of 2009 to communities and individuals, as 
        appropriate;
            ``(3) compiling and disseminating information on best 
        practices in individual and community preparedness;
            ``(4) providing information and training materials in 
        support of individual and community preparedness efforts;
            ``(5) conducting individual and community preparedness 
        outreach efforts; and
            ``(6) such other actions as the Administrator determines 
        appropriate.
    ``(b) Coordination.--Where appropriate, the Administrator shall 
coordinate with private sector and nongovernmental organizations to 
promote individual and community preparedness.
    ``(c) Support for Voluntary Programs.--In carrying out the 
responsibilities described in subsection (a), the Administrator shall, 
where appropriate, work with and provide support to individual and 
community preparedness programs, such as the Community Emergency 
Response Team Program, Fire Corps, Medical Reserve Corps Program, 
Volunteers in Police Service, USAonWatch-Neighborhood Watch, and other 
voluntary programs, including those sponsored by nongovernmental 
organizations.
    ``(d) Director.--The Administrator shall appoint a Director of 
Community Preparedness to coordinate and oversee the individual and 
community preparedness efforts of the Agency.
    ``(e) Grants.--
            ``(1) In general.--The Administrator may make grants to 
        States to support individual and community preparedness 
        efforts, including through the Citizen Corps Program.
            ``(2) Appropriations.--There are authorized to be 
        appropriated for grants under this section--
                    ``(A) $15,000,000 for fiscal year 2011;
                    ``(B) $20,000,000 for fiscal year 2012; and
                    ``(C) $20,000,000 for fiscal year 2013.''.
    (b) Enhancing Preparedness.--Section 504(a) of the Homeland 
Security Act of 2002 (6 U.S.C. 314(a)) is amended--
            (1) by redesignating paragraphs (20) and (21) as paragraphs 
        (21) and (22), respectively; and
            (2) by inserting after paragraph (19) the following:
            ``(20) enhancing and promoting the preparedness of 
        individuals and communities for natural disasters, acts of 
        terrorism, and other man-made disasters;''.
    (c) Table of Contents.--The table of contents in section 1(b) of 
the Homeland Security Act of 2002 (6 U.S.C. 101 et seq.), as amended by 
section 221, is amended by inserting after the item relating to section 
525 the following:

``Sec. 526. Individual and community preparedness.''.
                                                       Calendar No. 705

111th CONGRESS

  2d Session

                                S. 1649

                          [Report No. 111-377]

_______________________________________________________________________

                                 A BILL

To prevent the proliferation of weapons of mass destruction, to prepare 
 for attacks using weapons of mass destruction, and for other purposes.

_______________________________________________________________________

                           December 17, 2010

                       Reported with an amendment